CDISC SDTM ControlledTerminology

CDISC SDTM Controlled Terminology, 2012-03-23
Legend:
CodeList
CodeListItem
NCI attributes
C66767Action Taken with Study Treatment
C66768Outcome of Event
C66780Age Span
C66781Age Unit
C66797Category for Inclusion/Exclusion
C66783CDISC System Organ Class
C66784Common Terminology Criteria for Adverse Events
C87162Common Terminology Criteria for Adverse Events V4.0
C66785Control Type
C66786Country
C66787Diagnosis Group
C66788Dictionary Name
C66789Not Done
C66790Ethnic Group
C66726Pharmaceutical Dosage Form
C66727Completion/Reason for Non-Completion
C66728Relation to Reference Period
C66729Route of Administration
C66769Severity/Intensity Scale for Adverse Events
C66731Sex
C66732Sex of Participants
C66733Size
C66734Domain Abbreviation
C66735Trial Blinding Schema
C66736Trial Indication Type
C66737Trial Phase
C66738Trial Summary Parameter Test Code
C67152Trial Summary Parameter Test Name
C66739Trial Type
C66770Units for Vital Signs Results
C66741Vital Signs Test Code
C67153Vital Signs Test Name
C66742No Yes Response
C65047Laboratory Test Code
C67154Laboratory Test Name
C71113Frequency
C71148Position
C71150ECG Result
C71153ECG Test Code
C71152ECG Test Name
C71151ECG Test Method
C71620Unit
C74456Anatomical Location
C74558Category for Disposition Event
C76351Skin Classification
C74561Skin Type
C74559Subject Characteristic Code
C76348Marital Status
C74457Race
C78731Drug Accountability Test Name
C78732Drug Accountability Test Code
C78733Specimen Condition
C78734Specimen Type
C78735Evaluator
C78736Reference Range Indicator
C78737Relationship Type
C78738Never/Current/Former Classification
C85495Microbiology Susceptibility Testing Result Category
C85492Method
C85494PK Parameter Units of Measure
C85491Microorganism
C85493PK Parameters
C85839PK Parameters Code
C90013ECG Lead
C95120Physical Properties Test Name
C95121Physical Properties Test Code
C96780Tumor Identification Results
C96782Tumor Response Assessment Test Code
C96781Tumor Response Assessment Test Name
C96785Tumor Response Result
C96784Tumor Identification Test Code
C96783Tumor Identification Test Name
C96777Medical Evaluator
C96779Oncology Tumor Properties Test Code
C96778Oncology Tumor Properties Test Name
C99073Laterality
C99074Directionality
C99075Portion/Totality
C88025Neoplasm Type
C99079Epoch
C99076Intervention Model
C99078Intervention Type
C99077Study Type
C100130Relationship to Subject

Codelist Definitions

OIDName
(CDISC Submission Value)
DataType
Extensible
NCI CodeCDISC SynonymCDISC DefinitionPreferred Term
CDISC Submission Value [ODM:CodedValue]
CL.C66767.ACNAction Taken with Study Treatment
(ACN)
text
Extensible: No
C66767Action Taken with Study TreatmentAction Taken with Study TreatmentCDISC SDTM Action Taken with Study Treatment Terminology
DOSE INCREASEDC49503An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)Dose Increased
DOSE NOT CHANGEDC49504An indication that a medication schedule was maintained. (NCI)Dose Not Changed
DOSE REDUCEDC49505An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)Dose Reduced
DRUG INTERRUPTEDC49501An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)Drug Interrupted
DRUG WITHDRAWNC49502An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)Drug Withdrawn
NOT APPLICABLEC48660NA;Not ApplicableDetermination of a value is not relevant in the current context. (NCI)Not Applicable
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66768.OUTOutcome of Event
(OUT)
text
Extensible: No
C66768Outcome of EventA condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)CDISC SDTM Adverse Event Outcome Terminology
FATALC48275Grade 5;5;FATALThe termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
NOT RECOVERED/NOT RESOLVEDC49494One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)Not Recovered or Not Resolved
RECOVERED/RESOLVEDC49498One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)Recovered or Resolved
RECOVERED/RESOLVED WITH SEQUELAEC49495One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)Recovered or Resolved with Sequelae
RECOVERING/RESOLVINGC49496One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)Recovering or Resolving
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66780.AGESPANAge Span
(AGESPAN)
text
Extensible: Yes
C66780Age SpanSubgroups of populations based on age. (NCI)CDISC SDTM Age Group Terminology
ADOLESCENT (12-17 YEARS)C27954A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)Adolescent
ADULT (18-65)C49685A person from 18 years to 65 years of age. (NCI)Adult 18-65 Years Old
CHILDREN (2-11 YEARS)C49683A person from 2 years to 11 years of age. (NCI)Children 2-11 Years Old
ELDERLY (> 65)C16268An age group comprised by people 65 years of age and older. (NCI)Elderly
IN UTEROC49641The period of time during which the embryo or fetus is present in the uterus of the female. Also describes the location of the embryo or fetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)In Utero
INFANT AND TODDLER (28 DAYS - 23 MONTHS)C49643A person from 28 days to 23 months of age. (NCI)Infant And Toddler
NEWBORN (0-27 DAYS)C16731An infant during the first month after birth. (NCI)Newborn
PRETERM NEWBORN INFANTSC49642An infant born prior to completion of the normal gestation period. (NCI)Preterm Newborn Infant
Back to top
CL.C66781.AGEUAge Unit
(AGEU)
text
Extensible: No
C66781Age UnitThose units of time that are routinely used to express the age of a subject.CDISC SDTM Age Unit Terminology
DAYSC25301The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)Day
HOURSC25529Hour;hrA unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)Hour
MONTHSC29846One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)Month
WEEKSC29844Any period of seven consecutive days. (NCI)Week
YEARSC29848The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)Year
Back to top
CL.C66797.IECATCategory for Inclusion/Exclusion
(IECAT)
text
Extensible: No
C66797Category for Inclusion/ExclusionA collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)CDISC SDTM Category for Inclusion And Or Exclusion Terminology
EXCLUSIONC25370List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)Exclusion Criteria
INCLUSIONC25532The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)Inclusion Criteria
Back to top
CL.C66783.SOCCDISC System Organ Class
(SOC)
text
Extensible: No
C66783CDISC System Organ ClassTerms at the highest level of the CDISC system organ class terminology.CDISC SDTM System Organ Class Terminology
BLOOD AND LYMPHATIC SYSTEM DISORDERSC35814Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)Hematopoietic and Lymphoid System Disorder
CARDIAC DISORDERSC3079Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)Heart Disorder
CONGENITAL, FAMILIAL AND GENETIC DISORDERSC49399A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characteristic set of symptoms and signs. (NCI)Congenital, Familial and Genetic Disorder Class
EAR AND LABYRINTH DISORDERSC49400Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)Ear and Labyrinth Disorder Class
ENDOCRINE DISORDERSC3009Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)Endocrine Disorder
EYE DISORDERSC26767Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)Eye Disorder
GASTROINTESTINAL DISORDERSC2990Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)Gastrointestinal Disorder
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONSC49401A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)General Disorders and Administration Site Conditions Class
HEPATOBILIARY DISORDERSC3959Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)Hepatobiliary Disorder
IMMUNE SYSTEM DISORDERSC3507A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)Immune System Disorder
INFECTIONS AND INFESTATIONSC26726A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)Infectious Disorder
INJURY, POISONING AND PROCEDURAL COMPLICATIONSC49402A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)Injury, Poisoning and Procedural Complication Class
INVESTIGATIONSC41198The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)Investigation
METABOLISM AND NUTRITION DISORDERSC49403A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)Metabolism and Nutrition Disorder Class
MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERSC27574Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)Connective and Soft Tissue Disorder
NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)C3262An abnormal tissue growth resulted from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)Neoplasm
NERVOUS SYSTEM DISORDERSC26835Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)Nervous System Disorder
PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONSC49404A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)Pregnancy, Puerperium and Perinatal Condition Class
PSYCHIATRIC DISORDERSC2893Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)Psychiatric Disorder
RENAL AND URINARY DISORDERSC3430Disorders of any part of the urologic system. (NCI)Urinary System Disorder
REPRODUCTIVE SYSTEM AND BREAST DISORDERSC49405Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)Reproductive System and Breast Disorder Class
RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERSC27669Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)Respiratory and Thoracic Disorder
SKIN AND SUBCUTANEOUS TISSUE DISORDERSC3371Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)Skin Disorder
SOCIAL CIRCUMSTANCESC20188A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)Social Circumstances
SURGICAL AND MEDICAL PROCEDURESC25218A particular course of action intended to achieve a result. (NCI)Intervention or Procedure
VASCULAR DISORDERSC35117Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)Vascular Disorder
Back to top
CL.C66784.TOXGRCommon Terminology Criteria for Adverse Events
(TOXGR)
text
Extensible: No
C66784Common Terminology Criteria for Adverse EventsA standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology
1C41338Grade 1;1A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.Mild Adverse Event
2C41339Grade 2;2A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.Moderate Adverse Event
3C41340Grade 3;3A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.Severe Adverse Event
4C41337Grade 4;4;LIFE THREATENINGAn adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.Life Threatening or Disabling Adverse Event
5C48275Grade 5;5;FATALThe termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
Back to top
CL.C87162.TOXGRCommon Terminology Criteria for Adverse Events V4.0
(TOXGR)
text
Extensible: No
C87162Common Terminology Criteria for Adverse Events V4.0The version 4.0 standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used to study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology Version 4.0
0C75533ABSENT;Grade 0;0Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.Absent Adverse Event
1C84263MILD;Grade 1;1An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.Mild Adverse Event
2C84264MODERATE;Grade 2;2An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).Moderate Adverse Event
3C84265SEVERE;Grade 3;3An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).Severe Adverse Event
4C84266LIFE THREATENING;Grade 4;4An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken; or that causes blindness or deafness.Life Threatening Adverse Event
5C48275FATAL;Grade 5;5The termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
Back to top
CL.C66785.TCNTRLControl Type
(TCNTRL)
text
Extensible: Yes
C66785Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).CDISC SDTM Control Type Terminology
ACTIVEC49649A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].Active Control
NONEC41132No person or thing, nobody, not any. (NCI)None
PLACEBOC49648Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)Placebo Control
Back to top
CL.C66786.COUNTRYCountry
(COUNTRY)
text
Extensible: No
C66786CountryA collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)CDISC SDTM Country Terminology
ABWC17884ARUBAIsland in the Caribbean Sea, north of Venezuela. (NCI)Aruba
AFGC16267AFGHANISTANA country in Southern Asia, north and west of Pakistan, east of Iran. (NCI)Afghanistan
AGOC16292ANGOLAA country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo. (NCI)Angola
AIAC20133ANGUILLAAn island in the Caribbean Sea, east of Puerto Rico. (NCI)Anguilla
ALAC44481ALAND ISLANDSAn archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland. (NCI)Aland Islands
ALBC16271ALBANIAA country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro. (NCI)Albania
ANDC16289ANDORRAA country in Southwestern Europe, between France and Spain. (NCI)Andorra
ANTC16904NETHERLANDS ANTILLESA country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands. (NCI)Netherlands Antilles
AREC17232UNITED ARAB EMIRATESA country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia. (NCI)United Arab Emirates
ARGC16305ARGENTINAA country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (NCI)Argentina
ARMC16306ARMENIAA country in Southwestern Asia, east of Turkey. (NCI)Armenia
ASMC17739AMERICAN SAMOAA group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand. (NCI)American Samoa
ATAC18007ANTARCTICAThe continent lying mostly south of the Antarctic Circle. (NCI)Antarctica
ATFC20105FRENCH SOUTHERN TERRITORIESIslands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia. (NCI)French Southern Territories
ATGC16303ANTIGUA AND BARBUDAIslands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico. (NCI)Antigua and Barbuda
AUSC16311AUSTRALIAThe continent between the Indian Ocean and the South Pacific Ocean. (NCI)Australia
AUTC16312AUSTRIAA country in Central Europe, north of Italy and Slovenia. (NCI)Austria
AZEC16316AZERBAIJANA country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia. (NCI)Azerbaijan
BDIC16371BURUNDIA country in Central Africa, east of Democratic Republic of the Congo. (NCI)Burundi
BELC16329BELGIUMA country in Western Europe, bordering the North Sea, between France and the Netherlands. (NCI)Belgium
BENC16333BENIN REPUBLICA country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo. (NCI)Benin
BFAC16369BURKINA FASOA country in Western Africa, north of Ghana. (NCI)Burkina Faso
BGDC16323BANGLADESHA country in Southern Asia, bordering the Bay of Bengal, between Burma and India. (NCI)Bangladesh
BGRC16368BULGARIAA country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. (NCI)Bulgaria
BHRC16322BAHRAINAn archipelago in the Persian Gulf, east of Saudi Arabia. (NCI)Bahrain
BHSC16321BAHAMASA chain of islands in the North Atlantic Ocean, southeast of Florida. (NCI)Bahamas
BIHC16361BOSNIA-HERZEGOVINAA country in Southeastern Europe, bordering the Adriatic Sea and Croatia. (NCI)Bosnia and Herzegovina
BLMC83609SAINT BARTHELEMYAn island in the Caribbean sea, between Saint Martin and Saint Kitts and Nevis. (NCI)Saint Barthelemy
BLRC16372BELARUSA country in Eastern Europe, east of Poland. (NCI)Belarus
BLZC16331BELIZEA country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico. (NCI)Belize
BMUC16334BERMUDAA group of islands in the North Atlantic Ocean, east of South Carolina. (NCI)Bermuda
BOLC16359BOLIVIAA country in Central South America, southwest of Brazil. (NCI)Bolivia
BRAC16364BRAZILA country in Eastern South America, bordering the Atlantic Ocean. (NCI)Brazil
BRBC16324BARBADOSAn island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)Barbados
BRNC16367BRUNEIA country in Southeastern Asia, bordering the South China Sea and Malaysia. (NCI)Brunei Darussalam
BTNC16336BHUTANA country in Southern Asia, between China and India. (NCI)Bhutan
BVTC20104BOUVET ISLANDAn island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa). (NCI)Bouvet Island
BWAC16363BOTSWANAA country in Southern Africa, north of South Africa. (NCI)Botswana
CAFC16409CENTRAL AFRICAN REPUBLICA country in Central Africa, north of Democratic Republic of the Congo. (NCI)Central African Republic
CANC16380CANADAA country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US. (NCI)Canada
CCKC16445COCOS (KEELING) ISLANDSA group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka. (NCI)Cocos (Keeling) Islands
CHEC17181SWITZERLANDA country in Central Europe, east of France, north of Italy. (NCI)Switzerland
CHLC16427CHILEA country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru. (NCI)Chile
CHNC16428CHINAA country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam. (NCI)China
CIVC16762COTE D'IVOIREA country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia. (NCI)Cote d'Ivoire
CMRC16379CAMEROONA country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria. (NCI)Cameroon
CODC17266DEMOCRATIC REPUBLIC OF THE CONGOA country in Central Africa, northeast of Angola. (NCI)Congo, the Democratic Republic of the
COGC16467CONGOA country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon. (NCI)Congo
COKC16469COOK ISLANDSA group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Cook Islands
COLC16449COLOMBIAA country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama. (NCI)Colombia
COMC16458COMOROSA group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique. (NCI)Comoros
CPVC16382CAPE VERDEA group of islands in the North Atlantic Ocean, west of Senegal. (NCI)Cape Verde
CRIC16470COSTA RICAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama. (NCI)Costa Rica
CUBC16477CUBAAn island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida. (NCI)Cuba
CXRC44482CHRISTMAS ISLANDAn Australian-administered island in the eastern Indian Ocean south of Java, Indonesia. (NCI)Christmas Island
CYMC16391CAYMAN ISLANDSAn island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras. (NCI)Cayman Islands
CYPC16480CYPRUSAn island in the Mediterranean Sea, south of Turkey. (NCI)Cyprus
CZEC17668CZECH REPUBLICA country in Central Europe, southeast of Germany. (NCI)Czech Republic
DEUC16636GERMANYA country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. (NCI)Germany
DJIC16506DJIBOUTIA country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia. (NCI)Djibouti
DMAC16519DOMINICAAn island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago. (NCI)Dominica
DNKC16496DENMARKA country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (NCI)Denmark
DOMC16520DOMINICAN REPUBLICA country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti. (NCI)Dominican Republic
DZAC16274ALGERIAA country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia. (NCI)Algeria
ECUC16528ECUADORA country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru. (NCI)Ecuador
EGYC16530EGYPTA country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip. (NCI)Egypt
ERIC16558ERITREAA country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan. (NCI)Eritrea
ESHC20113WESTERN SAHARAA country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco. (NCI)Western Sahara
ESPC17152SPAINA country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (NCI)Spain
ESTC16562ESTONIAA country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia. (NCI)Estonia
ETHC16563ETHIOPIAA country in Eastern Africa, west of Somalia. (NCI)Ethiopia
FINC16584FINLANDA country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (NCI)Finland
FJIC16582FIJIAn island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Fiji
FLKC17954FALKLAND ISLANDSIslands in the South Atlantic Ocean, east of southern Argentina. (NCI)Falkland Islands (Malvinas)
FRAC16592FRANCEA country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain. (NCI)France
FROC16573FAROE ISLANDSAn island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway. (NCI)Faroe Islands
FSMC17881MICRONESIA, FEDERATED STATES OFAn island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia. (NCI)Micronesia, Federated States of
GABC16596GABONA country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea. (NCI)Gabon
GBRC17233UNITED KINGDOMA country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France. (NCI)United Kingdom
GEOC16634GEORGIAA country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia. (NCI)Georgia
GGYC64375GUERNSEYThe island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK. (NCI)Guernsey
GHAC26330GHANAA country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo. (NCI)Ghana
GIBC16638GIBRALTARA dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain. (NCI)Gibraltar
GINC16655GUINEAA country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone. (NCI)Guinea
GLPC16651GUADELOUPEIslands in the eastern Caribbean Sea, southeast of Puerto Rico. (NCI)Guadeloupe
GMBC16598GAMBIAA country in Western Africa, bordering the North Atlantic Ocean and Senegal. (NCI)Gambia
GNBC16656GUINEA-BISSAUA country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal. (NCI)Guinea-Bissau
GNQC16557EQUATORIAL GUINEAA country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands. (NCI)Equatorial Guinea
GRCC16645GREECEA country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (NCI)Greece
GRDC16647GRENADAAn island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago. (NCI)Grenada
GRLC16646GREENLANDAn island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada. (NCI)Greenland
GTMC16654GUATEMALAA country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico. (NCI)Guatemala
GUFC16593FRENCH GUIANAA country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname. (NCI)French Guiana
GUMC16652GUAMIsland in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)Guam
GUYC16657GUYANAA country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela. (NCI)Guyana
HKGC16695HONG KONGA special administrative region of China, bordering the South China Sea and China. (NCI)Hong Kong
HMDC20106HEARD ISLAND AND MCDONALD ISLANDSIslands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica. (NCI)Heard Island and McDonald Islands
HNDC16694HONDURASA country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua. (NCI)Honduras
HRVC16474CROATIAA country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia. (NCI)Croatia
HTIC16660HAITIA country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic. (NCI)Haiti
HUNC16699HUNGARYA country in Central Europe, northwest of Romania. (NCI)Hungary
IDNC16728INDONESIAA country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean. (NCI)Indonesia
INDC16727INDIAA country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. (NCI)India
IMNC44480ISLE OF MANAn island in the Irish Sea, between Great Britain and Ireland. (NCI)Isle of Man
IOTC16365BRITISH INDIAN OCEAN TERRITORYAn archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia. (NCI)British Indian Ocean Territory
IRLC16757IRELANDA country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. (NCI)Ireland
IRNC16755IRANA country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. (NCI)Iran, Islamic Republic of
IRQC16756IRAQA country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait. (NCI)Iraq
ISLC16704ICELANDA country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI)Iceland
ISRC16760ISRAELA country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. (NCI)Israel
ITAC16761ITALYA country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. (NCI)Italy
JAMC16763JAMAICAAn island in the Caribbean Sea, south of Cuba. (NCI)Jamaica
JORC16765JORDANA country in the Middle East, northwest of Saudi Arabia. (NCI)Jordan
JPNC16764JAPANA country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. (NCI)Japan
JEYC64374JERSEYJersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK. (NCI)Jersey
KAZC20107KAZAKHSTANA country in Central Asia, northwest of China. (NCI)Kazakhstan
KENC16769KENYAA country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI)Kenya
KGZC16771KYRGYZSTANA country in Central Asia, west of China. (NCI)Kyrgyzstan
KHMC16378CAMBODIAA country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. (NCI)Cambodia
KIRC16639KIRIBATIA group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia. (NCI)Kiribati
KNAC17885SAINT KITTS AND NEVISIslands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago. (NCI)Saint Kitts and Nevis
KORC16774SOUTH KOREAA country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea. (NCI)Korea, Republic of
KWTC16775KUWAITA country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia. (NCI)Kuwait
LAOC16780LAO PEOPLE'S DEMOCRATIC REPUBLICA country in Southeastern Asia, northeast of Thailand, west of Vietnam. (NCI)Lao People's Democratic Republic
LBNC16784LEBANONA country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. (NCI)Lebanon
LBRC16791LIBERIAA country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone. (NCI)Liberia
LBYC16793LIBYAN ARAB JAMAHIRIYAA country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia. (NCI)Libyan Arab Jamahiriya
LCAC17113SAINT LUCIAA country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago. (NCI)Saint Lucia
LIEC16794LIECHTENSTEINA country in Central Europe, between Austria and Switzerland. (NCI)Liechtenstein
LKAC17163SRI LANKAA country in Southern Asia, occupying an island in the Indian Ocean, south of India. (NCI)Sri Lanka
LSOC16787LESOTHOA country in Southern Africa, an enclave of South Africa. (NCI)Lesotho
LTUC16799LITHUANIAA country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia. (NCI)Lithuania
LUXC16803LUXEMBOURGA country in Western Europe, between France, Belgium, and Germany. (NCI)Luxembourg
LVAC16783LATVIAA country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania. (NCI)Latvia
MACC16807MACAOA country in Eastern Asia, bordering the South China Sea and China. (NCI)Macao
MAFC83610SAINT MARTIN, FRENCHAn island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI)Saint Martin, French
MARC16878MOROCCOA country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara. (NCI)Morocco
MCOC16874MONACOA country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy. (NCI)Monaco
MDAC16871MOLDOVA, REPUBLIC OFA country in Eastern Europe, northeast of Romania. (NCI)Moldova, Republic of
MDGC16808MADAGASCARA country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique. (NCI)Madagascar
MDVC16815MALDIVESA country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India. (NCI)Maldives
MEXC16850MEXICOA country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US. (NCI)Mexico
MHLC16822MARSHALL ISLANDSA group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)Marshall Islands
MKDC17654REPUBLIC OF MACEDONIAA country in Southeastern Europe, north of Greece. (NCI)Macedonia, the Former Yugoslav Republic of
MLIC16816MALIA country in Western Africa, southwest of Algeria. (NCI)Mali
MLTC16817MALTAA country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy). (NCI)Malta
MMRC16370MYANMARA country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand. (NCI)Myanmar
MNEC64378MONTENEGROA republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)Montenegro
MNGC16875MONGOLIAA country in Northern Asia, between China and Russia. (NCI)Mongolia
MNPC17882NORTHERN MARIANA ISLANDSA country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)Northern Mariana Islands
MOZC16882MOZAMBIQUEA country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania. (NCI)Mozambique
MRTC16826MAURITANIAA country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara. (NCI)Mauritania
MSRC16876MONTSERRATA country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico. (NCI)Montserrat
MTQC16823MARTINIQUEAn island in the Caribbean Sea, north of Trinidad and Tobago. (NCI)Martinique
MUSC16827MAURITIUSA country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)Mauritius
MWIC16813MALAWIA country in Southern Africa, east of Zambia. (NCI)Malawi
MYSC16814MALAYSIAA country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam. (NCI)Malaysia
MYTC16828MAYOTTEA country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique. (NCI)Mayotte
NAMC16891NAMIBIAA country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI)Namibia
NCLC16913NEW CALEDONIAA country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia. (NCI)New Caledonia
NERC16916NIGERA country in Western Africa, southeast of Algeria. (NCI)Niger
NFKC16919NORFOLK ISLANDA country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia. (NCI)Norfolk Island
NGAC16917NIGERIAA country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon. (NCI)Nigeria
NICC16915NICARAGUAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras. (NCI)Nicaragua
NIUC16918NIUEA country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga. (NCI)Niue
NLDC16903NETHERLANDSA country in Western Europe, bordering the North Sea, between Belgium and Germany. (NCI)Netherlands
NORC16920NORWAYA country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (NCI)Norway
NPLC16901NEPALA country in Southern Asia, between China and India. (NCI)Nepal
NRUC16896NAURUA country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands. (NCI)Nauru
NZLC16914NEW ZEALANDA country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia. (NCI)New Zealand
OMNC16933OMANA country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates. (NCI)Oman
PAKC16949PAKISTANA country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. (NCI)Pakistan
PANC16951PANAMAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica. (NCI)Panama
PCNC16993PITCAIRNA country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand. (NCI)Pitcairn
PERC16972PERUA country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador. (NCI)Peru
PHLC16978PHILIPPINESA country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam. (NCI)Philippines
PLWC17733PALAUA country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines. (NCI)Palau
PNGC16952PAPUA NEW GUINEAA country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia. (NCI)Papua New Guinea
POLC17002POLANDA country in Central Europe, east of Germany. (NCI)Poland
PRIC17043PUERTO RICOAn island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic. (NCI)Puerto Rico
PRKC16773NORTH KOREAA country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea. (NCI)Korea, Democratic People's Republic of
PRTC17006PORTUGALA country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain. (NCI)Portugal
PRYC16953PARAGUAYA country in Central South America, northeast of Argentina. (NCI)Paraguay
PSEC20110PALESTINIAN TERRITORY, OCCUPIEDA collective name for the West Bank and the Gaza Strip, two territories in Palestine. (NCI)Palestinian Territory, Occupied
PYFC16594FRENCH POLYNESIAAn archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia. (NCI)French Polynesia
QATC17045QATARA country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia. (NCI)Qatar
REUC17095REUNIONA country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)Reunion
ROUC17108ROMANIAA country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. (NCI)Romania
RUSC17111RUSSIAN FEDERATIONA country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean. (NCI)Russian Federation
RWAC17112RWANDAA country in Central Africa, east of Democratic Republic of the Congo. (NCI)Rwanda
SAUC17117SAUDI ARABIAA country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. (NCI)Saudi Arabia
SRBC64377SERBIAA republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)Serbia
SDNC17170SUDANA country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea. (NCI)Sudan
SENC17121SENEGALA country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania. (NCI)Senegal
SGPC17134SINGAPOREA country in Southeastern Asia, comprised of islands between Malaysia and Indonesia. (NCI)Singapore
SGSC20111SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDSA group of islands in the South Atlantic Ocean, east of the tip of South America. (NCI)South Georgia and the South Sandwich Islands
SHNC17164SAINT HELENAIslands in the South Atlantic Ocean, about midway between South America and Africa. (NCI)Saint Helena
SJMC17178SVALBARD AND JAN MAYENIslands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway. (NCI)Svalbard and Jan Mayen
SLBC17148SOLOMON ISLANDSA group of islands in the South Pacific Ocean, east of Papua New Guinea. (NCI)Solomon Islands
SLEC17130SIERRA LEONEA country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia. (NCI)Sierra Leone
SLVC16532EL SALVADORA country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras. (NCI)El Salvador
SMRC17115SAN MARINOA country in Southern Europe, an enclave in central Italy. (NCI)San Marino
SOMC17149SOMALIAA country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia. (NCI)Somalia
SPMC17165SAINT PIERRE AND MIQUELONA country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada). (NCI)Saint Pierre and Miquelon
STPC17116SAO TOME AND PRINCIPEA country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon. (NCI)Sao Tome and Principe
SURC17175SURINAMEA country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana. (NCI)Suriname
SVKC17669SLOVAKIAA country in Central Europe, south of Poland. (NCI)Slovakia
SVNC17138SLOVENIAA country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia. (NCI)Slovenia
SWEC17180SWEDENA country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (NCI)Sweden
SWZC17179SWAZILANDA country in Southern Africa, between Mozambique and South Africa. (NCI)Swaziland
SYCC17129SEYCHELLESA country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar. (NCI)Seychelles
SYRC17182SYRIAN ARAB REPUBLICA country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey. (NCI)Syrian Arab Republic
TCAC17224TURKS AND CAICOS ISLANDSTwo island groups in the North Atlantic Ocean, southeast of The Bahamas. (NCI)Turks and Caicos Islands
TCDC16412CHADA country in Central Africa, south of Libya. (NCI)Chad
TGOC17202TOGOA country in Western Africa, bordering the Bight of Benin, between Benin and Ghana. (NCI)Togo
THAC17192THAILANDA country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma. (NCI)Thailand
TJKC17183TAJIKISTANA country in Central Asia, west of China. (NCI)Tajikistan
TKLC17704TOKELAUA group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Tokelau
TKMC17223TURKMENISTANA country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan. (NCI)Turkmenistan
TLSC17200TIMOR-LESTEA country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. (NCI)Timor-Leste
TONC17205TONGAAn archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Tonga
TTOC17217TRINIDAD AND TOBAGOIslands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)Trinidad and Tobago
TUNC17221TUNISIAA country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya. (NCI)Tunisia
TURC17222TURKEYA country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. (NCI)Turkey
TUVC17225TUVALUAn island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)Tuvalu
TWNC17184TAIWANA group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. (NCI)Taiwan, Province of China
TZAC17185TANZANIA, UNITED REPUBLIC OFA country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique. (NCI)Tanzania, United Republic of
UGAC17228UGANDAA country in Eastern Africa, west of Kenya. (NCI)Uganda
UKRC17229UKRAINEA country in Eastern Europe, bordering the Black Sea, between Poland and Russia. (NCI)Ukraine
UMIC20112UNITED STATES MINOR OUTLYING ISLANDSThe U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll). (NCI)United States Minor Outlying Islands
URYC17244URUGUAYA country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil. (NCI)Uruguay
USAC17234UNITED STATESA country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico. (NCI)United States
UZBC17246UZBEKISTANA country in Central Asia, north of Afghanistan. (NCI)Uzbekistan
VATC17249VATICAN CITY STATEAn enclave of Rome (Italy). (NCI)Holy See (Vatican City State)
VCTC17114SAINT VINCENT AND THE GRENADINESA country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago. (NCI)Saint Vincent and the Grenadines
VENC17250VENEZUELAA country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (NCI)Venezuela
VGBC17653VIRGIN ISLANDS, BRITISHIslands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)Virgin Islands, British
VIRC17255VIRGIN ISLANDS, U.S.Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)Virgin Islands, U.S.
VNMC17252VIETNAMA country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia. (NCI)Viet Nam
VUTC17247VANUATUA group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia. (NCI)Vanuatu
WLFC17259WALLIS AND FUTUNAIslands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Wallis and Futuna
WSMC17740SAMOAA group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Samoa
YEMC17264YEMENA country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia. (NCI)Yemen
ZAFC17151SOUTH AFRICAA country in Southern Africa, at the southern tip of the continent of Africa. (NCI)South Africa
ZMBC17267ZAMBIAA country in Southern Africa, east of Angola. (NCI)Zambia
ZWEC17268ZIMBABWEA country in Southern Africa, between South Africa and Zambia. (NCI)Zimbabwe
Back to top
CL.C66787.TDIGRPDiagnosis Group
(TDIGRP)
text
Extensible: Yes
C66787Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)CDISC SDTM Diagnosis Group Terminology
HEALTHY SUBJECTSC49651An individual who is or becomes a participant in a research study and has no significant health-related issues. (NCI)Healthy Subject
Back to top
CL.C66788.DICTNAMDictionary Name
(DICTNAM)
text
Extensible: Yes
C66788Dictionary NameA name given to a reference source that lists words and gives their meaning. (NCI)CDISC SDTM Dictionary Name Terminology
COSTARTC49471Coding Symbols for a Thesaurus of Adverse Reaction TermsA terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)Thesaurus of Adverse Reaction Term Coding Symbols
ICDC49474International Classification of DiseasesA system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)International Classification of Diseases
LOINCC49476Logical Observation Identifiers Names and CodesPublished by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)Logical Observation Identifiers Names and Codes
MedDRAC43820Medical Dictionary for Regulatory ActivitiesMedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)MedDRA
SNOMEDC53489Systematized Nomenclature of MedicineA multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)Systematized Nomenclature of Medicine
WHOARTC49468World Health Organization Adverse Reaction TermsA terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)World Health Organization Adverse Reaction Terminology
WHODDC49475World Health Organization Drug DictionaryA reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)World Health Organization Drug Dictionary
Back to top
CL.C66789.NDNot Done
(ND)
text
Extensible: No
C66789Not DoneIndicates a task, process or examination that has either not been initiated or completed. (NCI)CDISC SDTM Not Done Terminology
NOT DONEC49484Indicates a task, process or examination that has either not been initiated or completed. (NCI)Not Done
Back to top
CL.C66790.ETHNICEthnic Group
(ETHNIC)
text
Extensible: Yes
C66790Ethnic GroupA social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)CDISC SDTM Ethnic Group Terminology
HISPANIC OR LATINOC17459A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI)Hispanic or Latino
NOT HISPANIC OR LATINOC41222A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)Not Hispanic or Latino
NOT REPORTEDC43234Not reportedNot provided or available.Not Stated
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66726.FRMPharmaceutical Dosage Form
(FRM)
text
Extensible: Yes
C66726Pharmaceutical Dosage Form;Dose FormThe form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.CDISC SDTM Pharmaceutical Dosage Form Terminology
AEROSOLC42887aerA product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)Aerosol Dosage Form
AEROSOL, FOAMC42888A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)Aerosol Foam Dosage Form
AEROSOL, METEREDC42960A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)Metered Aerosol Dosage Form
AEROSOL, POWDERC42971A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)Powder Aerosol Dosage Form
AEROSOL, SPRAYC42889An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)Aerosol Spray Dosage Form
BAR, CHEWABLEC42892A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)Chewable Bar Dosage Form
BEADC42890A solid dosage form in the shape of a small ball. (NCI)Bead Dosage Form
BEAD, IMPLANT, EXTENDED RELEASEC43451A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)Extended Release Bead Implant Dosage Form
BLOCKC42891Solid dosage form, usually in the shape of a square or rectangle. (NCI)Block Dosage Form
CAPLETC97197A solid dosage form in which a tablet has been compacted into capsule shape.Caplet Dosage Form
CAPSULEC25158capA solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)Capsule Dosage Form
CAPSULE, COATEDC42895A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)Coated Capsule Dosage Form
CAPSULE, COATED PELLETSC42896A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)Coated Pellets in Capsule Dosage Form
CAPSULE, COATED, EXTENDED RELEASEC42917A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Coated Capsule Dosage Form
CAPSULE, DELAYED RELEASEC42902A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Capsule Dosage Form
CAPSULE, DELAYED RELEASE PELLETSC42904A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)Delayed Release Pellets in Capsule Dosage Form
CAPSULE, EXTENDED RELEASEC42916A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Capsule Dosage Form
CAPSULE, FILM COATED, EXTENDED RELEASEC42928A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Film Coated Capsule Dosage Form
CAPSULE, GELATIN COATEDC42936A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)Gelatin Coated Capsule Dosage Form
CAPSULE, LIQUID FILLEDC42954A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)Liquid Filled Capsule Dosage Form
CEMENTC45414A substance that serves to produce solid union between two surfaces. (NCI)Cement Dosage Form
CIGARETTEC42678A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)Cigarette Dosage Form
CLOTHC60884A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)Cloth Dosage Form
CONCENTRATEC60891A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)Concentrate Dosage Form
CONEC42900A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)Cone Dosage Form
CORE, EXTENDED RELEASEC42919An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)Extended Release Core Dosage Form
CREAMC28944A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)Cream Dosage Form
CREAM, AUGMENTEDC60897A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)Augmented Cream Dosage Form
CRYSTALC42901A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.Crystal Dosage Form
CULTUREC45415The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)Culture Dosage Form
DIAPHRAGMC47890A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)Diaphragm Dosage Form
DISCC43525A circular plate-like organ or structure. (FDA)Disc Dosage Form
DOUCHEC42679A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)Douche Dosage Form
DRESSINGC42763The application of various materials for protecting a wound.(FDA)Dressing Dosage Form
DRUG DELIVERY SYSTEMC17423Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)Drug Delivery System
ELIXIRC42912A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)Elixir Dosage Form
EMULSIONC42913A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)Emulsion Dosage Form
ENEMAC42915A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI)Enema Dosage Form
EXTRACTC42929A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)Extract Dosage Form
FIBER, EXTENDED RELEASEC60926A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)Extended Release Fiber Dosage Form
FILMC42932A thin layer or coating. (NCI)Film Dosage Form
FILM, EXTENDED RELEASEC42920A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)Extended Release Film Dosage Form
FILM, SOLUBLEC42984A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)Soluble Film Dosage Form
FOR SOLUTIONC60927A product, usually a solid, intended for solution prior to administration. (FDA)Dosage Form For Solution
FOR SUSPENSIONC60928A product, usually a solid, intended for suspension prior to administration. (FDA)Dosage Form For Suspension
FOR SUSPENSION, EXTENDED RELEASEC60929A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)Extended Release Dosage Form For Suspension
GASC42933Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)Gas Dosage Form
GELC42934A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)Gel Dosage Form
GEL, DENTIFRICEC42906A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)Dentifrice Gel Dosage Form
GEL, METEREDC60930A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)Metered Gel Dosage Form
GENERATORC48193An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)Generator Dosage Form
GLOBULEC42937Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)Globule Dosage Form
GRAFTC45416A slip of skin or of other tissue for implantation. (NCI)Graft Dosage Form
GRANULEC42938A small particle or grain. (NCI)Granule Dosage Form
GRANULE, DELAYED RELEASEC42903A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)Delayed Release Granule Dosage Form
GRANULE, EFFERVESCENTC42909A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)Effervescent Granule Dosage Form
GRANULE, FOR SOLUTIONC42939A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)Granule For Solution Dosage Form
GRANULE, FOR SUSPENSIONC42940A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)Granule For Suspension Dosage Form
GRANULE, FOR SUSPENSION, EXTENDED RELEASEC42921A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)Extended Release Granule For Suspension Dosage Form
GUMC42941A mucilaginous excretion from various plants. (NCI)Gum Dosage Form
GUM, CHEWINGC42894A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)Chewing Gum Dosage Form
GUM, RESINC42978Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)Resin Gum Dosage Form
IMPLANTC42942A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)Implant Dosage Form
INHALANTC42944A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)Inhalant Dosage Form
INJECTABLE, LIPOSOMALC60931An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)Liposomal Injection Dosage Form
INJECTIONC42946A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)Injectable Dosage Form
INJECTION, EMULSIONC42914An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)Emulsion for Injection Dosage Form
INJECTION, LIPID COMPLEXC42950[definition pending](FDA)Injectable Lipid Complex Dosage Form
INJECTION, POWDER, FOR SOLUTIONC42974A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)Powder For Injectable Solution Dosage Form
INJECTION, POWDER, FOR SUSPENSIONC42976A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)Powder For Injectable Suspension Dosage Form
INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASEC42977A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)Powder For Injectable Extended Release Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSIONC42959A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)Lyophilized Powder For Injectable Liposomal Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONC42957A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)Lyophilized Powder For Injectable Solution Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONC42958A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)Lyophilized Powder For Injectable Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASEC42956A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)Lyophilized Powder For Extended Release Injectable Suspension Dosage Form
INJECTION, SOLUTIONC42945A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)Injectable Solution Dosage Form
INJECTION, SOLUTION, CONCENTRATEC42899A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)Concentrate for Injectable Solution Dosage Form
INJECTION, SUSPENSIONC42995A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)Injectable Suspension Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASEC42926A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Injectable Extended Release Suspension Dosage Form
INJECTION, SUSPENSION, LIPOSOMALC42951A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)Injectable Liposomal Suspension Dosage Form
INJECTION, SUSPENSION, SONICATEDC42988A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)Injectable Sonicated Suspension Dosage Form
INSERTC60933A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)Insert Dosage Form
INSERT, EXTENDED RELEASEC42922A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)Extended Release Insert Dosage Form
INTRAUTERINE DEVICEC47915A device inserted and left in the uterus to prevent effective conception. (NCI)Intrauterine Device Dosage Form
IRRIGANTC42947A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)Irrigant Dosage Form
JELLYC42948A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)Jelly Dosage Form
KITC47916A packaged collection of related material. (NCI)Kit Dosage Form
LINER, DENTALC45413A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)Dental Liner Dosage Form
LINIMENTC42949A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)Liniment Dosage Form
LIPSTICKC42952A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)Lipstick Dosage Form
LIQUIDC42953A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)Liquid Dosage Form
LIQUID, EXTENDED RELEASEC60934A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)Extended Release Liquid Dosage Form
LOTIONC29167An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)Lotion Dosage Form
LOTION, AUGMENTEDC60957A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)Augmented Lotion Dosage Form
LOTION/SHAMPOOC60958A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)Lotion Shampoo Dosage Form
LOZENGEC42955A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)Lozenge Dosage Form
MOUTHWASHC29269An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)Mouthwash Dosage Form
NOT APPLICABLEC48624The use of a dosage form term is not relevant or appropriate. (NCI)Dosage Form Not Applicable
OILC42965An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)Oil Dosage Form
OINTMENTC42966ointA suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)Ointment Dosage Form
OINTMENT, AUGMENTEDC60984An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)Augmented Ointment Dosage Form
PACKINGC47887A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)Packing Dosage Form
PASTEC42967A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)Paste Dosage Form
PASTE, DENTIFRICEC42907A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)Dentifrice Paste Dosage Form
PASTILLEC60985An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)Pastille Dosage Form
PATCHC42968A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)Patch Dosage Form
PATCH, EXTENDED RELEASEC42923A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Extended Release Patch Dosage Form
PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLEDC42911A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Electrically Controlled Extended Release Patch Dosage Form
PELLETC42969A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)Pellet Dosage Form
PELLET, IMPLANTABLEC42943A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)Implantable Pellet Dosage Form
PELLETS, COATED, EXTENDED RELEASEC42918A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Coated Pellets Dosage Form
PILLC25394A dose of medicine in the form of a small pellet. (NCI)Pill Dosage Form
PLASTERC42970Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)Plaster Dosage Form
POULTICEC47913A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)Poultice Dosage Form
POWDERC42972An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)Powder Dosage Form
POWDER, DENTIFRICEC42908A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)Dentifrice Powder Dosage Form
POWDER, FOR SOLUTIONC42973An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)Powder for Solution Dosage Form
POWDER, FOR SUSPENSIONC42975An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)Powder for Suspension Dosage Form
POWDER, METEREDC42961A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)Metered Powder Dosage Form
RINGC60988A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)Ring Dosage Form
RINSEC42979A liquid used to cleanse by flushing. (NCI)Rinse Dosage Form
SALVEC42980A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)Salve Dosage Form
SHAMPOOC42981A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)Shampoo Dosage Form
SHAMPOO, SUSPENSIONC42982A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)Shampoo Suspension Dosage Form
SOAPC42983Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)Soap Dosage Form
SOLUTIONC42986A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)Solution Dosage Form
SOLUTION, CONCENTRATEC42898A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)Concentrate for Solution Dosage Form
SOLUTION, FOR SLUSHC42987A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)Solution For Slush Dosage Form
SOLUTION, GEL FORMING / DROPSC60994A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)Gel Forming Drops Solution Dosage Form
SOLUTION, GEL FORMING, EXTENDED RELEASEC42935A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency. (FDA)Extended Release Gel Forming Solution Dosage Form
SOLUTION/ DROPSC60992A solution which is usually administered in a drop-wise fashion. (FDA)Drops Solution Dosage Form
SPONGEC47912A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape.(FDA)Sponge Dosage Form
SPRAYC42989A liquid minutely divided as by a jet of air or steam. (NCI)Spray Dosage Form
SPRAY, METEREDC42962A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)Metered Spray Dosage Form
SPRAY, SUSPENSIONC42990A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)Spray Suspension Dosage Form
STICKC42991A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)Stick Dosage Form
STRIPC47914A long narrow piece of material.Strip Dosage Form
SUPPOSITORYC42993suppA solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)Suppository Dosage Form
SUPPOSITORY, EXTENDED RELEASEC42924A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)Extended Release Suppository Dosage Form
SUSPENSIONC42994suspA liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)Suspension Dosage Form
SUSPENSION, EXTENDED RELEASEC42925A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Extended Release Suspension Dosage Form
SUSPENSION/DROPSC60995A suspension which is usually administered in a dropwise fashion. (FDA)Drops Suspension Dosage Form
SUTUREC47889A strand or fiber used to hold wound edges in apposition during healing. (NCI)Suture Dosage Form
SWABC47898A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. (NCI)Swab Dosage Form
SYRUPC42996An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI)Syrup Dosage Form
TABLETC42998tabA solid dosage form containing medicinal substances with or without suitable diluents. (NCI)Tablet Dosage Form
TABLET, CHEWABLEC42893A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)Chewable Tablet Dosage Form
TABLET, COATEDC42897A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)Coated Tablet Dosage Form
TABLET, COATED PARTICLESC60997A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)Tablet Coated Particles Dosage Form
TABLET, DELAYED RELEASEC42905A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Tablet Dosage Form
TABLET, DELAYED RELEASE PARTICLESC42997A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Particles Tablet Dosage Form
TABLET, EFFERVESCENTC42910A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)Effervescent Tablet Dosage Form
TABLET, EXTENDED RELEASEC42927A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)Extended Release Tablet Dosage Form
TABLET, FILM COATEDC42931A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)Film Coated Tablet Dosage Form
TABLET, FILM COATED, EXTENDED RELEASEC42930A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)Film Coated Extended Release Tablet Dosage Form
TABLET, FOR SOLUTIONC61004A tablet that forms a solution when placed in a liquid. (FDA)Tablet For Solution Dosage Form
TABLET, FOR SUSPENSIONC61005A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).Tablet For Suspension Dosage Form
TABLET, MULTILAYERC42964A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)Multilayered Tablet Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASEC42963A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)Multilayered Extended Release Tablet Dosage Form
TABLET, ORALLY DISINTEGRATINGC42999A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI)Orally Disintegrating Tablet Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEC61006A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)Tablet Orally Disintegrating Delayed Release Dosage Form
TABLET, SOLUBLEC42985A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)Soluble Tablet Dosage Form
TABLET, SUGAR COATEDC42992A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)Sugar Coated Tablet Dosage Form
TAMPONC47892A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)Tampon Dosage Form
TAPEC47897A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)Tape Dosage Form
TINCTUREC43000An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI)Tincture Dosage Form
TROCHEC43001A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI)Troche Dosage Form
UNASSIGNEDC43002A dosage form has yet to be assigned. (NCI)Unassigned Dosage Form
WAFERC43003A thin slice of material containing a medicinal agent. (NCI)Wafer Dosage Form
Back to top
CL.C66727.NCOMPLTCompletion/Reason for Non-Completion
(NCOMPLT)
text
Extensible: Yes
C66727Completion/Reason for Non-CompletionThe status of the subject's completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study.CDISC SDTM Reason for Non-Completion Terminology
ADVERSE EVENTC41331Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience. (CDISC glossary)Adverse Event
COMPLETEDC25250To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)Complete
DEATHC28554The absence of life or state of being dead. (NCI)Death
LACK OF EFFICACYC48226The lack of expected or desired effect related to a therapy. (NCI)Lack of Efficacy
LOST TO FOLLOW-UPC48227The loss or lack of continuation of a subject to follow-up.Lost To Follow-up
NON-COMPLIANCE WITH STUDY DRUGC49631An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)Non-Compliance With Study Drug
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
PHYSICIAN DECISIONC48250A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)Physician Decision
PREGNANCYC25742Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)Pregnancy
PROGRESSIVE DISEASEC35571A disease process that is increasing in scope or severity. (NCI)Progressive Disease
PROTOCOL VIOLATIONC48251An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)Protocol Violation
RECOVERYC25746A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)Recovery
SCREEN FAILUREC49628The potential subject who does not meet one or more criteria required for participation in a trial.Trial Screen Failure
STUDY TERMINATED BY SPONSORC49632An indication that a clinical study was stopped by its sponsor. (NCI)Study Terminated By Sponsor
TECHNICAL PROBLEMSC49633A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI)Technical Problem
WITHDRAWAL BY SUBJECTC49634An indication that a study participant has removed itself from the study. (NCI)Withdrawal by Subject
Back to top
CL.C66728.STENRFRelation to Reference Period
(STENRF)
text
Extensible: No
C66728Relation to Reference PeriodThe relative relationship of a timepoint to a reference timepoint.CDISC SDTM Relation to Reference Period Terminology
AFTERC38008The time period following a point or another period of time. (NCI)Post
BEFOREC25629Earlier in time or order. (NCI)Prior
DURINGC25490At some point in a given period of time. (NCI)During
DURING/AFTERC49640Within a certain period of time or after a certain point or period in time. (NCI)During Or After
UC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
COINCIDENTC25456Occurring or operating at the same time.Concurrent
ONGOINGC53279ContinuousRemain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)Continue
Back to top
CL.C66729.ROUTERoute of Administration
(ROUTE)
text
Extensible: Yes
C66729Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.CDISC SDTM Route of Administration Terminology
AURICULAR (OTIC)C38192Administration to or by way of the ear. (FDA)Auricular Route of Administration
BUCCALC38193Administration directed toward the cheek, generally from within the mouth. (FDA)Buccal Route of Administration
CONJUNCTIVALC38194Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA)Conjunctival Route of Administration
CUTANEOUSC38675Administration to the skin. (FDA)Cutaneous Route of Administration
DENTALC38197Administration to a tooth or teeth. (FDA)Dental Route of Administration
ELECTRO-OSMOSISC38633Administration of through the diffusion of substance through a membrane in an electric field. (FDA)Electro-osmosis Route of Administration
ENDOCERVICALC38205Administration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA)Endocervical Route of Administration
ENDOSINUSIALC38206Administration within the nasal sinuses of the head. (FDA)Endosinusial Route of Administration
ENDOTRACHEALC38208Administration directly into the trachea. Synonymous with the term intratracheal. (FDA)Endotracheal Route of Administration
ENTERALC38209Administration directly into the intestines. (FDA)Enteral Route of Administration
EPIDURALC38210Administration upon or over the dura mater. (FDA)Epidural Route of Administration
EXTRA-AMNIOTICC38211Administration to the outside of the membrane enveloping the fetus. (FDA)Extraamniotic Route of Administration
EXTRACORPOREALC38212Administration outside of the body. (FDA)Extracorporeal Circulation Route of Administration
HEMODIALYSISC38200Administration through hemodialysate fluid. (FDA)Administration Via Hemodialysis
INFILTRATIONC38215Administration that results in substances passing into tissue spaces or into cells. (FDA)Infiltration Route of Administration
INTERSTITIALC38219Administration to or in the interstices of a tissue. (FDA)Interstitial Route of Administration
INTRA-ABDOMINALC38220Administration within the abdomen. (FDA)Intraabdominal Route of Administration
INTRA-AMNIOTICC38221Administration within the amnion. (FDA)Intraamniotic Route of Administration
INTRA-ARTERIALC38222Administration within an artery or arteries. (FDA)Intraarterial Route of Administration
INTRA-ARTICULARC38223Administration within a joint. (FDA)Intraarticular Route of Administration
INTRABILIARYC38224Administration within the bile, bile ducts or gallbladder. (FDA)Intrabiliary Route of Administration
INTRABRONCHIALC38225Administration within a bronchus. (FDA)Intrabronchial Route of Administration
INTRABURSALC38226Administration within a bursa. (FDA)Intrabursal Route of Administration
INTRACARDIACC38227Administration within the heart. (FDA)Intracardiac Route of Administration
INTRACARTILAGINOUSC38228Administration within a cartilage; endochondral. (FDA)Intracartilaginous Route of Administration
INTRACAUDALC38229Administration within the cauda equina. (FDA)Intracaudal Route of Administration
INTRACAVERNOUSC38230Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA)Intracavernous Route of Administration
INTRACAVITARYC38231Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA)Intracavitary Route of Administration
INTRACEREBRALC38232Administration within the cerebrum. (FDA)Intracerebral Route of Administration
INTRACISTERNALC38233Administration within the cisterna magna cerebellomedularis. (FDA)Intracisternal Route of Administration
INTRACORNEALC38234Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA)Intracorneal Route of Administration
INTRACORONAL, DENTALC38217Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA)Intracoronal Dental Route of Administration
INTRACORONARYC38218Administration within the coronary arteries. (FDA)Intracoronary Route of Administration
INTRACORPORUS CAVERNOSUMC38235Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA)Intracorporus Cavernosum Route of Administration
INTRADERMALC38238Administration within the dermis. (FDA)Intradermal Route of Administration
INTRADISCALC38239Administration within a disc. (FDA)Intradiscal Route of Administration
INTRADUCTALC38240Administration within the duct of a gland. (FDA)Intraductal Route of Administration
INTRADUODENALC38241Administration within the duodenum. (FDA)Intraduodenal Route of Administration
INTRADURALC38242Administration within or beneath the dura. (FDA)Intradural Route of Administration
INTRAEPIDERMALC38243Administration within the epidermis. (FDA)Intraepidermal Route of Administration
INTRAESOPHAGEALC38245Administration within the esophagus. (FDA)Intraesophageal Route of Administration
INTRAGASTRICC38246Administration within the stomach. (FDA)Intragastric Route of Administration
INTRAGINGIVALC38247Administration within the gingivae. (FDA)Intragingival Route of Administration
INTRAILEALC38249Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA)Intraileal Route of Administration
INTRALESIONALC38250Administration within or introduced directly into a localized lesion. (FDA)Intralesional Route of Administration
INTRALUMINALC38251Administration within the lumen of a tube. (FDA)Intraluminal Route of Administration
INTRALYMPHATICC38252Administration within the lymph. (FDA)Intralymphatic Route of Administration
INTRAMEDULLARYC38253Administration within the marrow cavity of a bone. (FDA)Intramedullary Route of Administration
INTRAMENINGEALC38254Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA)Intrameningeal Route of Administration
INTRAMUSCULARC28161Administration within a muscle. (FDA)Intramuscular Route of Administration
INTRAOCULARC38255Administration within the eye. (FDA)Intraocular Route of Administration
INTRAOVARIANC38256Administration within the ovary. (FDA)Intraovarian Route of Administration
INTRAPERICARDIALC38257Administration within the pericardium. (FDA)Intrapericardial Route of Administration
INTRAPERITONEALC38258Administration within the peritoneal cavity. (FDA)Intraperitoneal Route of Administration
INTRAPLEURALC38259Administration within the pleura. (FDA)Intrapleural Route of Administration
INTRAPROSTATICC38260Administration within the prostate gland. (FDA)Intraprostatic Route of Administration
INTRAPULMONARYC38261Administration within the lungs or its bronchi. (FDA)Intrapulmonary Route of Administration
INTRASINALC38262Administration within the nasal or periorbital sinuses. (FDA)Intrasinal Route of Administration
INTRASPINALC38263Administration within the vertebral column. (FDA)Intraspinal Route of Administration
INTRASYNOVIALC38264Administration within the synovial cavity of a joint. (FDA)Intrasynovial Route of Administration
INTRATENDINOUSC38265Administration within a tendon. (FDA)Intratendinous Route of Administration
INTRATESTICULARC38266Administration within the testicle. (FDA)Intratesticular Route of Administration
INTRATHECALC38267Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA)Intrathecal Route of Administration
INTRATHORACICC38207Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA)Endothoracic Route of Administration
INTRATUBULARC38268Administration within the tubules of an organ. (FDA)Intratubular Route of Administration
INTRATUMORC38269Intratumor Route of AdministrationAdministration within a tumor. (FDA)Intratumoral Route of Administration
INTRATYMPANICC38270Administration within the auris media. (FDA)Intratympanic Route of Administration
INTRAUTERINEC38272Administration within the uterus. (FDA)Intrauterine Route of Administration
INTRAVASCULARC38273Administration within a vessel or vessels. (FDA)Intravascular Route of Administration
INTRAVENOUSC38276Administration within or into a vein or veins. (FDA)Intravenous Route of Administration
INTRAVENOUS BOLUSC38274Administration within or into a vein or veins all at once. (FDA)Intravenous Bolus
INTRAVENOUS DRIPC38279Administration within or into a vein or veins over a sustained period of time. (FDA)Intravenous Drip
INTRAVENTRICULARC38277Administration within a ventricle. (FDA)Intraventricular Route of Administration
INTRAVESICALC38278Administration within the bladder. (FDA)Intravesical Route of Administration
INTRAVITREALC38280Administration within the vitreous body of the eye. (FDA)Intravitreal Route of Administration
IONTOPHORESISC38203Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA)Iontophoresis Route of Administration
IRRIGATIONC38281Administration to bathe or flush open wounds or body cavities. (FDA)Irrigation-Route of Administration
LARYNGEALC38282Administration directly upon the larynx. (FDA)Laryngeal Route of Administration
NASALC38284Administration to the nose; administered by way of the nose. (FDA)Nasal Route of Administration
NASOGASTRICC38285Administration through the nose and into the stomach, usually by means of a tube. (FDA)Nasogastric Route of Administration
NOT APPLICABLEC48623Routes of administration are not applicable. (FDA)Route of Administration Not Applicable
OCCLUSIVE DRESSING TECHNIQUEC38286Administration by the topical route which is then covered by a dressing which occludes the area. (FDA)Occlusive Dressing Technique
OPHTHALMICC38287Administration to the external eye. (FDA)Ophthalmic Route of Administration
ORALC38288POAdministration to or by way of the mouth. (FDA)Oral Route of Administration
OROPHARYNGEALC38289Administration directly to the mouth and pharynx. (FDA)Oropharyngeal Route of Administration
OTHERC38290Administration is different from others on this list. (FDA)Other Route of Administration
PARENTERALC38291Administration by injection, infusion, or implantation. (FDA)Parenteral Route of Administration
PERCUTANEOUSC38676Administration through the skin. (FDA)Percutaneous Route of Administration
PERIARTICULARC38292Administration around a joint. (FDA)Periarticular Route of Administration
PERIDURALC38677Administration to the outside of the dura mater of the spinal cord. (FDA)Peridural Route of Administration
PERINEURALC38293Administration surrounding a nerve or nerves. (FDA)Perineural Route of Administration
PERIODONTALC38294Administration around a tooth. (FDA)Periodontal Route of Administration
RECTALC38295Administration to the rectum. (FDA)Rectal Route of Administration
RESPIRATORY (INHALATION)C38216Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA)Inhalation Route of Administration
RETROBULBARC38296Administration behind the pons or behind the eyeball. (FDA)Retrobulbar Route of Administration
SOFT TISSUEC38198Administration into any soft tissue. (FDA)Soft Tissue Route Of Administration
SUBARACHNOIDC38297Administration beneath the arachnoid. (FDA)Subarachnoid Route of Administration
SUBCONJUNCTIVALC38298Administration beneath the conjunctiva. (FDA)Subconjunctival Route of Administration
SUBCUTANEOUSC38299SCAdministration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)Subcutaneous Route of Administration
SUBLINGUALC38300Administration beneath the tongue. (FDA)Sublingual Route of Administration
SUBMUCOSALC38301Administration beneath the mucous membrane. (FDA)Submucosal Route of Administration
TOPICALC38304TOPAdministration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA)Topical Route of Administration
TRANSDERMALC38305Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA)Transdermal Route of Administration
TRANSMUCOSALC38283Administration across the mucosa. (FDA)Mucosal Route of Administration
TRANSPLACENTALC38307Administration through or across the placenta. (FDA)Transplacental Route of Administration
TRANSTRACHEALC38308Administration through the wall of the trachea. (FDA)Transtracheal Route of Administration
TRANSTYMPANICC38309Administration across or through the tympanic cavity. (FDA)Transtympanic Route of Administration
UNASSIGNEDC38310Route of administration has not yet been assigned. (FDA)Unassigned Route of Administration
UNKNOWNC38311Route of administration is unknown. (FDA)Unknown Route of Administration
URETERALC38312Administration into the ureter. (FDA)Ureteral Route of Administration
URETHRALC38271Administration into the urethra. (FDA)Intraurethral Route of Administration
VAGINALC38313Administration into the vagina. (FDA)Vaginal Route of Administration
DIETARYC78373Administration by way of food stuff. (NCI)Dietary Route of Administration
ORAL GAVAGEC78374Administration through the mouth and into the stomach, usually by means of a tube. (NCI)Oral Gavage Route of Administration
Back to top
CL.C66769.AESEVSeverity/Intensity Scale for Adverse Events
(AESEV)
text
Extensible: No
C66769Severity/Intensity Scale for Adverse EventsA scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)CDISC SDTM Severity Intensity Scale for Adverse Event Terminology
MILDC41338Grade 1;1A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.Mild Adverse Event
MODERATEC41339Grade 2;2A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.Moderate Adverse Event
SEVEREC41340Grade 3;3A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.Severe Adverse Event
Back to top
CL.C66731.SEXSex
(SEX)
text
Extensible: No
C66731SexThe assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)CDISC SDTM Sex of Individual Terminology
FC16576FemaleA person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)Female
MC20197MaleA person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)Male
UC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
UNC45908UndifferentiatedA person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)Intersex
Back to top
CL.C66732.SEXPOPSex of Participants
(SEXPOP)
text
Extensible: No
C66732Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)CDISC SDTM Sex of Study Group Terminology
BOTHC49636One and the other; relating to or being two in conjunction. (NCI)Both
FC16576FemaleA person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)Female
MC20197MaleA person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)Male
Back to top
CL.C66733.SIZESize
(SIZE)
text
Extensible: Yes
C66733SizeThe physical magnitude of something. (NCI)CDISC SDTM Size Terminology
LARGEC49508Of considerable or relatively great size, extent, or capacity. (NCI)Large
MEDIUMC49507Mid-way between small and large in number, quantity, magnitude or extent. (NCI)Medium
SMALLC25376Limited in number, quantity, magnitude or extent. (NCI)Small
Back to top
CL.C66734.DOMAINDomain Abbreviation
(DOMAIN)
text
Extensible: Yes
C66734Domain AbbreviationA unique, 2-character domain code used in the regulatory submission process. The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)CDISC SDTM Submission Domain Abbreviation Terminology
ADC49563Analysis DatasetDatasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.Analysis Dataset Domain
AEC49562Adverse EventsAdverse events may be captured either as free text or a pre-specified list of terms.Adverse Event Domain
AUC49565AutopsyAdditional data about deaths, specific to findings from autopsies.Autopsy Domain
BMC49566Bone MeasurementsFindings resulting from evaluations of bone mineral density.Bone Measurements Domain
BRC49567BiopsyFindings resulting from biopsies.Biopsy Domain
CEC85441Clinical EventsA dataset used to capture clinical events of interest that would not be classified as adverse events.Clinical Events Domain
CMC49568Concomitant MedsCase report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.Concomitant Medication Domain
COC49569CommentsThe Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.Comment Domain
DAC49578Drug AccountabilityData regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.Drug Accountability Domain
DCC49570Disease CharacteristicsData related to the characteristics of a specific disease state under study for a subject.Disease Characteristics Domain
DMC49572DemographicsThe Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjectsDemographics Domain
DSC49576DispositionA subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)Disposition Domain
DVC49585Protocol DeviationsThe intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.Protocol Deviations Domain
EEC49625ElectroencephalogramFindings resulting from electroencephalogram (EEG) tests.Electroencephalogram Domain
EGC49626ElectrocardiogramFindings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.Electrocardiogram Domain
EXC49587ExposureThe Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.Exposure Domain
FAC85442Findings About Events or InterventionsA dataset used to capture the findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier.Findings About Events or Interventions Domain
FHC49588Family HistoryA subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)Family History Domain
HUC49589Healthcare Resource UtilizationHealthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.Healthcare Resource Utilization Domain
IEC61536Inclusion/ExclusionThe intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.Inclusion Exclusion Domain
LBC49592Laboratory DataLaboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.Laboratory Data Domain
MBC49602MicrobiologyMicrobiology specimen findings, including gram stain results, and organisms found.Microbiology Specimen Domain
MHC49603Medical HistoryThe medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.Medical History Domain
MLC49604Meal DataInformation regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.Meal Data Domain
MSC61531Microbiology SusceptibilityThis includes microbiology susceptibility test results, plus results of any other organism-related tests.Microbiology Susceptibility Domain
OMC49605Organ MeasurementsFindings from organ measurement evaluations.Organ Measurement Domain
PCC49606Pharmacokinetic ConcentrationConcentrations of drugs/metabolites in fluids or tissues as a function of time.Pharmacokinetic Concentration Domain
PEC49608Physical ExamFindings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.Physical Exam Domain
PGC61529PharmacogenomicsPharmacogenomics findings that initially focus on genotype and gene expression data.Pharmacogenomics Domain
PPC49607Pharmacokinetic ParametersPharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.Pharmacokinetic Parameters Domain
QSC49609QuestionnairesQuestionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).Questionnaire Domain
SCC49610Subject CharacteristicsThe subject characteristics domain is for data not collected in other domains that is subject-related.Subject Characteristics Domain
SEC49616Subject ElementThe subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.Subject Element Domain
SGC49611SurgerySurgical information.Surgery Domain
SKC49612Skin TestFindings from diagnostic skin tests.Skin Test Domain
SLC49613Sleep Polysomnography DataFindings from diagnostic sleep tests (polysomnography).Sleep Polysomnography Domain
STC49614Stress (Exercise) Test DataFindings from exercise stress tests.Stress Exercise Test Data Domain
SUC49615Substance UseThe intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.Substance Use Domain
SVC49617Subject VisitsThe subject visits table describes the actual start and end data/time for each visit of each individual subject.Subject Visits Domain
TAC49618Trial ArmsThe trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.Trial Arms Domain
TEC49619Trial ElementsThe trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.Trial Elements Domain
TIC49620Trial Inclusion/Exclusion CriteriaThe trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.Trial Inclusion and Exclusion Criteria Domain
TSC53483Trial SummaryThe trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.Trial Summary Domain
TVC49621Trial VisitsThe trial visits table describes the planned order and number of visits in the study within each arm.Trial Visits Domain
VSC49622Vital SignsMeasurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.Vital Signs Domain
BGC95083Body Weight GainBody weight gain is the actual difference between two body weight measurements for any given interval for a subject. This is most commonly shown as the difference between two consecutive body weight measurements.Body Weight Gain Domain
BHC95084BehavioralThis domain captures behavioral testing measurements on individual subjects.Behavioral Domain
BWC95085Body WeightThis domain captures body weights collected for subjects during the study and at the end of the study (terminal body weights).Body Weight Domain
CLC95086Clinical ObservationThis domain captures clinical sign information including ophthalmology, physical examination, and dermal examination collected in life while executing the study.Clinical Observation Domain
DDC95087Death DiagnosisThis domain captures the diagnosis of the cause of death for a subject.Death Diagnosis Domain
DPC95088Developmental MilestoneThis domain captures the outcome of developmental milestone testing during a scheduled period of observation.Developmental Milestone Domain
FEC95089FertilityThis domain captures test results relative to male and female fertility.Fertility Domain
FWC95090Food And WaterThis domain captures food/water consumption of animals in the study. The data in this domain is derived data.Food and Water Consumption Domain
FXC95091Fetal and Neonatal Developmental MorphologyThis domain captures observations for fetal and pup morphological examinations.Fetal and Neonatal Developmental Morphology Domain
ICC95092Implantation ClassificationThe Implantation Classification domain provides a record for each implantation identified for the scheduled cesarean section component of a study.Implantation Classification Domain
LRC95093Cesarean Section and Delivery Litter ResultsThis domain captures litter based results in female animals for cesarean section and/or delivery components of a study, including litter survival during preweaning.Cesarean Section and Delivery Litter Results Domain
MAC95094Macroscopic FindingsThe gross pathology findings recorded at necropsy.Macroscopic Findings Domain
MIC95095Microscopic FindingsThe histopathology findings and microscopic evaluations recorded.Microscopic Findings Domain
PMC95097Palpable MassesThis domain captures information of any palpable masses examined during the experimental phase.Palpable Masses Domain
SJC95099Subject StagesThe Subject Stages domain captures subject level non-treatment related blocks of time known as stages, such as Gestation, Lactation and Premating.Subject Stages Domain
TFC95100Tumor FindingsThis domain captures the tumor findings of the nonclinical subject.Tumor Findings Domain
TPC95101Trial PathsThe trial paths domain is not subject oriented. This domain provides the complete planned non-treatment related sequences of stages for each path in a study.Trial Paths Domain
TTC95102Trial StagesThe trial stages domain is not subject oriented. It captures non-treatment related planned blocks of time known as stages, such as Gestation, Lactation and Premating.Trial Stages Domain
TXC95103Trial SetsThe trial stages domain is not subject oriented. It contains one record for each trial set characteristic including experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations.Trial Sets Domain
Back to top
CL.C66735.TBLINDTrial Blinding Schema
(TBLIND)
text
Extensible: Yes
C66735Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)CDISC SDTM Trial Blinding Schema Terminology
DOUBLE BLINDC15228A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)Double Blind Study
OPEN LABELC49659A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)Open Label Study
SINGLE BLINDC28233A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)Single Blind Study
Back to top
CL.C66736.TINDTPTrial Indication Type
(TINDTP)
text
Extensible: Yes
C66736Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)CDISC SDTM Trial Indication Type Terminology
CUREC49654A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition. (NCI)Cure Study
DIAGNOSISC49653A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition. (NCI)Diagnosis Study
MITIGATIONC49655A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI)Adverse Effect Mitigation Study
PREVENTIONC49657A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.Prevention Study
TREATMENTC49656A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.Treatment Study
Back to top
CL.C66737.TPHASETrial Phase
(TPHASE)
text
Extensible: Yes
C66737Trial PhaseClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)CDISC SDTM Trial Phase Terminology
Phase I TrialC15600Trial Phase 1;1The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase I Trial
Phase I/II TrialC15693Trial Phase 1-2;1-2A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.Phase I/II Trial
Phase II TrialC15601Trial Phase 2;2Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase II Trial
Phase II/III TrialC15694Trial Phase 2-3;2-3A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.Phase II/III Trial
Phase IIa TrialC49686Trial Phase 2A;2AA clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)Phase IIa Trial
Phase IIb TrialC49688Trial Phase 2B;2BA clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)Phase IIb Trial
Phase III TrialC15602Trial Phase 3;3Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase III Trial
Phase IIIa TrialC49687Trial Phase 3A;3AA classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.Phase IIIa Trial
Phase IIIb TrialC49689Trial Phase 3B;3BA subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.Phase IIIb Trial
Phase IV TrialC15603Trial Phase 4;4Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase IV Trial
Phase V TrialC47865Trial Phase 5;5Postmarketing surveillance is sometimes referred to as Phase V.Phase V Trial
NAC48660NADetermination of a value is not relevant in the current context. (NCI)Not Applicable
Back to top
CL.C66738.TSPARMCDTrial Summary Parameter Test Code
(TSPARMCD)
text
Extensible: Yes
C66738Trial Summary Parameter Test CodeIndividual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)CDISC SDTM Trial Summary Parameter Terminology by Code
ADDONC49703Added on to Existing TreatmentsThe addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.Test Product Added to Existing Treatment
AGEMAXC49694Planned Maximum Age of SubjectsThe anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)Planned Maximum Age of Subjects
AGEMINC49693Planned Minimum Age of SubjectsThe anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)Planned Minimum Age of Subjects
AGESPANC20587Age SpanSubgroups of populations based on age. (NCI)Age Group
DOSEC25488Dose per AdministrationThe amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)Dose
LENGTHC49697Trial LengthPlanned length of observation for a single subject.Trial Length
PLANSUBC49692Planned Number of Subjects;Planned Enrollment;Target Enrollment;Anticipated EnrollmentThe planned number of subjects to be entered in a clinical trial. (NCI)Planned Subject Number
RANDOMC25196Trial is RandomizedThe process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)Randomization
ROUTEC38114Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.Route of Administration
SEXPOPC49696Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)Sex of Study Group
STOPRULEC49698Study Stop RulesThe rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)Study Stop Rules
TBLINDC49658Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)Trial Blinding Schema
TCNTRLC49647Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).Control Type
TDIGRPC49650Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)Diagnosis Group
TINDTPC49652Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)Trial Indication Type
TITLEC49802Trial TitleThe name of a clinical trial. (NCI)Trial Title
TPHASEC48281Trial Phase ClassificationClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)Trial Phase
TTYPEC49660Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)Trial Type
CURTRTC85582Current Therapy or TreatmentThe literal identifier of the therapy or medication that is currently being given per protocol.Current Therapy
OBJPRIMC85826Trial Primary ObjectiveThe principal purpose of the trial.Trial Primary Objective
OBJSECC85827Trial Secondary ObjectiveThe auxiliary purpose of the trial.Trial Secondary Objective
SPONSORC70793Clinical Study Sponsor;Study Sponsor;SponsorAn entity that is responsible for the initiation, management, and/or financing of a clinical study.Clinical Study Sponsor
COMPTRTC68612Comparative Treatment NameA therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.Active Comparator Drug
DOSUC73558Dose UnitsThe unit of measure for the dosage form.Dosage Form Unit
DOSFRQC89081Dosing FrequencyThe number of doses administered per a specific interval.Dose Frequency
INDICC41184Trial IndicationThe basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).Indication
TRTC41161Investigational Therapy or TreatmentThe investigational product under study.Protocol Agent
ACTSUBC98703Actual Number of SubjectsActual number of subjects enrolled; may include subjects who were not randomized.Actual Subject Number
ADAPTC98704Adaptive DesignIndicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.Adaptive Design
CRMDURC98715Confirmed Response Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.Confirmed Response Minimum Duration
DCUTDESCC98718Data Cutoff DescriptionText that describes the cutoff date.Data Cutoff Date Description
DCUTDTCC98717Data Cutoff DateA date which indicates any data collected by this date will be used for analysis.Data Cutoff Date
FCNTRYC98770Planned Country of Investigational Site(s)The country name of planned study facility which has received IRB approval.Planned Country of Investigational Site
HLTSUBJIC98737Healthy Subject IndicatorIndicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.Healthy Subject Indicator
INTMODELC98746Intervention ModelThe trial design developed to compare treatment groups.Intervention Model
INTTYPEC98747Intervention TypeThe kind of product or procedure studied in a trial.Intervention Type
NARMSC98771Planned Number of ArmsThe planned number of intervention groups.Planned Number of Arms
OUTMSEXPC98724Exploratory Outcome MeasureExploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.Exploratory Outcome Measure
OUTMSPRIC98772Primary Outcome MeasureThe primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).Primary Outcome Measure
OUTMSSECC98781Secondary Outcome MeasureOther key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).Secondary Outcome Measure
PCLASC98768Pharmacological Class of Investigational TherapyThe pharmacological class of the investigational product.Pharmacological Class of Investigational Therapy
RANDQTC98775Randomization QuotientThe randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.Randomization Quotient
REGIDC98714Registry IdentifierIdentification numbers assigned to the protocol by ct.gov, EudraCT, or other registries.Clinical Trial Registry Identifier
SDMDURC98783Stable Disease Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of stable disease.Stable Disease Minimum Duration
SENDTCC90462Study End DateFinal date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.Study End Date
SSTDTCC69208Study Start DateThe earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included.Study Date
STYPEC15320Study TypeDescribes the role the study plays in determining the interventions a subject receives.Study Design
Back to top
CL.C67152.TSPARMTrial Summary Parameter Test Name
(TSPARM)
text
Extensible: Yes
C67152Trial Summary Parameter Test NameIndividual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)CDISC SDTM Trial Summary Parameter Terminology by Name
Added on to Existing TreatmentsC49703Added on to Existing TreatmentsThe addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.Test Product Added to Existing Treatment
Planned Maximum Age of SubjectsC49694Planned Maximum Age of SubjectsThe anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)Planned Maximum Age of Subjects
Planned Minimum Age of SubjectsC49693Planned Minimum Age of SubjectsThe anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)Planned Minimum Age of Subjects
Age SpanC20587Age SpanSubgroups of populations based on age. (NCI)Age Group
Dose per AdministrationC25488Dose per AdministrationThe amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)Dose
Trial LengthC49697Trial LengthPlanned length of observation for a single subject.Trial Length
Planned Number of SubjectsC49692Planned Number of Subjects;Planned Enrollment;Target Enrollment;Anticipated EnrollmentThe planned number of subjects to be entered in a clinical trial. (NCI)Planned Subject Number
Trial is RandomizedC25196Trial is RandomizedThe process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)Randomization
Route of AdministrationC38114Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.Route of Administration
Sex of ParticipantsC49696Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)Sex of Study Group
Study Stop RulesC49698Study Stop RulesThe rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)Study Stop Rules
Trial Blinding SchemaC49658Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)Trial Blinding Schema
Control TypeC49647Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).Control Type
Diagnosis GroupC49650Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)Diagnosis Group
Trial Indication TypeC49652Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)Trial Indication Type
Trial TitleC49802Trial TitleThe name of a clinical trial. (NCI)Trial Title
Trial Phase ClassificationC48281Trial Phase ClassificationClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)Trial Phase
Trial TypeC49660Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)Trial Type
Current Therapy or TreatmentC85582Current Therapy or TreatmentThe literal identifier of the therapy or medication that is currently being given per protocol. This does not include treatment that has been given in the past.Current Therapy
Trial Primary ObjectiveC85826Trial Primary ObjectiveThe principal purpose of the trial.Trial Primary Objective
Trial Secondary ObjectiveC85827Trial Secondary ObjectiveThe auxiliary purpose of the trial.Trial Secondary Objective
Clinical Study SponsorC70793Clinical Study Sponsor;Study Sponsor;SponsorAn entity that is responsible for the initiation, management, and/or financing of a clinical study.Clinical Study Sponsor
Comparative Treatment NameC68612Comparative Treatment NameA therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.Active Comparator Drug
Dose UnitsC73558Dose UnitsThe unit of measure for the dosage form.Dosage Form Unit
Dosing FrequencyC89081Dosing FrequencyThe number of doses administered per a specific interval.Dose Frequency
Trial IndicationC41184Trial IndicationThe basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).Indication
Investigational Therapy or TreatmentC41161Investigational Therapy or TreatmentThe investigational product under study.Protocol Agent
Actual Number of SubjectsC98703Actual Number of SubjectsActual number of subjects enrolled; may include subjects who were not randomized.Actual Subject Number
Adaptive DesignC98704Adaptive DesignIndicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.Adaptive Design
Confirmed Response Minimum DurationC98715Confirmed Response Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.Confirmed Response Minimum Duration
Data Cutoff DescriptionC98718Data Cutoff DescriptionText that describes the cutoff date.Data Cutoff Date Description
Data Cutoff DateC98717Data Cutoff DateA date which indicates any data collected by this date will be used for analysis.Data Cutoff Date
Planned Country of Investigational Site(s)C98770Planned Country of Investigational Site(s)The country name of planned study facility which has received IRB approval.Planned Country of Investigational Site
Healthy Subject IndicatorC98737Healthy Subject IndicatorIndicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.Healthy Subject Indicator
Intervention ModelC98746Intervention ModelThe trial design developed to compare treatment groups.Intervention Model
Intervention TypeC98747Intervention TypeThe kind of product or procedure studied in a trial.Intervention Type
Planned Number of ArmsC98771Planned Number of ArmsThe planned number of intervention groups.Planned Number of Arms
Exploratory Outcome MeasureC98724Exploratory Outcome MeasureExploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.Exploratory Outcome Measure
Primary Outcome MeasureC98772Primary Outcome MeasureThe primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).Primary Outcome Measure
Secondary Outcome MeasureC98781Secondary Outcome MeasureOther key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).Secondary Outcome Measure
Pharmacological Class of Investigational TherapyC98768Pharmacological Class of Investigational TherapyThe pharmacological class of the investigational product.Pharmacological Class of Investigational Therapy
Randomization QuotientC98775Randomization QuotientThe randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.Randomization Quotient
Registry IdentifierC98714Registry IdentifierIdentification numbers assigned to the protocol by ct.gov, EudraCT, or other registries.Clinical Trial Registry Identifier
Stable Disease Minimum DurationC98783Stable Disease Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of stable disease.Stable Disease Minimum Duration
Study End DateC90462Study End DateFinal date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.Study End Date
Study Start DateC69208Study Start DateThe earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included.Study Date
Study TypeC15320Study TypeDescribes the role the study plays in determining the interventions a subject receives.Study Design
Back to top
CL.C66739.TTYPETrial Type
(TTYPE)
text
Extensible: Yes
C66739Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)CDISC SDTM Trial Type Terminology
BIO-AVAILABILITYC49664A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)Bioavailability Study
BIO-EQUIVALENCEC49665A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)Therapeutic Equivalency Study
EFFICACYC49666A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)Efficacy Study
PHARMACODYNAMICC49662A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)Pharmacodynamic Study
PHARMACOECONOMICC39493A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)Pharmacoeconomic Study
PHARMACOGENOMICC49661A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)Pharmacogenomic Study
PHARMACOKINETICC49663A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)Pharmacokinetic Study
SAFETYC49667A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests.Safety Study
FOOD EFFECTC98729Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug.Food Effect Study
TOLERABILITYC98791A type of safety study thatassesses the degree to which overt adverse effects can be toleratedby the subject.Tolerability Study
Back to top
CL.C66770.VSRESUUnits for Vital Signs Results
(VSRESU)
text
Extensible: Yes
C66770Units for Vital Signs ResultsThe unit used to record and describe the result of a test investigating a vital sign. (NCI)CDISC SDTM Unit for Vital Sign Result Terminology
%C25613PercentageA fraction or ratio with 100 understood as the denominator. (NCI)Percentage
BEATS/MINC49673Beats per MinuteThe number of heartbeats measured per minute time. (NCI)Beats per Minute
BREATHS/MINC49674Breaths per MinuteThe number of breaths (inhalation and exhalation) taken per minute time. (NCI)Breaths per Minute
CC42559Degree CelsiusA unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)Degree Celsius
cmC49668CentimeterA basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)Centimeter
FC44277Degree FahrenheitThe Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)Degree Fahrenheit
gC48155GramA metric unit of mass equal to one one thousandth of a kilogram. (NCI)Gram
INC48500InchA traditional unit of length equal to 2.54 centimeters. (NCI)Inch
kgC28252KilogramThe basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)Kilogram
kg/m2C49671Kilogram Per Square MeterThe SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)Kilogram Per Square Meter
LBC48531PoundA traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)Pound
m2C42569Square MeterThe SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)Square Meter
mmHgC49670Millimeter of MercuryA unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)Millimeter of Mercury
ohmC42554OhmA unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in Siemens. (NCI)Ohm
Back to top
CL.C66741.VSTESTCDVital Signs Test Code
(VSTESTCD)
text
Extensible: Yes
C66741Vital Signs Test CodeThe name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)CDISC SDTM Vital Sign Terminology by Code
BMIC16358Body Mass IndexA general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)Body Mass Index
BODYFATC12472Adipose TissueA specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.Adipose Tissue
BSAC25157Body Surface AreaA measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)Body Surface Area
DIABPC25299Diastolic Blood PressureThe blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)Diastolic Blood Pressure
FRMSIZEC49680Body Frame SizeThe categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)Body Frame Size
HEIGHTC25347HeightThe vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)Height
HRC49677Heart RateThe number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)Heart Rate
MAPC49679Mean Arterial PressureThe mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)Mean Arterial Pressure
PULSEC49676Pulse RateThe rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)Pulse Rate
RESPC49678Respiratory RateThe rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)Respiratory Rate
SYSBPC25298Systolic Blood PressureThe blood pressure during the contraction of the left ventricle of the heart.Systolic Blood Pressure
TEMPC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
WEIGHTC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
SADC87054Sagittal Abdominal DiameterA standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI)Sagittal Abdominal Diameter
KNEEHEELC84372Knee to Heel Length;Lower Leg LengthA measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)Knee to Heel Length Measurement
HDCIRCC81255Head CircumferenceA circumferential measurement of the head at the widest point, which is traditionally above the eyebrows.Head Circumference
SSSKNFC98785Subscapular Skinfold ThicknessA measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)Subscapular Skinfold Thickness
TRSKNFC98793Triceps Skinfold ThicknessA measurement of the thickness of a pinch of skin on the triceps. (NCI)Triceps Skinfold Thickness
FARMCIRC100946Forearm CircumferenceThe distance around an individual's forearm.Forearm Circumference
HIPCIRC100947Hip CircumferenceThe distance around an individual's pelvic area or hips.Hip Circumference
LBMC71258Lean Body MassThe weight of all organs and tissue in an individual less the weight of the individual's body fat.Lean Body Mass
PULSEPRC100945Pulse PressureThe change in systolic to diastolic pressure which produces a pulse.Pulse Pressure
WSTCIRC100948Waist CircumferenceThe distance around an individual's midsection or waist.Waist Circumference
Back to top
CL.C67153.VSTESTVital Signs Test Name
(VSTEST)
text
Extensible: Yes
C67153Vital Signs Test NameThe name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)CDISC SDTM Vital Sign Terminology by Name
Body Mass IndexC16358Body Mass IndexA general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)Body Mass Index
Adipose TissueC12472Adipose TissueA specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.Adipose Tissue
Body Surface AreaC25157Body Surface AreaA measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)Body Surface Area
Diastolic Blood PressureC25299Diastolic Blood PressureThe blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)Diastolic Blood Pressure
Body Frame SizeC49680Body Frame SizeThe categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)Body Frame Size
HeightC25347HeightThe vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)Height
Heart RateC49677Heart RateThe number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)Heart Rate
Mean Arterial PressureC49679Mean Arterial PressureThe mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)Mean Arterial Pressure
Pulse RateC49676Pulse RateThe rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)Pulse Rate
Respiratory RateC49678Respiratory RateThe rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)Respiratory Rate
Systolic Blood PressureC25298Systolic Blood PressureThe blood pressure during the contraction of the left ventricle of the heart.Systolic Blood Pressure
TemperatureC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
WeightC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
Sagittal Abdominal DiameterC87054Sagittal Abdominal DiameterA standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI)Sagittal Abdominal Diameter
Knee to Heel LengthC84372Knee to Heel Length;Lower Leg LengthA measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)Knee to Heel Length Measurement
Head CircumferenceC81255Head CircumferenceA circumferential measurement of the head at the widest point, which is traditionally above the eyebrows.Head Circumference
Subscapular Skinfold ThicknessC98785Subscapular Skinfold ThicknessA measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)Subscapular Skinfold Thickness
Triceps Skinfold ThicknessC98793Triceps Skinfold ThicknessA measurement of the thickness of a pinch of skin on the triceps. (NCI)Triceps Skinfold Thickness
Forearm CircumferenceC100946Forearm CircumferenceThe distance around an individual's forearm.Forearm Circumference
Hip CircumferenceC100947Hip CircumferenceThe distance around an individual's pelvic area or hips.Hip Circumference
Lean Body MassC71258Lean Body MassThe weight of all organs and tissue in an individual less the weight of the individual's body fat.Lean Body Mass
Pulse PressureC100945Pulse PressureThe change in systolic to diastolic pressure which produces a pulse.Pulse Pressure
Waist CircumferenceC100948Waist CircumferenceThe distance around an individual's midsection or waist.Waist Circumference
Back to top
CL.C66742.NYNo Yes Response
(NY)
text
Extensible: No
C66742No Yes ResponseA term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.CDISC SDTM Yes No Unknown or Not Applicable Response Terminology
NC49487NoThe non-affirmative response to a question. (NCI)No
NAC48660NADetermination of a value is not relevant in the current context. (NCI)Not Applicable
UC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
YC49488YesThe affirmative response to a question. (NCI)Yes
Back to top
CL.C65047.LBTESTCDLaboratory Test Code
(LBTESTCD)
text
Extensible: Yes
C65047Laboratory Test CodeTerminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.CDISC SDTM Laboratory Test Terminology by Code
ANISOC74797AnisocytesA measurement of the inequality in the size of the red blood cells in a whole blood specimen.Anisocyte Measurement
POIKILOC79602PoikilocytesA measurement of the odd-shaped erythrocytes in a whole blood specimen.Poikilocyte Measurement
BILIC38037Bilirubin;Total BilirubinA measurement of the total bilirubin in a biological specimen.Total Bilirubin Measurement
APTTC38462Activated Partial Thromboplastin TimeA measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.Partial Thromboplastin Time
GLUCC41376GlucoseA measurement of the glucose in a biological specimen.Plasma Glucose Measurement
PHC45997pHA measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.pH
RBCC51946Erythrocytes;Red Blood CellsA measurement of the total erythrocytes in a biological specimen.Erythrocyte Count
RETIC51947ReticulocytesA measurement of the reticulocytes in a biological specimen.Reticulocyte Count
WBCC51948Leukocytes;White Blood CellsA measurement of the leukocytes in a biological specimen.Leukocyte Count
LYMC51949LymphocytesA measurement of the lymphocytes in a biological specimen.Lymphocyte Count
PLATC51951PlateletsA measurement of the platelets in a biological specimen.Platelet Count
BUNC61019Blood Urea NitrogenA measurement of the urea nitrogen in a blood specimen.Blood Urea Nitrogen Measurement
CHOLC61032Cholesterol;Total CholesterolA measurement of the cholesterol in a biological specimen.Serum Total Cholesterol Measurement
HDLC61041HDL CholesterolA measurement of the high density lipoprotein cholesterol in a biological specimen.Serum HDL Cholesterol Measurement
LDLC61042LDL CholesterolA measurement of the low density lipoprotein cholesterol in a biological specimen.Serum LDL Cholesterol Measurement
PTC62656Prothrombin TimeA blood clotting measurement that evaluates the extrinsic pathway of coagulation.Prothrombin Time
NEUTC63321NeutrophilsA measurement of the neutrophils in a biological specimen.Absolute Neutrophil Count
ALBC64431Albumin;MicroalbuminA measurement of the albumin protein in a biological specimen.Albumin Measurement
ALPC64432Alkaline PhosphataseA measurement of the alkaline phosphatase in a biological specimen.Alkaline Phosphatase Measurement
ALTC64433Alanine Aminotransferase;SGPTA measurement of the alanine aminotransferase in a biological specimen.Alanine Aminotransferase Measurement
AMYLASEC64434AmylaseA measurement of the total enzyme amylase in a biological specimen.Amylase Measurement
ASTC64467Aspartate Aminotransferase;SGOTA measurement of the aspartate aminotransferase in a biological specimen.Aspartate Aminotransferase Measurement
BACTC64469BacteriaA measurement of the bacteria in a biological specimen.Bacterial Count
BASOC64470BasophilsA measurement of the basophils in a biological specimen.Total Basophil Count
BASOLEC64471Basophils/LeukocytesA relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.Basophil To Leukocyte Ratio
BILDIRC64481Direct BilirubinA measurement of the conjugated or water-soluble bilirubin in a biological specimen.Direct Bilirubin Measurement
BILINDC64483Indirect BilirubinA measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.Indirect Bilirubin Measurement
BLASTLEC64487Blasts/LeukocytesA relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.Blast To Leukocyte Ratio
CAC64488CalciumA measurement of the calcium in a biological specimen.Calcium Measurement
CKC64489Creatine KinaseA measurement of the total creatine kinase in a biological specimen.Creatine Kinase Measurement
CKBBC64490Creatine Kinase BBA measurement of the homozygous B-type creatine kinase in a biological specimen.Creatine Kinase BB Measurement
CKMBC64491Creatine Kinase MBA measurement of the heterozygous MB-type creatine kinase in a biological specimen.Creatine Kinase MB Measurement
CKMMC64494Creatine Kinase MMA measurement of the homozygous M-type creatine kinase in a biological specimen.Creatine Kinase MM Measurement
CLC64495ChlorideA measurement of the chloride in a biological specimen.Chloride Measurement
CO2C64545Carbon DioxideA measurement of the carbon dioxide gas in a biological specimen.Carbon Dioxide Measurement
COLORC64546ColorA measurement of the color of a biological specimen.Color Assessment
CREATC64547CreatinineA measurement of the creatinine in a biological specimen.Creatinine Measurement
CRPC64548C Reactive ProteinA measurement of the C reactive protein in a biological specimen.C-Reactive Protein Measurement
ELLIPCYC64549Elliptocytes;OvalocytesA measurement of the elliptically shaped erythrocytes in a biological specimen.Elliptocyte Count
EOSC64550EosinophilsA measurement of the eosinophils in a biological specimen.Eosinophil Count
EOSLEC64604Eosinophils/LeukocytesA relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.Eosinophil To Leukocyte Ratio
EPICC64605Epithelial CellsA measurement of the epithelial cells in a biological specimen.Epithelial Cell Count
FIBRINOC64606FibrinogenA measurement of the fibrinogen in a biological specimen.Fibrinogen Measurement
HCTC64796HematocritThe percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).Hematocrit
MCHC64797Ery. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin
MCHCC64798Ery. Mean Corpuscular HGB ConcentrationA quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin Concentration
MCVC64799Ery. Mean Corpuscular VolumeA quantitative measurement of the mean volume of erythrocytes in a biological specimen.Erythrocyte Mean Corpuscular Volume
RDWC64800Erythrocytes Distribution WidthA value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.Erythrocyte Distribution Width Measurement
TEARDCYC64801Dacryocytes;Tear Shaped Erythrocytes;Teardrop CellsA measurement of dacryocytes in a biological specimen.Dacryocyte Analysis
HPOCROMC64802HypochromiaAn observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.Hypochromia
POLYCHRC64803PolychromasiaA measurement of the blue-staining characteristic of newly generated erythrocytes.Polychromasia
INRC64805Prothrombin Intl. Normalized RatioA ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.International Normalized Ratio of Prothrombin Time
VLDLC64806VLDL CholesterolA measurement of the very low density lipoprotein cholesterol in a biological specimen.Serum VLDL Cholesterol Measurement
LIPASEC64807Triacylglycerol LipaseA measurement of the pancreatic lipase in a biological specimen.Triacylglycerol Lipase Measurement
SODIUMC64809SodiumA measurement of the sodium in a biological specimen.Sodium Measurement
NITRITEC64810NitriteA measurement of the nitrite in a urine specimen.Nitrite Measurement
TRIGC64812TriglyceridesA measurement of the triglycerides in a biological specimen.Triglyceride Measurement
TSHC64813ThyrotropinA measurement of the thyrotropin in a biological specimen.Thyrotropin Measurement
URATEC64814Urate;Uric AcidA measurement of the urate in a biological specimen.Urate Measurement
UREAC64815UreaA measurement of the urea in a biological specimen.Urea Measurement
UROBILC64816UrobilinogenA measurement of the urobilinogen in a biological specimen.Urobilinogen Measurement
VITB12C64817Vitamin B12A measurement of the Vitamin B12 in a serum specimen.Vitamin B12 Measurement
LYMATC64818Lymphocytes AtypicalA measurement of the atypical lymphocytes in a biological specimen.Atypical Lymphocyte Count
LYMATLEC64819Lymphocytes Atypical/LeukocytesA relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.Atypical Lymphocyte To Leukocyte Ratio
LYMLEC64820Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.Lymphocyte To Leukocyte Ratio
MACROCYC64821MacrocytesA measurement of the macrocytes in a biological specimen.Macrocyte Count
MICROCYC64822MicrocytesA measurement of the microcytes in a biological specimen.Microcyte Count
MONOC64823MonocytesA measurement of the monocytes in a biological specimen.Monocyte Count
MONOLEC64824Monocytes/LeukocytesA relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.Monocyte To Leukocyte Ratio
MYBLALEC64825Myeloblasts/LeukocytesA relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.Myeloblast To Leukocyte Ratio
MYCYLEC64826Myelocytes/LeukocytesA relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.Myelocyte To Leukocyte Ratio
NEUTLEC64827Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.Neutrophil To Leukocyte Ratio
RETIRBCC64828Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.Reticulocyte To Erythrocyte Ratio
PRLYMLEC64829Prolymphocytes/LeukocytesA relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.Prolymphocyte To Leukocyte Ratio
NEUTBC64830Neutrophils Band FormA measurement of the banded neutrophils in a biological specimen.Neutrophil Band Form Count
NEUTBLEC64831Neutrophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.Neutrophil Band Form To Leukocyte Ratio
SPGRAVC64832Specific GravityA ratio of the density of a fluid to the density of water.Specific Gravity
MGC64840MagnesiumA measurement of the magnesium in a biological specimen.Magnesium Measurement
GGTC64847Gamma Glutamyl TransferaseA measurement of the gamma glutamyl transferase in a biological specimen.Gamma Glutamyl Transpeptidase Measurement
HGBC64848HemoglobinA measurement of the hemoglobin in a biological specimen.Hemoglobin Measurement
HBA1CC64849Hemoglobin A1CA measurement of the glycosylated hemoglobin in a biological specimen.Glycosylated Hemoglobin Measurement
HBSAGC64850HBsAg;Hepatitis B Virus Surface AntigenA measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Virus Surface Antigen Measurement
HCGC64851Choriogonadotropin Beta;Pregnancy TestA measurement of the Choriogonadotropin Beta in a biological specimen.Choriogonadotropin Beta Measurement
KC64853PotassiumA measurement of the potassium in a biological specimen.Potassium Measurement
KETONESC64854KetonesA measurement of the ketones in a biological specimen.Ketone Measurement
LDHC64855Lactate DehydrogenaseA measurement of the lactate dehydrogenase in a biological specimen.Lactate Dehydrogenase Measurement
LEUKASEC64856Leukocyte EsteraseA measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.Leukocyte Esterase Measurement
PHOSC64857Phosphate;Phosphorus;Inorganic PhosphateA measurement of the phosphate in a biological specimen.Phosphate Measurement
PROTC64858ProteinA measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.Total Protein Measurement
PSAC17634Prostate Specific AntigenA measurement of the prostate specific antigen in a biological specimen.Prostate Specific Antigen Measurement
CREATCLRC25747Creatinine ClearanceA measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).Creatinine Clearance
HAIRYCEC74604Hairy CellsA measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.Hairy Cell Count
BLASTC74605BlastsA measurement of the blast cells in a biological specimen.Blast Count
CD19C74606CD19A count of the CD19 B cells per unit of a biological specimen.CD19 Expressing B Cell Count
CD3C74607CD3A count of the CD3 T cells per unit of a biological specimen.CD3 Expressing T Cell Count
CD4C74608CD4A count of the CD4 T cells per unit of a biological specimen.CD4 Expressing T Cell Count
CD8C74609CD8A count of the CD8 T cells per unit of a biological specimen.CD8 Expressing T Cell Count
DOHLEC74610Dohle BodiesA measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.Dohle Body Measurement
ESRC74611Erythrocyte Sedimentation Rate;Biernacki ReactionThe distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).Erythrocyte Sedimentation Rate Measurement
HYPSEGCEC74612Hypersegmented CellsA measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.Hypersegmented Neutrophil Measurement
LYMMCEC74613Lymphoma CellsA measurement of the malignant lymphocytes in a biological specimen.Lymphoma Cell Count
MAYHEGC74614May-Hegglin AnomalyA measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.May-Hegglin Anomaly Measurement
METAMYC74615MetamyelocytesA measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.Metamyelocyte Count
PAPPENC74616Pappenheimer BodiesA measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.Pappenheimer Body Count
PELGERHC74617Pelger Huet AnomalyA measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.Pelger Huet Anomaly Measurement
LYMPLC74618Plasmacytoid Lymphocytes;PlymphocytesA measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.Plasmacytoid Lymphocyte Count
PLSPCEC74619Precursor Plasma Cells;PlasmablastA measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.Precursor Plasma Cell Count
PROLYMC74620ProlymphocytesA measurement of the prolymphocytes in a biological specimen.Prolymphocyte Count
PROMONOC74621PromonocytesA measurement of the promonocytes in a biological specimen.Promonocyte Count
PROMYC74622PromyelocytesA measurement of the promyelocytes (immature myelocytes) in a biological specimen.Promyelocyte Count
ROULEAUXC74624Rouleaux FormationA measurement of the number of stacking red blood cells within a biological specimen.Rouleaux Formation Count
SEZCEC74625Sezary CellsA measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.Sezary Cell Count
SCKLCEC74626Sickle CellsA measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.Sickle Cell Count
SMDGCEC74627Smudge Cells;Basket CellsA measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.Smudge Cell Count
NEUTVACC74628Vacuolated NeutrophilsA measurement of the neutrophils containing small vacuoles in a biological specimen.Vacuolated Neutrophil Count
BLASTLMC74630Leukemic Blasts;Leukemic Lymphoblasts;Immunoblastic LymphocytesA measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.Leukemic Blast Count
MONOBLC74631MonoblastsA measurement of the monoblast cells in a biological specimen.Monoblast Count
MYBLAC74632MyeloblastsA measurement of the myeloblast cells in a biological specimen.Myeloblast Count
ACANTRBCC74633Acanthocytes/ErythrocytesA relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.Acanthocyte to Erythrocyte Ratio Measurement
BTECERBCC74634Bite Cells/ErythrocytesA relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen .Bite Cell to Erythrocyte Ratio Measurement
CD19LYC74635CD19/LymphocytesA relative measurement (ratio or percentage) of CD19 B cells to all lymphocytes in a biological specimen.CD19 B Cell to Lymphocyte Ratio Measurement
CD3LYC74636CD3/LymphocytesA relative measurement (ratio or percentage) of CD3 T cells to all lymphocytes in a biological specimen.CD3 T Cell to Lymphocyte Ratio Measurement
CD4CD8C74637CD4/CD8A relative measurement (ratio or percentage) of CD4 T cells to the CD8 T cells in a biological specimen.CD4 T Cell to CD8 T Cell Ratio Measurement
CD4LYC74638CD4/LymphocytesA relative measurement (ratio or percentage) of CD4 T cells to all lymphocytes in a biological specimen.CD4 T Cell to Lymphocyte Ratio Measurement
CD8LYC74639CD8/LymphocytesA relative measurement (ratio or percentage) of CD8 T cells to all lymphocytes in a biological specimen.CD8 T Cell to Lymphocyte Ratio Measurement
HRYCELYC74640Hairy Cells/LymphocytesA relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .Hairy Cell to Lymphocyte Ratio Measurement
BLSTLMLYC74641Leukemic Blasts/LymphocytesA relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.Leukemic Blast to Lymphocyte Ratio Measurement
MLIGCEBCC74643Malignant Cells, NOS/Blood CellsA relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.Malignant Cell to Blood Cell Ratio Measurement
METAMYLEC74645Metamyelocytes/LeukocytesA relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.Metamyelocyte to Leukocyte Ratio Measurement
MONOBLLEC74646Monoblasts/LeukocytesA relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.Monoblast to Leukocyte Ratio Measurement
RBCNURBCC74647Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/ErythrocytesA relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.Nucleated Red Blood Cell to Erythrocyte Ratio Measurement
LYMPLLYC74648Plasmacytoid Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement
POIKRBCC74649Poikilocytes/ErythrocytesA relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.Poikilocyte to Erythrocyte Ratio Measurement
PLSPCELYC74650Precursor Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.Precursor Plasma Cell to Lymphocyte Ratio Measurement
PROLYMLYC74651Prolymphocytes/LymphocytesA relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.Prolymphocyte to Lymphocyte Ratio Measurement
PROMONLEC74652Promonocytes/LeukocytesA relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.Promonocyte to Lymphocyte Ratio Measurement
PROMYLEC74653Promyelocytes/LeukocytesA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.Promyelocyte to Lymphocyte Ratio Measurement
LYMRCTLYC74654Reactive Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.Reactive Lymphocyte to Lymphocyte Ratio Measurement
SEZCELYC74655Sezary Cells/LymphocytesA relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.Sezary Cell to Lymphocyte Ratio Measurement
SCKCERBCC74656Sickle Cells/ErythrocytesA relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.Sickle Cell to Erythrocyte Ratio Measurement
AUERRODSC74657Auer RodsA measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.Auer Rod Measurement
HELMETCEC74658Helmet CellsA measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.Helmet Cell Count
LGUNSCEC74659Large Unstained CellsA measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.Large Unstained Cell Count
MLIGCEC74660Malignant Cells, NOSA measurement of the malignant cells of all types in a biological specimen.Malignant Cell Count
PLSMCEC74661Mature Plasma Cells;PlasmacytesA measurement of the mature plasma cells (plasmacytes) in a biological specimen.Mature Plasma Cell Count
MYCYC74662MyelocytesA measurement of the myelocytes in a biological specimen.Myelocyte Count
SPERMC74663SpermatozoaA measurement of the spermatozoa cells present in a biological specimen.Spermatozoa Cell Count
YEASTC74664Yeast CellsA measurement of the yeast cells present in a biological specimen.Yeast Cell Measurement
CYAMORPHC74665Amorphous CrystalsA measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.Amorphous Crystal Measurement
AMORPHSDC74666Amorphous Sediment;Amorphous DebrisA measurement of the amorphous sediment present in a biological specimen.Amorphous Sediment Measurement
BICARBC74667Bicarbonate;HCO3A measurement of the bicarbonate in a biological specimen.Bicarbonate Measurement
CYBILIC74668Bilirubin CrystalsA measurement of the bilirubin crystals present in a biological specimen.Bilirubin Crystal Measurement
CYCACARC74669Calcium Carbonate CrystalsA measurement of the calcium carbonate crystals present in a biological specimen.Calcium Carbonate Crystal Measurement
CYCAOXAC74670Calcium Oxalate CrystalsA measurement of the calcium oxalate crystals present in a biological specimen.Calcium Oxalate Crystal Measurement
CYCAPHOSC74671Calcium Phosphate CrystalsA measurement of the calcium phosphate crystals present in a biological specimen.Calcium Phosphate Crystal Measurement
CYCHOLC74672Cholesterol CrystalsA measurement of the cholesterol crystals present in a biological specimen.Cholesterol Crystal Measurement
CRYSTALSC74673CrystalsA statement that indicates crystals were looked for and not found in a biological specimen.Crystal Present Or Absent
CYCYSTINC74674Cystine CrystalsA measurement of the cystine crystals present in a biological specimen.Cystine Crystal Measurement
VITB9C74676Folic Acid;Vitamin B9A measurement of the folic acid in a biological specimen.Folic Acid Measurement
CARNITFC74677Carnitine, FreeA measurement of the free carnitine in a biological specimen.Free Carnitine Measurement
FRUCTC74678Fructosamine;Glycated Serum ProteinA measurement of the fructosamine in a biological specimen.Fructosamine Measurement
IRONC74679Iron;FEA measurement of the iron in a biological specimen.Iron Measurement
CYLEUCC74680Leucine CrystalsA measurement of the leucine crystals present in a biological specimen.Leucine Crystal Measurement
CYMSUC74681Monosodium Urate CrystalsA measurement of the monosodium urate crystals present in a biological specimen.Monosodium Urate Crystal Measurement
CARNITC74682CarnitineA measurement of the total carnitine in a biological specimen.Total Carnitine Measurement
CYTYROC74683Tyrosine CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Tyrosine Crystal Measurement
CYURIACC74684Uric Acid CrystalsA measurement of the uric acid crystals present in a biological specimen.Uric Acid Crystal Measurement
ANIONGC74685Anion GapA computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.Anion Gap Measurement
OCCBLDC74686Occult BloodA measurement of the blood in body products such as a stool sample, not detectable on gross examination.Occult Blood Measurement
AMPHETC74687AmphetamineA measurement of any amphetamine class drug present in a biological specimen.Amphetamine Drug Class Measurement
BARBC74688BarbituratesA measurement of any barbiturate class drug present in a biological specimen.Barbiturate Drug Class Measurement
CANNABC74689CannabinoidsA measurement of any cannabinoid class drug present in a biological specimen.Cannabinoid Drug Class Measurement
COCAINEC74690CocaineA measurement of the cocaine present in a biological specimen.Cocaine Measurement
EPIROCEC74698Round Epithelial CellsA measurement of the round epithelial cells present in a biological specimen.Round Epithelial Cell Count
ACANTC74699AcanthocytesA measurement of the acanthocytes in a biological specimen.Acanthocyte Count
BITECEC74700Bite CellsA measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen .Bite Cell Count
BURRCEC74701Burr Cells;KeratocytesA measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.Burr Cell Count
CABOTC74702Cabot RingsA measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.Cabot Ring Count
CRENCEC74703Crenated Cells;EchinocytesA measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.Crenated Cell Measurement
HOWJOLC74704Howell-Jolly BodiesA measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.Howell-Jolly Body Measurement
RBCNUCC74705Nucleated Erythrocytes;Nucleated Red Blood CellsA measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.Nucleated Red Blood Cell Count
SCHISTOC74706SchistocytesA measurement of the schistocytes (fragmented red blood cells) in a biological specimen.Schistocyte Count
SPHEROC74707SpherocytesA measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.Spherocyte Count
STOMCYC74708StomatocytesA measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.Stomatocyte Count
HEINZC74709Heinz Bodies;Heinz-Erhlich BodiesA measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.Heinz-Ehrlich Body Measurement
HAABC92534Hepatitis A Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.Hepatitis A Antibody Measurement
HBSABC74711Anti-HBs;HBsAb;Hepatitis B Virus Surface AntibodyA measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Surface Antibody Measurement
HCABC92535Hepatitis C Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.Hepatitis C Antibody Measurement
HIV1ABC74713HIV-1 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-1 virus.HIV-1 Antibody Measurement
HIV12ABC74714HIV-1/2 AntibodyA measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.HIV-1 HIV-2 Antibody Measurement
HIV2ABC74715HIV-2 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-2 virus.HIV-2 Antibody Measurement
RPRC74716Rapid Plasma ReaginA measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.Rapid Plasma Reagin Measurement
RFC74717Rheumatoid FactorA measurement of the rheumatoid factor antibody in a biological specimen.Rheumatoid Factor Measurement
IBCTC74718Total Iron Binding CapacityA measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.Total Iron Binding Capacity
IBCUC74719Unsaturated Iron Binding CapacityA measurement of the binding capacity of unsaturated iron in a biological specimen.Unsaturated Iron Binding Capacity Measurement
MUCTHRC74721Mucous ThreadsA measurement of the mucous threads present in a biological specimen.Mucous Thread Measurement
TURBC74723TurbidityA measurement of the opacity of a biological specimen.Turbidity Measurement
HAVVLDC92541HAV Viral LoadA measurement of the hepatitis A viral load in a biological specimen.Hepatitis A Viral Load Measurement
HBVVLDC92542HBV Viral LoadA measurement of the hepatitis B viral load in a biological specimen.Hepatitis B Viral Load Measurement
HCVVLDC92543HCV Viral LoadA measurement of the hepatitis C viral load in a biological specimen.Hepatitis C Viral Load Measurement
HIVVLDC92544HIV Viral LoadA measurement of the HIV viral load in a biological specimen.HIV Viral Load Measurement
PLATGNTC74728Giant PlateletsA measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.Giant Platelet Count
PLATLRGC74729Large PlateletsA measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.Large Platelet Count
MPVC74730Mean Platelet VolumeA measurement of the average size of the platelets present in a blood sample.Mean Platelet Volume Measurement
ALDOLASEC74731AldolaseA measurement of the aldolase enzyme in a biological specimen.Aldolase Measurement
AFPC74732Alpha FetoproteinA measurement of the alpha fetoprotein in a biological specimen.Alpha-fetoprotein Measurement
APOA1C74733Apolipoprotein A1A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.Apolipoprotein A1 Measurement
APOBC74734Apolipoprotein BA measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.Apolipoprotein B Measurement
BNPC74735Brain Natriuretic Peptide;B-Type Natriuretic PeptideA measurement of the brain (B-type) natriuretic peptide in a biological specimen.Brain Natriuretic Peptide Measurement
CPEPTIDEC74736C-peptideA measurement of the C (connecting) peptide of insulin in a biological specimen.C-peptide Measurement
FERRITINC74737FerritinA measurement of the ferritin in a biological specimen.Ferritin Measurement
GLOBULC74738GlobulinA measurement of the globulin protein in a biological specimen.Globulin Protein Measurement
GLUTAMC74739Glutamate;Glutamic AcidA measurement of the glutamate in a biological specimen.Glutamate Measurement
HAPTOGC74740HaptoglobinA measurement of the haptoglobin protein in a biological specimen.Haptoglobin Protein Measurement
HOMOCYC74741HomocysteineA measurement of the homocysteine amino acid in a biological specimen.Homocysteine Acid Measurement
NTELOPC74743N-telopeptideA measurement of the N-telopeptide in a biological specimen.N-telopeptide Measurement
OSTEOCC74744OsteocalcinA measurement of the osteocalcin in a biological specimen.Osteocalcin Measurement
SHBGC74745Sex Hormone Binding Globulin;Sex Hormone Binding ProteinA measurement of the sex hormone binding (globulin) protein in a biological specimen.Sex Hormone Binding Protein Measurement
TBGC74746Thyroxine Binding GlobulinA measurement of the thyroxine binding globulin protein in a biological specimen.Thyroxine Binding Globulin Protein Measurement
T3C74747Triiodothyronine;Total T3A measurement of the total (free and bound) triiodothyronine in a biological specimen.Triiodothyronine Measurement
T3UPC74748Triiodothyronine UptakeA measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.Triiodothyronine Uptake Measurement
TROPONIC74749Troponin IA measurement of the actin binding troponin in a biological specimen.Troponin I Measurement
TROPONTC74750Troponin TA measurement of the tropomyosin binding troponin in a biological specimen.Troponin T Measurement
TNFC74751Tumor Necrosis Factor;Tumor Necrosis Factor alphaA measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.Tumor Necrosis Factor Measurement
BUNCREATC74753BUN/CreatinineA relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.Blood Urea Nitrogen To Creatinine Ratio Measurement
CYHIPPACC74754Hippuric Acid CrystalsA measurement of the hippuric acid crystals present in a biological specimen.Hippuric Acid Crystal Measurement
CYSULFAC74755Sulfa CrystalsA measurement of the sulfa crystals present in a biological specimen.Sulfa Crystal Measurement
CYTRPHOSC74756Triple Phosphate CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Triple Phosphate Crystal Measurement
CYUNCLAC74757Unclassified CrystalsA measurement of the unclassifiable crystals present in a biological specimen.Unclassified Crystal Measurement
CYAMMBIUC74758Ammonium Biurate Crystals;Ammonium UrateA measurement of the ammonium biurate crystals present in a biological specimen.Urine Ammonium Biurate Crystal Measurement
CYAMMOXC74759Ammonium Oxalate CrystalsA measurement of the ammonium oxalate crystals present in a urine specimen.Urine Ammonium Oxalate Crystal Measurement
ALBCREATC74761Albumin/Creatinine;Microalbumin/Creatinine RatioA relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.Albumin To Creatinine Protein Ratio Measurement
CSBACTC74762Bacterial CastsA measurement of the bacterial casts present in a biological specimen.Bacterial Cast Measurement
CASTSC74763CastsA statement that indicates casts were looked for and not found in a biological specimen.Cast Present Or Absent
CSCELLC74764Cellular CastsA measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.Cellular Cast Measurement
CSGRANCC74765Granular Coarse CastsA measurement of the coarse granular casts present in a biological specimen.Coarse Granular Cast Measurement
CSFATC74766Fatty CastsA measurement of the fatty casts present in a biological specimen.Fatty Cast Measurement
CSGRANC74768Granular CastsA measurement of the granular (coarse and fine) casts present in a biological specimen.Granular Cast Measurement
CSGRANFC74769Granular Fine CastsA measurement of the fine granular casts present in a biological specimen.Granular Fine Cast Measurement
CSHYALC74770Hyaline CastsA measurement of the hyaline casts present in a biological specimen.Hyaline Cast Measurement
CSMIXC74771Mixed CastsA measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.Mixed Cast Count
CSRBCC74772RBC CastsA measurement of the red blood cell casts present in a biological specimen.Red Blood Cell Cast Measurement
EPISQCEC74773Squamous Epithelial CellsA measurement of the squamous epithelial cells present in a biological specimen.Squamous Epithelial Cell Count
EPISQTCEC74774Squamous Transitional Epithelial Cells;Epithelial CellsA measurement of the squamous transitional epithelial cells present in a biological specimen.Squamous Transitional Epithelial Cell Count
EPITUCEC74775Tubular Epithelial Cells;Renal Tubular Epithelial CellsA measurement of the tubular epithelial cells present in a biological specimen.Tubular Epithelial Cell Count
CSUNCLAC74776Unclassified CastsA measurement of the unclassifiable casts present in a biological specimen.Unclassified Cast Measurement
CSWAXC74777Waxy CastsA measurement of the waxy casts present in a biological specimen.Waxy Cell Cast Measurement
CSWBCC74778WBC CastsA measurement of the white blood cell casts present in a biological specimen.White Blood Cell Cast Measurement
CSEPIC74779Epithelial CastsA measurement of the epithelial cell casts present in a biological specimen.Epithelial-Cast Measurement
ACTHC74780Adrenocorticotropic HormoneA measurement of the adrenocorticotropic hormone in a biological specimen.Adrenocorticotropic Hormone Measurement
CORTISOLC74781Cortisol;Total CortisolA measurement of the cortisol in a biological specimen.Cortisol Measurement
ESTRDIOLC74782Estradiol;OestradiolA measurement of the estradiol in a biological specimen.Estradiol Measurement
FSHC74783Follicle Stimulating HormoneA measurement of the follicle stimulating hormone (FSH) in a biological specimen.Follicle Stimulating Hormone Measurement
PTHFGC74784Parathyroid Hormone, FragmentedA measurement of the fragmented parathyroid hormone in a biological specimen.Fragmented Parathyroid Hormone Measurement
TESTOSFRC74785Testosterone, FreeA measurement of the free testosterone in a biological specimen.Free Testosterone Measurement
T4FRC74786Thyroxine, Free;Free T4A measurement of the free thyroxine in a biological specimen.Free Thyroxine Measurement
T3FRC74787Triiodothyronine, Free;Free T3A measurement of the free triiodothyronine in a biological specimen.Free Triiodothyronine Measurement
INSULINC74788InsulinA measurement of the insulin in a biological specimen.Insulin Measurement
PTHIC74789Parathyroid Hormone, IntactA measurement of the intact parathyroid hormone in a biological specimen.Intact Parathyroid Hormone Measurement
LHC74790Luteinizing HormoneA measurement of the luteinizing hormone in a biological specimen.Luteinizing Hormone Measurement
PROGESTC74791ProgesteroneA measurement of the progesterone hormone in a biological specimen.Progesterone Measurement
SOMATROC80360Somatotrophin;Growth HormoneA measurement of the somatotrophin (growth) hormone in a biological specimen.Somatotropin Measurement
TESTOSC74793Testosterone;Total TestosteroneA measurement of the total (free and bound) testosterone in a biological specimen.Total Testosterone Measurement
T4C74794Thyroxine;Total T4A measurement of the total (free and bound) thyroxine in a biological specimen.Total Thyroxine Measurement
OPIATEC74796OpiateA measurement of any opiate class drug present in a biological specimen.Opiate Measurement
LYMMCELYC74910Lymphoma Cells/LymphocytesA relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.Lymphoma Cell to Lymphocyte Ratio Measurement
PLSMCELYC74911Mature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.Mature Plasma Cell to Lymphocyte Ratio Measurement
CYACIDUC74912Acid Urate CrystalsA measurement of the ammonium acid urate crystals present in a biological specimen.Acid Urate Crystal Measurement
ADSDNAC74913Anti-Double Stranded DNAA measurement of the anti-double stranded DNA antibody in a biological specimen.Anti-Double Stranded DNA Measurement
ANAC74916Antinuclear AntibodiesA measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.Antinuclear Antibody Measurement
NCTD5PC794375 Prime Nucleotidase;5'-Ribonucleotide PhosphohydrolaseA measurement of the 5'-nucleotidase in a biological specimen.5 Prime Nucleotidase Measurement
SIXMAMC748766-MonoacetylmorphineA measurement of the 6-monoacetylmorphine present in a biological specimen.6-Monoacetylmorphine Measurement
ACHC74838AcetylcholineA measurement of the acetylcholine hormone in a biological specimen.Acetylcholine Measurement
ADPNCTNC74839AdiponectinA measurement of the adiponectin hormone in a biological specimen.Adiponectin Measurement
ALBGLOBC74894Albumin/GlobulinThe ratio of albumin to globulin in a biological specimen.Albumin to Globulin Ratio Measurement
ALDSTRNC74841AldosteroneA measurement of the aldosterone hormone in a biological specimen.Aldosterone Measurement
ALPCREATC79438Alkaline Phosphatase/CreatinineA relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.Alkaline Phosphatase to Creatinine Ratio Measurement
GSTALC79433Alpha Glutathione-S-TransferaseA measurement of the alpha form of glutathione S-transferase in a biological specimen.Alpha Glutathione-S-Transferase Measurement
AMMONIAC74799Ammonia;NH3A measurement of the ammonia in a biological specimen.Ammonia Measurement
ANDSTNDLC74842AndrostenediolA measurement of the androstenediol metabolite in a biological specimen.Androstenediol Metabolite Measurement
ANDSTNDNC74843Androstenedione;4-AndrostenedioneA measurement of the androstenedione hormone in a biological specimen.Androstenedione Measurement
ANGTNS1C74844Angiotensin IA measurement of the angiotensin I hormone in a biological specimen.Angiotensin I Measurement
ANGTNS2C74845Angiotensin IIA measurement of the angiotensin II hormone in a biological specimen.Angiotensin II Measurement
ANGTNSGNC74846Angiotensinogen;Angiotensin PrecursorA measurement of the angiotensinogen hormone in a biological specimen.Angiotensinogen Measurement
ANTIDPRSC74691AntidepressantsA measurement of any antidepressant class drug present in a biological specimen.Antidepressant Measurement
ADHC74847Antidiuretic Hormone;VasopressinA measurement of the antidiuretic hormone in a biological specimen.Antidiuretic Hormone Measurement
ANPC74886Atrial Natriuretic Peptide;AtriopeptinA measurement of the atrial natriuretic peptide in a biological specimen.Atrial Natriuretic Peptide Measurement
BNZDZPNC74692BenzodiazepineA measurement of any benzodiazepine class drug present in a biological specimen.Benzodiazepine Measurement
BILEACC74800Bile Acid;Bile Salts;Bile Acids;Bile SaltA measurement of the total bile acids in a biological specimen.Bile Acid Measurement
CLCTONNC74848CalcitoninA measurement of the calcitonin hormone in a biological specimen.Calcitonin Measurement
CLCTRIOLC74849CalcitriolA measurement of the calcitriol hormone in a biological specimen.Calcitriol Measurement
CACREATC79439Calcium/CreatinineA relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.Calcium to Creatinine Ratio Measurement
CLCREATC79440Chloride/CreatinineA relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.Chloride to Creatinine Ratio Measurement
CCKC74850Cholecystokinin;PancreozyminA measurement of the cholecystokinin hormone in a biological specimen.Cholecystokinin Measurement
CODEINEC74877CodeineA measurement of the codeine present in a biological specimen.Codeine Measurement
CRTRONEC79434CorticosteroneA measurement of corticosterone in a biological specimen.Corticosterone Measurement
CRHC74851Corticotropin Releasing Hormone;Corticotropin Releasing FactorA measurement of the corticotropin releasing hormone in a biological specimen.Corticotropin Releasing Hormone Measurement
CKBBCKC79466Creatine Kinase BB/Total Creatine KinaseA relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase BB to Total Creatine Kinase Ratio Measurement
CKMBCKC79441Creatine Kinase MB/Total Creatine KinaseA relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MB to Total Creatine Kinase Ratio Measurement
CKMMCKC79442Creatine Kinase MM/Total Creatine KinaseA relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MM to Total Creatine Kinase Ratio Measurement
DHEAC74852Dehydroepiandrosterone;DehydroisoandrosteroneA measurement of the dehydroepiandrosterone hormone in a biological specimen.Dehydroepiandrosterone Measurement
DPDC79443DeoxypyridinolineA measurement of the deoxypyridinoline in a biological specimen.Deoxypyridinoline Measurement
DPDCREATC79444Deoxypyridinoline/CreatinineA relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.Deoxypyridinoline to Creatinine Ratio Measurement
DIHYDCDNC74878DihydrocodeineA measurement of the dihydrocodeine present in a biological specimen.Dihydrocodeine Measurement
DHTC74853Dihydrotestosterone;AndrostanaloneA measurement of the dihydrotestosterone hormone in a biological specimen.Dihydrotestosterone Measurement
DOPAMINEC74854DopamineA measurement of the dopamine hormone in a biological specimen.Dopamine Measurement
EPINC79445Epinephrine;AdrenalineA measurement of the epinephrine hormone in a biological specimen.Epinephrine Measurement
EPOC74855Erythropoietin;HematopoietinA measurement of the erythropoietin hormone in a biological specimen.Erythropoietin Measurement
ESTRIOLC74856Estriol;OestriolA measurement of the estriol hormone in a biological specimen.Estriol Measurement
ESTRONEC74857Estrone;OestroneA measurement of the estrone hormone in a biological specimen.Estrone Measurement
ETHANOLC74693Ethanol;AlcoholA measurement of the ethanol present in a biological specimen.Ethanol Measurement
GGTCREATC79446Gamma Glutamyl Transferase/CreatinineA relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.Gamma Glutamyl Transferase to Creatinine Ratio Measurement
GASTRINC74858GastrinA measurement of the gastrin hormone in a biological specimen.Gastrin Measurement
GLUCAGONC74859GlucagonA measurement of the glucagon hormone in a biological specimen.Glucagon Measurement
GLUCCRTC79447Glucose/CreatinineA relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.Glucose to Creatinine Ratio Measurement
GLDHC79448Glutamate DehydrogenaseA measurement of the glutamate dehydrogenase in a biological specimen.Glutamate Dehydrogenase Measurement
GSTCREATC79435Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.Glutathione-S-Transferase to Creatinine Ratio Measurement
GNRHC74860Gonadotropin Releasing Hormone;Luteinising Hormone Releasing HormoneA measurement of the gonadotropin releasing hormone in a biological specimen.Gonadotropin Releasing Hormone Measurement
GRWHIHC74861Growth Hormone Inhibiting Hormone;SomatostatinA measurement of the growth hormone inhibiting hormone in a biological specimen.Growth Hormone Inhibiting Hormone Measurement
GRWHRHC74862Growth Hormone Releasing Hormone;SomatocrininA measurement of the growth hormone releasing hormone in a biological specimen.Growth Hormone Releasing Hormone Measurement
HVAC74863Homovanillic AcidA measurement of the homovanillic acid metabolite in a biological specimen.Homovanillic Acid Measurement
HYDCDNC74879HydrocodoneA measurement of the hydrocodone present in a biological specimen.Hydrocodone Measurement
HYDMRPHNC74880HydromorphoneA measurement of the hydromorphone present in a biological specimen.Hydromorphone Measurement
IGF1C74864Insulin-like Growth Factor-1A measurement of the insulin-like growth factor-1 in a biological specimen.Insulin Like Growth Factor-1 Measurement
IGF2C74865Insulin-like Growth Factor-2A measurement of the insulin-like growth factor-2 in a biological specimen.Insulin Like Growth Factor-2 Measurement
INTLK1C74805Interleukin 1A measurement of the interleukin 1 in a biological specimen.Interleukin 1 Measurement
INTLK10C74806Interleukin 10A measurement of the interleukin 10 in a biological specimen.Interleukin 10 Measurement
INTLK11C74807Interleukin 11A measurement of the interleukin 11 in a biological specimen.Interleukin 11 Measurement
INTLK12C74808Interleukin 12A measurement of the interleukin 12 in a biological specimen.Interleukin 12 Measurement
INTLK13C74809Interleukin 13A measurement of the interleukin 13 in a biological specimen.Interleukin 13 Measurement
INTLK14C74810Interleukin 14A measurement of the interleukin 14 in a biological specimen.Interleukin 14 Measurement
INTLK15C74811Interleukin 15A measurement of the interleukin 15 in a biological specimen.Interleukin 15 Measurement
INTLK16C74812Interleukin 16A measurement of the interleukin 16 in a biological specimen.Interleukin 16 Measurement
INTLK17C74813Interleukin 17A measurement of the interleukin 17 in a biological specimen.Interleukin 17 Measurement
INTLK18C74814Interleukin 18A measurement of the interleukin 18 in a biological specimen.Interleukin 18 Measurement
INTLK19C74815Interleukin 19A measurement of the interleukin 19 in a biological specimen.Interleukin 19 Measurement
INTLK2C74816Interleukin 2A measurement of the interleukin 2 in a biological specimen.Interleukin 2 Measurement
INTLK20C74817Interleukin 20A measurement of the interleukin 20 in a biological specimen.Interleukin 20 Measurement
INTLK21C74818Interleukin 21A measurement of the interleukin 21 in a biological specimen.Interleukin 21 Measurement
INTLK22C74819Interleukin 22A measurement of the interleukin 22 in a biological specimen.Interleukin 22 Measurement
INTLK23C74820Interleukin 23A measurement of the interleukin 23 in a biological specimen.Interleukin 23 Measurement
INTLK24C74821Interleukin 24A measurement of the interleukin 24 in a biological specimen.Interleukin 24 Measurement
INTLK25C74822Interleukin 25A measurement of the interleukin 25 in a biological specimen.Interleukin 25 Measurement
INTLK26C74823Interleukin 26A measurement of the interleukin 26 in a biological specimen.Interleukin 26 Measurement
INTLK27C74824Interleukin 27A measurement of the interleukin 27 in a biological specimen.Interleukin 27 Measurement
INTLK28C74825Interleukin 28A measurement of the interleukin 28 in a biological specimen.Interleukin 28 Measurement
INTLK29C74826Interleukin 29A measurement of the interleukin 29 in a biological specimen.Interleukin 29 Measurement
INTLK3C74827Interleukin 3A measurement of the interleukin 3 in a biological specimen.Interleukin 3 Measurement
INTLK30C74828Interleukin 30A measurement of the interleukin 30 in a biological specimen.Interleukin 30 Measurement
INTLK31C74829Interleukin 31A measurement of the interleukin 31 in a biological specimen.Interleukin 31 Measurement
INTLK32C74830Interleukin 32A measurement of the interleukin 32 in a biological specimen.Interleukin 32 Measurement
INTLK33C74831Interleukin 33A measurement of the interleukin 33 in a biological specimen.Interleukin 33 Measurement
INTLK4C74832Interleukin 4A measurement of the interleukin 4 in a biological specimen.Interleukin 4 Measurement
INTLK5C74833Interleukin 5A measurement of the interleukin 5 in a biological specimen.Interleukin 5 Measurement
INTLK6C74834Interleukin 6A measurement of the interleukin 6 in a biological specimen.Interleukin 6 Measurement
INTLK7C74835Interleukin 7A measurement of the interleukin 7 in a biological specimen.Interleukin 7 Measurement
INTLK8C74836Interleukin 8A measurement of the interleukin 8 in a biological specimen.Interleukin 8 Measurement
INTLK9C74837Interleukin 9A measurement of the interleukin 9 in a biological specimen.Interleukin 9 Measurement
LDH1C74887LDH Isoenzyme 1A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.Lactate Dehydrogenase Isoenzyme 1 Measurement
LDH2C74888LDH Isoenzyme 2A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.Lactate Dehydrogenase Isoenzyme 2 Measurement
LDH3C74889LDH Isoenzyme 3A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.Lactate Dehydrogenase Isoenzyme 3 Measurement
LDH4C74890LDH Isoenzyme 4A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.Lactate Dehydrogenase Isoenzyme 4 Measurement
LDH5C74891LDH Isoenzyme 5A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.Lactate Dehydrogenase Isoenzyme 5 Measurement
LDHCREATC79449Lactate Dehydrogenase/CreatinineA relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.Lactate Dehydrogenase to Creatinine Ratio Measurement
LACTICACC79450Lactic Acid;2-hydroxypropanoic acid;LactateA measurement of the lactic acid in a biological specimen.Lactic Acid Measurement
LGLUCLEC79467Large Unstained Cells/LeukocytesA relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.Large Unstained Cells to Leukocytes Ratio Measurement
LDH1LDHC79451LDH Isoenzyme 1/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 1 to LDH Ratio Measurement
LDH2LDHC79452LDH Isoenzyme 2/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 2 to LDH Ratio Measurement
LDH3LDHC79453LDH Isoenzyme 3/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 3 to LDH Ratio Measurement
LDH4LDHC79454LDH Isoenzyme 4/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 4 to LDH Ratio Measurement
LDH5LDHC79455LDH Isoenzyme 5/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 5 to LDH Ratio Measurement
LEPTINC74866LeptinA measurement of the leptin hormone in a biological specimen.Leptin Measurement
MGCREATC79456Magnesium/CreatinineA relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.Magnesium to Creatinine Ratio Measurement
MLATONINC74867MelatoninA measurement of the melatonin hormone in a biological specimen.Melatonin Measurement
METHDNC74881MethadoneA measurement of the methadone present in a biological specimen.Methadone Measurement
METHQLDNC74882MethaqualoneA measurement of the methaqualone present in a biological specimen.Methaqualone Measurement
MORPHINEC74883MorphineA measurement of the morphine present in a biological specimen.Morphine Measurement
GSTMUC79457Mu Glutathione-S-TransferaseA measurement of the mu form of glutathione S-transferase in a biological specimen.Mu Glutathione-S-Transferase Measurement
GSTMUCRTC79458Mu Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.Mu Glutathione-S-Transferase to Creatinine Ratio Measurement
MGBC79436MyoglobinA measurement of myoglobin in a biological specimen.Myoglobin Measurement
NAGC79459N-Acetyl Glucosamide;N-Acetyl GlucosamineA measurement of N-acetyl glucosamide in a biological specimen.N-Acetyl Glucosamide Measurement
NAGCREATC79460N-Acetyl Glucosamide/CreatinineA relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.N-Acetyl Glucosamide to Creatinine Ratio Measurement
NPYC74892Neuropeptide YA measurement of the neuropeptide Y in a biological specimen.Neuropeptide Y Measurement
NOREPINC74868Noradrenaline;NorepinephrineA measurement of the norepinephrine hormone in a biological specimen.Noradrenaline Measurement
OSMLTYC74801OsmolalityA measurement of the osmoles of solute per unit of biological specimen.Osmolality Measurement
OXYCDNC74884Oxycodone;OxycontinA measurement of the oxycodone present in a biological specimen.Oxycodone Measurement
OXYTOCINC74869Oxytocin;OxytoxinA measurement of the oxytocin hormone in a biological specimen.Oxytocin Measurement
PCPC74694Phencyclidine;PhenylcyclohexylpiperidineA measurement of the phencyclidine present in a biological specimen.Phencyclidine Measurement
PHENTHZC74695Phenothiazine;DibenzothiazineA measurement of the phenothiazine present in a biological specimen.Phenothiazine Measurement
PHOSCRTC79461Phosphate/CreatinineA relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.Phosphate to Creatinine Ratio Measurement
KCREATC79462Potassium/CreatinineA relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.Potassium to Creatinine Ratio Measurement
PROLCTNC74870ProlactinA measurement of the prolactin hormone in a biological specimen.Prolactin Measurement
PROPOXC74885PropoxypheneA measurement of the propoxyphene present in a biological specimen.Propoxyphene Measurement
PROTCRTC79463Protein/CreatinineA relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.Protein to Creatinine Ratio Measurement
PSDEPHDC74696PseudoephedrineA measurement of the pseudoephedrine present in a biological specimen.Pseudoephedrine Measurement
LYMRCTC74629Reactive LymphocytesA measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.Reactive Lymphocyte Count Measurement
RENINC74893Renin;AngiotensinogenaseA measurement of the renin in a biological specimen.Renin Measurement
SECRETINC74871SecretinA measurement of the secretin hormone in a biological specimen.Secretin Measurement
SRTONINC74872SerotoninA measurement of the serotonin hormone in a biological specimen.Serotonin Measurement
NACREATC79464Sodium/CreatinineA relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.Sodium to Creatinine Ratio Measurement
SDHC79465Sorbitol DehydrogenaseA measurement of the sorbitol dehydrogenase in a biological specimen.Sorbitol Dehydrogenase Measurement
THRMPTNC74873ThrombopoietinA measurement of the thrombopoietin hormone in a biological specimen.Thrombopoietin Measurement
TRHC74874Thyrotropin Releasing Hormone;Thyrotropin Releasing FactorA measurement of the thyrotropin releasing hormone in a biological specimen.Thyrotropin Releasing Hormone Measurement
VMAC74875Vanillyl Mandelic Acid;Vanilmandelic AcidA measurement of the vanillyl mandelic acid metabolite in a biological specimen.Vanillyl Mandelic Acid Measurement
VITAC74895Vitamin A;RetinolA measurement of the Vitamin A in a biological specimen.Vitamin A Measurement
VITB1C74896Thiamine;Vitamin B1A measurement of the thiamine in a biological specimen.Vitamin B1 Measurement
VITB17C74897Vitamin B17;AmygdalinA measurement of the Vitamin B17 in a biological specimen.Vitamin B17 Measurement
VITB2C74898Riboflavin;Vitamin B2A measurement of the riboflavin in a biological specimen.Vitamin B2 Measurement
VITB3C74899Niacin;Vitamin B3A measurement of the niacin in a biological specimen.Vitamin B3 Measurement
VITB5C74900Vitamin B5;Pantothenic AcidA measurement of the Vitamin B5 in a biological specimen.Vitamin B5 Measurement
VITB6C74901Vitamin B6;PyridoxineA measurement of the Vitamin B6 in a biological specimen.Vitamin B6 Measurement
VITB7C74902Vitamin B7;BiotinA measurement of the Vitamin B7 in a biological specimen.Vitamin B7 Measurement
VITCC74903Vitamin C;Ascorbic AcidA measurement of the Vitamin C in a biological specimen.Vitamin C Measurement
VITD2C74904Vitamin D2;ErgocalciferolA measurement of the Vitamin D2 in a biological specimen.Vitamin D2 Measurement
VITD3C74905Vitamin D3;CholecalciferolA measurement of the Vitamin D3 in a biological specimen.Vitamin D3 Measurement
VITEC74906Vitamin E;TocopherolA measurement of the Vitamin E in a biological specimen.Vitamin E Measurement
VITKC74907Vitamin K;NaphthoquinoneA measurement of the Vitamin K in a biological specimen.Vitamin K Measurement
VOLUMEC74720VolumeA measurement of the volume of a biological specimen.Volume Measurement
A1ANTRYPC80167Alpha-1 Antitrypsin;Serum Trypsin InhibitorA measurement of the alpha-1 antitrypsin in a biological specimen.Alpha-1 Antitrypsin Measurement
A2MACGC80168Alpha-2 MacroglobulinA measurement of the alpha-2 macroglobulin in a biological specimen.Alpha-2 Macroglobulin Measurement
ACEC80169Angiotensin Converting EnzymeA measurement of the angiotensin converting enzyme in a biological specimen.Angiotensin Converting Enzyme Measurement
ACPHOSC80163Acid PhosphataseA measurement of the acid phosphatase in a biological specimen.Acid Phosphatase Measurement
AMAC81975Antimitochondrial Antibodies;Mitochondrial AntibodyA measurement of the antimitochondrial antibodies in a biological specimen.Antimitochondrial Antibody Measurement
AMYLB42C84809Amyloid Beta 42;Amyloid Beta 42 ProteinA measurement of the 42 amino acid amyloid beta protein isoform in a biological specimen.Beta Amyloid 42 Measurement
AMYLOIDBC81999Amyloid, Beta;Beta AmyloidA measurement of the total amyloid beta in a biological specimen.Beta Amyloid Measurement
AMYLOIDPC81998Amyloid PA measurement of the total amyloid P in a biological specimen.Amyloid P Measurement
ANGLOBDRC81974Antiglobulin Test, Direct;Direct Coombs TestA measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.Direct Antiglobulin Test
ANTHRMC81958Antithrombin;Antithrombin III;Antithrombin Activity;Antithrombin III ActivityA measurement of the antithrombin activity in a biological specimen.Antithrombin Measurement
ANTHRMAGC81977Antithrombin Antigen;Antithrombin III AntigenA measurement of the antithrombin antigen in a biological specimen.Antithrombin Antigen Measurement
APOA2C82000Apolipoprotein AIIA measurement of the apolipoprotein AII in a biological specimen.Apolipoprotein AII Measurement
APOC3C82001Apolipoprotein CIIIA measurement of the apolipoprotein CIII in a biological specimen.Apolipoprotein CIII Measurement
APOEC82002Apolipoprotein EA measurement of the apolipoprotein E in a biological specimen.Apolipoprotein E Measurement
APOHC82003Apolipoprotein HA measurement of the apolipoprotein H in a biological specimen.Apolipoprotein H Measurement
APPEARC25377Specimen AppearanceThe outward or visible aspect of a specimen.Appearance
ASCABC81976Anti-Saccharomyces cerevisiae AntibodyA measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.Anti-Saccharomyces cerevisiae Antibody Measurement
ASTAGC81978Aspartate Aminotransferase Antigen;SGOT AntigenA measurement of the aspartate aminotransferase antigen in a biological specimen.Aspartate Aminotransferase Antigen Measurement
B2GLYABC81979Beta-2 Glycoprotein AntibodyA measurement of the beta-2 glycoprotein antibody in a biological specimen.Beta-2 Glycoprotein Antibody Measurement
B2MICGC81980Beta-2 MicroglobulinA measurement of the beta-2 microglobulin in a biological specimen.Beta-2 Microglobulin Measurement
BDNFC82004Brain-Derived Neurotrophic FactorA measurement of the brain-derived neurotrophic factor in a biological specimen.Brain-Derived Neurotrophic Factor Measurement
BNPPROC82032ProB-type Natriuretic Peptide;proBNP;Pro-Brain Natriuretic PeptideA measurement of the proB-type natriuretic peptide in a biological specimen.ProB-Type Natriuretic Peptide Measurement
C1QABC80173Complement C1q AntibodyA measurement of the complement C1q antibody in a biological specimen.Complement C1q Antibody Measurement
C3C80174Complement C3A measurement of the complement C3 in a biological specimen.Complement C3 Measurement
C3AC80175Complement C3a;ASP, Complement C3 DesArg, Acetylation-stimulating ProteinA measurement of the complement C3a in a biological specimen.Complement C3a Measurement
C3BC80176Complement C3bA measurement of the complement C3b in a biological specimen.Complement C3b Measurement
C4C80177Complement C4A measurement of the complement C4 in a biological specimen.Complement C4 Measurement
C4AC80178Complement C4aA measurement of the complement C4a in a biological specimen.Complement C4a Measurement
C5AC80179Complement C5aA measurement of the complement C5a in a biological specimen.Complement C5a Measurement
CA125AGC81981Cancer Antigen 125A measurement of the cancer antigen 125 in a biological specimen.Cancer Antigen 125 Measurement
CA19_9AGC81982Cancer Antigen 19-9A measurement of the cancer antigen 19-9 in a biological specimen.Cancer Antigen 19-9 Measurement
CAIONC81948Calcium, IonizedA measurement of the ionized calcium in a biological specimen.Ionized Calcium Measurement
CALPROC82005CalprotectinA measurement of the calprotectin in a biological specimen.Calprotectin Measurement
CBBC80172Complement BbA measurement of the complement Bb in a biological specimen.Complement Bb Measurement
CD40C82006CD40A measurement of the CD40 in a biological specimen.CD40 Measurement
CD40LC82007CD40 LigandA measurement of the CD40 ligand in a biological specimen.CD40 Ligand Measurement
CEAC81983Carcinoembryonic AntigenA measurement of the carcinoembryonic antigen in a biological specimen.Carcinoembryonic Antigen Measurement
CHOLHDLC80171Cholesterol/HDL-CholesterolA relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.Cholesterol to HDL-Cholesterol Ratio Measurement
CTOTC80160Complement TotalA measurement of the total complement in a biological specimen.Complement Measurement
CTXIC82038Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptideA measurement of the type I collagen C-telopeptides in a biological specimen.Type I Collagen C-Telopeptide Measurement
CTXIIC82040Type II Collagen C-TelopeptidesA measurement of the type II collagen C-telopeptides in a biological specimen.Type II Collagen C-Telopeptide Measurement
CYSTARCHC81951Starch CrystalsA measurement of the starch crystals in a biological specimen.Starch Crystal Measurement
DDIMERC82621D-DimerA measurement of the d-dimers in a biological specimen.D-Dimer Measurement
DNAABC81973Anti-DNA Antibodies;Anti-ds-DNA AntibodiesA measurement of the anti-DNA antibodies in a biological specimen.Anti-DNA Antibody Measurement
EGFC82009Epidermal Growth FactorA measurement of the epidermal growth factor in a biological specimen.Epidermal Growth Factor Measurement
ELA1C82028Pancreatic Elastase 1A measurement of the pancreatic elastase 1 in a biological specimen.Pancreatic Elastase Measurement
ELA1PMNC82029Pancreatic Elastase 1, PolymorphonuclearA measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.Polymorphonuclear Pancreatic Elastase Measurement
ELA2C82026Neutrophil ElastaseA measurement of the neutrophil elastase in a biological specimen.Neutrophil Elastase Measurement
ELA2PMNC82027Neutrophil Elastase, PolymorphonuclearA measurement of the polymorphonuclear neutrophil elastase in a biological specimen.Polymorphonuclear Neutrophil Elastase Measurement
ENA78C82010Epith Neutrophil-Activating Peptide 78A measurement of the epithelial neutrophil-activating peptide in a biological specimen.Epithelial Neutrophil-Activating Peptide 78 Measurement
ENDOTH1C82008Endothelin-1A measurement of the endothelin-1 in a biological specimen.Endothelin-1 Measurement
ENRAGEC82011Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.Extracell Newly Ident RAGE Bind Protein Measurement
EOSMMC84819Eosinophilic MetamyelocytesA measurement of the eosinphilic metamyelocytes in a biological specimen.Eosinophilic Metamyelocyte Count
EOSMYLC84821Eosinophilic MyelocytesA measurement of the eosinophilic myelocytes in a biological specimen.Eosinophilic Myelocyte Count
EOTAXIN1C81952Eotaxin-1;Chemokine Ligand 11A measurement of the eotaxin-1 in a biological specimen.Eotaxin-1 Measurement
EOTAXIN2C81953Eotaxin-2;Chemokine Ligand 24A measurement of the eotaxin-2 in a biological specimen.Eotaxin-2 Measurement
EOTAXIN3C81954Eotaxin-3;Chemokine Ligand 26A measurement of the eotaxin-3 in a biological specimen.Eotaxin-3 Measurement
ESTRIOLFC81963Estriol, FreeA measurement of the free estriol in a biological specimen.Free Estriol Measurement
FABP1C82012Fatty Acid Binding Protein 1A measurement of the fatty acid binding protein 1 in a biological specimen.Fatty Acid Binding Protein 1 Measurement
FACTIIIC81959Factor III;Tissue Factor, CD142A measurement of the factor III in a biological specimen.Factor III Measurement
FACTVIIC81960Factor VIIA measurement of the factor VII in a biological specimen.Factor VII Measurement
FACTVIIIC81961Factor VIIIA measurement of the factor VIII in a biological specimen.Factor VIII Measurement
FATACFRC80200Free Fatty Acid;Non-Esterified Fatty Acid, FreeA measurement of the total non-esterified fatty acids in a biological specimen.Non-esterified Fatty Acids Measurement
FATACFRSC80206Free Fatty Acid, Saturated;Non-esterified Fatty Acid, SaturatedA measurement of the saturated non-esterified fatty acids in a biological specimen.Saturated Non-esterified Fatty Acids Measurement
FATACFRUC80209Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, UnsaturatedA measurement of the unsaturated non-esterified fatty acids in a biological specimen.Unsaturated Non-esterified Fatty Acids Measurement
FATBODOVC81947Fat Bodies, OvalA measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.Oval Fat Body Measurement
FDPC82013Fibrin Degradation ProductsA measurement of the fibrin degradation products in a biological specimen.Fibrin Degradation Products Measurement
FGFBFC82014Fibroblast Growth Factor Basic Form;FGF2A measurement of the basic form of fibroblast growth factor in a biological specimen.Fibroblast Growth Factor Basic Form Measurement
G6PDC80184Glucose-6-Phosphate DehydrogenaseA measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.Glucose-6-Phosphate Dehydrogenase Measurement
GAD1C82015Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67A measurement of the glutamic acid decarboxylase 1 in a biological specimen.Glutamic Acid Decarboxylase 1 Measurement
GAD2C82016Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65A measurement of the glutamic acid decarboxylase 2 in a biological specimen.Glutamic Acid Decarboxylase 2 Measurement
GAD2ABC82017Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 AntibodyA measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.Glutamic Acid Decarboxylase 2 Antibody Measurement
GALANINC80182GalaninA measurement of the galanin in a biological specimen.Galanin Measurement
GCSFC82018Granulocyte Colony Stimulating FactorA measurement of the granulocyte colony stimulating factor in a biological specimen.Granulocyte Colony Stimulating Factor Measurement
GLP1C80183Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1A measurement of the total glucagon-like peptide-1 in a biological specimen.Glucagon-like Peptide-1 Measurement
GLP1ACC80164Glucagon-Like Peptide-1, Active FormA measurement of the active form of glucagon-like peptide-1 in a biological specimen.Active Glucagon-like Peptide-1 Measurement
GMCSFC82019Granulocyte Macrophage Colony Stm FactorA measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.Granulocyte Macrophage Colony Stm Factor Measurement
GOLDC80186GoldA measurement of the gold in a biological specimen.Gold Measurement
GSTC80185Glutathione S-Transferase, TotalA measurement of the total glutathione-s-transferase in a biological specimen.Glutathione-S-Transferase Measurement
GSTALCRTC80166Glutathione S-Transferase, Alpha/CreatA relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement
GSTPIC80203Glutathione S-Transferase, PiA measurement of the Pi glutathione-s-transferase in a biological specimen.Pi Glutathione S-Transferase Measurement
GSTTHC80207Glutathione S-Transferase, ThetaA measurement of the theta glutathione-s-transferase in a biological specimen.Theta Glutathione S-Transferase Measurement
GUSAC80165Glucuronidase, AlphaA measurement of the alpha glucuronidase in a biological specimen.Alpha Glucuronidase Measurement
GUSBC80170Glucuronidase, BetaA measurement of the beta glucuronidase in a biological specimen.Beta Glucuronidase Measurement
HDL2C80187HDL-Cholesterol Subclass 2A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.HDL-Cholesterol Subclass 2 Measurement
HDL3C80188HDL-Cholesterol Subclass 3A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.HDL-Cholesterol Subclass 3 Measurement
HISTAMINC80189HistamineA measurement of the histamine in a biological specimen.Histamine Measurement
HTPHABC81984Heterophile AntibodiesA measurement of the heterophile antibodies in a biological specimen.Heterophile Antibody Measurement
HYPRLNC80190HydroxyprolineA measurement of the total hydroxyproline in a biological specimen.Hydroxyproline Measurement
IC512ABC81985Islet Cell 512 AntibodyA measurement of the islet cell 512 antibody in a biological specimen.Islet Cell 512 Antibody Measurement
IC512AGC81986Islet Cell 512 AntigenA measurement of the islet cell 512 antigen in a biological specimen.Islet Cell 512 Antigen Measurement
IFNAC81994Interferon AlphaA measurement of the interferon alpha in a biological specimen.Interferon Alpha Measurement
IFNBC81995Interferon BetaA measurement of the interferon beta in a biological specimen.Interferon Beta Measurement
IFNGC81996Interferon GammaA measurement of the interferon gamma in a biological specimen.Interferon Gamma Measurement
IGAC81969Immunoglobulin AA measurement of the Immunoglobulin A in a biological specimen.Immunoglobulin A Measurement
IGEC81970Immunoglobulin EA measurement of the Immunoglobulin E in a biological specimen.Immunoglobulin E Measurement
IGGC81971Immunoglobulin GA measurement of the Immunoglobulin G in a biological specimen.Immunoglobulin G Measurement
IGMC81972Immunoglobulin MA measurement of the Immunoglobulin M in a biological specimen.Immunoglobulin M Measurement
INDICANC82044IndicanA measurement of the indican present in a biological specimen.Indican Measurement
INGAPABC81987Islet Neogenesis Assoc Protein AntibodyA measurement of the islet neogenesis associated protein antibody in a biological specimen.Islet Neogenesis Associated Protein Antibody Measurement
INHIBINAC82020Inhibin AA measurement of the inhibin A in a biological specimen.Inhibin A Measurement
ISOPRF2C80180F2-IsoprostaneA measurement of the F2-isoprostane in a biological specimen.F2 Isoprostane Measurement
LPAC82022Lipoprotein-aA measurement of the lipoprotein-a in a biological specimen.Lipoprotein a Measurement
LTFC82021Lactoferrin;LactotransferrinA measurement of the lactoferrin in a biological specimen.Lactoferrin Measurement
LYMPHOTCC81955Lymphotactin;Chemokine Ligand 1A measurement of the lymphotactin in a biological specimen.Lymphotactin Measurement
MCP1C82025Monocyte Chemotactic Protein 1A measurement of the monocyte chemotactic protein 1 in a biological specimen.Monocyte Chemotactic Protein 1 Measurement
MCSFC80191Macrophage Colony Stimulating FactorA measurement of the macrophage colony stimulating factor in a biological specimen.Macrophage Colony Stimulating Factor Measurement
MDCC81956Macrophage-Derived Chemokine;Chemokine Ligand 22A measurement of the macrophage-derived chemokine in a biological specimen.Macrophage-Derived Chemokine Measurement
MIP1AC82023Macrophage Inflammatory Protein 1 Alpha;Chemokine Ligand 3A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.Macrophage Inflammatory Protein 1 Alpha Measurement
MIP1BC82024Macrophage Inflammatory Protein 1 Beta;Chemokine Ligand 4A measurement of the macrophage inflammatory protein 1 beta in a biological specimen.Macrophage Inflammatory Protein 1 Beta Measurement
MMP1C80192Matrix Metalloproteinase 1;Interstitial CollagenaseA measurement of the matrix metalloproteinase 1 in a biological specimen.Matrix Metalloproteinase 1 Measurement
MMP2C80193Matrix Metalloproteinase 2;Gelatinase AA measurement of the matrix metalloproteinase 2 in a biological specimen.Matrix Metalloproteinase 2 Measurement
MMP3C80194Matrix Metalloproteinase 3;Stromelysin 1A measurement of the matrix metalloproteinase 3 in a biological specimen.Matrix Metalloproteinase 3 Measurement
MMP7C80195Matrix Metalloproteinase 7;MatrilysinA measurement of the matrix metalloproteinase 7 in a biological specimen.Matrix Metalloproteinase 7 Measurement
MMP8C80196Matrix Metalloproteinase 8;Neutrophil CollagenaseA measurement of the matrix metalloproteinase 8 in a biological specimen.Matrix Metalloproteinase 8 Measurement
MMP9C80197Matrix Metalloproteinase 9;Gelatinase BA measurement of the matrix metalloproteinase 9 in a biological specimen.Matrix Metalloproteinase 9 Measurement
MPOC80198MyeloperoxidaseA measurement of the myeloperoxidase in a biological specimen.Myeloperoxidase Measurement
NEOPTERNC80199NeopterinA measurement of the neopterin in a biological specimen.Neopterin Measurement
NEUTMMC84822Neutrophilic MetamyelocytesA measurement of the neutrophilic metamyelocytes in a biological specimen.Neutrophilic Metamyelocyte Count
NEUTMYC84823Neutrophilic MyelocytesA measurement of the neutrophilic myelocytes in a biological specimen.Neutrophilic Myelocyte Count
NEUTSGC81997Neutrophils, SegmentedA measurement of the segmented neutrophils in a biological specimen.Segmented Neutrophil Count
NEUTSGLEC82045Neutrophils, Segmented/LeukocytesA relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.Segmented Neutrophil to Leukocyte Ratio Measurement
NTXIC82039Type I Collagen N-TelopeptidesA measurement of the type I collagen N-telopeptides in a biological specimen.Type I Collagen N-Telopeptide Measurement
NTXIIC82041Type II Collagen N-TelopeptidesA measurement of the type II collagen N-telopeptides in a biological specimen.Type II Collagen N-Telopeptide Measurement
PAI1C82030Plasminogen Activator Inhibitor-1A measurement of the plasminogen activator inhibitor-1 in a biological specimen.Plasminogen Activator Inhibitor-1 Measurement
PAI1AGC81989Plasminogen Activator Inhibitor-1 AGA measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.Plasminogen Activator Inhibitor-1 Antigen Measurement
PAPC80204Prostatic Acid PhosphataseA measurement of the prostatic acid phosphatase in a biological specimen.Prostatic Acid Phosphatase Measurement
PAPPAC82031Pregnancy-Associated Plasma Protein-AA measurement of the pregnancy-associated plasma protein-A in a biological specimen.Pregnancy-Associated Plasma Protein-A Measurement
PCO2C82625Partial Pressure Carbon DioxideA measurement of the pressure of carbon dioxide in a biological specimen.Partial Pressure of Carbon Dioxide Measurement
PDWC81962Platelet Distribution WidthA measurement of the range of platelet sizes in a biological specimen.Platelet Distribution Width
PEMABC81988Pemphigoid AntibodiesA measurement of the pemphigoid antibodies in a biological specimen.Pemphigoid Antibody Measurement
PICPC82033Procollagen Type I Carboxy Term PeptideA measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.Procollagen Type I Carboxy Terminal Peptide Measurement
PNCTPPC80201Pancreatic PolypeptideA measurement of the pancreatic polypeptide in a biological specimen.Pancreatic Polypeptide Measurement
PO2C71251Partial Pressure OxygenA measurement of the pressure of oxygen in a biological specimen.Partial Pressure of Oxygen Measurement
PROINSULC81967ProinsulinA measurement of the proinsulin in a biological specimen.Proinsulin Measurement
PTF1_2C82034Prothrombin Fragments 1 + 2A measurement of the prothrombin fragments 1 and 2 in a biological specimen.Prothrombin Fragments 1 and 2 Measurement
PTHCTC81964Parathyroid Hormone, C-TerminalA measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.C-Terminal Parathyroid Hormone Measurement
PTHMMC81965Parathyroid Hormone, Mid-MoleculeA measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.Mid-Molecule Parathyroid Hormone Measurement
PTHNTC81966Parathyroid Hormone, N-TerminalA measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.N-Terminal Parathyroid Hormone Measurement
PYRIDNLNC80211PyridinolineA measurement of the pyridinoline in a biological specimen.Pyridinoline Measurement
PYYC80202Peptide YY;Peptide Tyrosine TyrosineA measurement of the peptide YY in a biological specimen.Peptide YY Measurement
RANTESC81957Reg upon Act Normal T-cell Exprd Secrtd;Chemokine Ligand 5A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.Reg upon Act Normal T-cell Exprd Secrtd Measurement
RBCNUCLEC82046Nucleated Erythrocytes/LeukocytesA relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.Nucleated Erythrocyte to Leukocyte Ratio Measurement
RESISTINC80205ResistinA measurement of the resistin in a biological specimen.Resistin Measurement
RT3C81968Triiodothyronine, ReverseA measurement of the reverse triiodothyronine in a biological specimen.Reverse Triiodothyronine Measurement
SCFC82035Stem Cell Factor;KIT LigandA measurement of the stem cell factor in a biological specimen.Stem Cell Factor Measurement
TFERRINC82037TransferrinA measurement of the transferrin in a biological specimen.Transferrin Measurement
THYABC81990Thyroid AntibodiesA measurement of the thyroid antibodies in a biological specimen.Thyroid Antibody Measurement
THYAMABC81991Thyroid Antimicrosomal AntibodiesA measurement of the thyroid antimicrosomal antibodies in a biological specimen.Thyroid Antimicrosomal Antibody Measurement
THYATABC81992Thyroid Antithyroglobulin AntibodiesA measurement of the thyroid antithyroglobulin antibodies in a biological specimen.Thyroid Antithyroglobulin Antibody Measurement
TIMP1C82036Tissue Inhibitor of Metalloproteinase 1A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.Tissue Inhibitor of Metalloproteinase 1 Measurement
TPAAGC81993Tissue Plasminogen Activator AntigenA measurement of the tissue plasminogen activator antigen in a biological specimen.Tissue Plasminogen Activator Antigen Measurement
TPRONPC84811Non-Phosphorylated Tau ProteinA measurement of the non-phosphorylated Tau protein in a biological specimen.Nonphosphorylated Tau Protein Measurement
TPROTC84810Tau Protein;Total Tau ProteinA measurement of the total Tau protein in a biological specimen.Tau Protein Measurement
TPROTPC84812Phosphorylated Tau ProteinA measurement of the phosphorylated Tau protein in a biological specimen.Phosphorylated Tau Protein Measurement
TRAPC80208Total Radical-Trap Antioxidant PotentialA measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.Total Radical-Trap Antioxidant Potential Measurement
TTC80365Thrombin TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)Thrombin Time
VCAM1C82042Vascular Cell Adhesion Molecule 1A measurement of the vascular cell adhesion molecule 1 in a biological specimen.Vascular Cell Adhesion Molecule 1 Measurement
VEGFC92514Vascular Endothelial Growth FactorA measurement of the vascular endothelial growth factor in a biological specimen.Vascular Endohelial Growth Factor Measurement
VISCC75912ViscosityThe resistance of a liquid to sheer forces and flow. (NCI)Viscosity
VITDC84818Vitamin D;Total Vitamin DA measurement of the total Vitamin D in a biological specimen.Vitamin D Measurement
ZINCC80210ZincA measurement of the zinc in a biological specimen.Zinc Measurement
CORTFRC88113Cortisol, FreeA measurement of the free, unbound cortisol in a biological specimen.Free Cortisol Measurement
VITDATC922671, 25-Dihydroxyvitamin D;Active Vitamin DA measurement of the total active Vitamin D in a biological specimen.1, 25-Dihydroxyvitamin D Measurement
VITDITC9226825-Hydroxyvitamin D;Inactive Vitamin DA measurement of the total inactive Vitamin D in a biological specimen.25-Hydroxyvitamin D Measurement
ACETOACC92247Acetoacetic Acid;AcetoacetateA measurement of the acetoacetic acid in a biological specimen.Acetoacetic Acid Measurement
ACYLCAOXC92286Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase;Acyl CoA OxidaseA measurement of the acyl coenzyme A oxidase in a biological specimen.Acyl Coenzyme A Oxidase Measurement
GLOBA1C92252Alpha-1 Globulin;A1-GlobulinA measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.Alpha-1 Globulin Measurement
GLOBA1PTC92253Alpha-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.Alpha-1 Globulin to Total Protein Ratio Measurement
GLOBA2C92254Alpha-2 Globulin;A2-GlobulinA measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.Alpha-2 Globulin Measurement
GLOBA2PTC92255Alpha-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.Alpha-2 Globulin to Total Protein Ratio Measurement
CYAMPPHC92243Amorphous Phosphate CrystalsA measurement of the amorphous phosphate crystals in a biological specimen.Amorphous Phosphate Crystals Measurement
CYAMPURTC92244Amorphous Urate CrystalsA measurement of the amorphous urate crystals in a biological specimen.Amorphous Urate Crystals Measurement
ASSDNAC92269Anti-Single Stranded DNA IgGA measurement of the anti-single stranded DNA IgG antibody in a biological specimen.Anti-Single Stranded DNA IgG Measurement
APOE4C92293Apolipoprotein E4A measurement of the apolipoprotein E4 in a biological specimen.Apolipoprotein E4 Measurement
GLOBBC92256Beta GlobulinA measurement of the proteins contributing to the beta fraction in a biological specimen.Beta Globulin Measurement
GLOBBPTC92294Beta Globulin/Total ProteinA relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.Beta Globulin to Total Protein Ratio Measurement
ALPBSC92287Bone Specific Alkaline PhosphataseA measurement of the bone specific alkaline phosphatase isoform in a biological specimen.Bone Specific Alkaline Phosphatase Measurement
CARNITATC92288Carnitine Acetyl TransferaseA measurement of the carnitine acetyl transferase in a biological specimen.Carnitine Acetyl Transferase Measurement
CPNIGAABC92432Chlamydia pneumoniae IgA AntibodyA measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.Chlamydia pneumoniae IgA Antibody Measurement
CPNIGMABC92433Chlamydia pneumoniae IgM AntibodyA measurement of the Chlamydia pneumoniae IgM in a biological specimen.Chlamydia pneumoniae IgM Antibody Measurement
CHOLINESC92289CholinesteraseA measurement of the cholinesterase in a biological specimen.Cholinesterase Measurement
CITRATEC92248CitrateA measurement of the citrate in a biological specimen.Citrate Measurement
COTININEC92249CotinineA measurement of the cotinine in a biological specimen.Cotinine Measurement
CYSTATCC92290Cystatin CA measurement of the cystatin C in a biological specimen.Cystatin C Measurement
RBCCLMPC92245Erythrocyte Cell Clumps;Red Blood Cell Clumps;RBC ClumpsA measurement of red blood cell clumps in a biological specimen.Erythrocyte Cell Clumps Measurement
RBCMORPHC92296Erythrocyte Cell Morphology;Red Blood Cell Morphology;RBC MorphologyAn examination or assessment of the form and structure of red blood cells.Erythrocyte Cell Morphology
ENAABC92270Anti-ENA;Extractable Nuclear Antigen AntibodyA measurement of the extractable nuclear antigen antibody in a biological specimen.Extractable Nuclear Antigen Antibody Measurement
GLOBGC92257Gamma GlobulinA measurement of the proteins contributing to the gamma fraction in a biological specimen.Gamma Globulin Measurement
GLOBGPTC92295Gamma Globulin/Total ProteinA relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.Gamma Globulin to Total Protein Ratio Measurement
GFRC90505Glomerular Filtration RateA kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.Glomerular Filtration Rate
HGBAC92258Hemoglobin AA measurement of the hemoglobin A in a biological specimen.Hemoglobin A Measurement
HGBA2C92259Hemoglobin A2A measurement of the hemoglobin A2 in a biological specimen.Hemoglobin A2 Measurement
HGBBC92260Hemoglobin BA measurement of the hemoglobin B in a biological specimen.Hemoglobin B Measurement
HGBCC92261Hemoglobin CA measurement of the hemoglobin C in a biological specimen.Hemoglobin C Measurement
HGBFC92262Hemoglobin F;Fetal HemoglobinA measurement of the hemoglobin F in a biological specimen.Hemoglobin F Measurement
HAABIGMC92271Hepatitis A Virus Antibody IgMA measurement of hepatitis A virus antibody IgM in a biological specimen.Hepatitis A Virus Antibody IgM Measurement
HGRNAC92272Hepatitis G RNAA measurement of the Hepatitis G RNA in a biological specimen.Hepatitis G RNA Measurement
HIVIMONAC92263HIV-1 Group M and O Nucleic AcidA measurement of the HIV-1 group M and O nucleic acids in a biological specimen.HIV-1 Group M and O Nucleic Acid Measurement
HIVIOABC92264HIV-1 Group O AntibodyA measurement of the HIV-1 group O antibody in a biological specimen.HIV-1 Group O Antibody Measurement
HIVI24AGC92265HIV-1 p24 AntigenA measurement of the HIV-1 p24 antigen in a biological specimen.HIV-1 p24 Antigen Measurement
HIV2NUACC92266HIV-2 Nucleic AcidA measurement of the HIV-2 nucleic acids in a biological specimen.HIV-2 Nucleic Acid Measurement
IAH1N1VLC92273Influenza A H1N1 Viral LoadA measurement of the Influenza A H1N1 viral load in a biological specimen.Influenza A H1N1 Viral Load Measurement
INFAVLDC92274Influenza A Viral LoadA measurement of the Influenza A viral load in a biological specimen.Influenza A Viral Load Measurement
LPNAGC92275Legionella pneumophila AntigenA measurement of the Legionella pneumophila antigen in a biological specimen.Legionella pneumophila Antigen Measurement
LPNIGGABC92276Legionella pneumophila IgG AntibodyA measurement of the Legionella pneumophila IgG antibody in a biological specimen.Legionella pneumophila IgG Antibody Measurement
LPNGMABC92277Legionella pneumophila IgG IgM AntibodyA measurement of the Legionella pneumophila IgG and IgM in a biological specimen.Legionella pneumophila IgG IgM Antibody Measurement
LPNIGMABC92278Legionella pneumophila IgM AntibodyA measurement of the Legionella pneumophila IgM antibody in a biological specimen.Legionella pneumophila IgM Antibody Measurement
WBCMORPHC92297Leukocyte Cell Morphology;White Blood Cell Morphology;WBC MorphologyAn examination or assessment of the form and structure of white blood cells.Leukocyte Cell Morphology
WBCCLMPC92246Leukocyte Cell Clumps;White Blood Cell Clumps;WBC ClumpsA measurement of white blood cell clumps in a biological specimen.Leukocyte Cell Clumps Measurement
MCPROTC92291Monoclonal Immunoglobulin Protein;ParaproteinA measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.Monoclonal Protein Measurement
MYTBGIRC92241Mycobacterium tuberculosis IFN Gamma ResponseA measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.Mycobacterium tuberculosis Interferon Gamma Response
MYTBNUACC92279Mycobacterium tuberculosis Nucleic AcidA measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.Mycobacterium tuberculosis Nucleic Acid Measurement
MYPCERPCC92242Myeloid/Erythroid RatioA relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.Myeloid to Erythroid Ratio Measurement
MPOABC92280Myeloperoxidase AntibodyA measurement of the myeloperoxidase antibody in a biological specimen.Myeloperoxidase Antibody Measurement
NGONC92298Neisseria gonorrhoeae ScreeningExamination of a biological specimen to detect the presence of Neisseria gonorrhoeae.Neisseria gonorrhoeae Screening
OSMRTYC74802OsmolarityA measurement of the osmoles of solute per liter of solution.Osmolarity Measurement
OXALATEC92250Oxalate;EthanedioateA measurement of the oxalate in a biological specimen.Oxalate Measurement
PROTOSMLC92240Protein/Osmolality;Protein/Osmolality RatioA relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.Protein to Osmolality Ratio Measurement
SJSSAABC92236Ro Antibody;Sjogrens SS-A AntibodyA measurement of the Sjogrens SS-A antibody in a biological specimen.Sjogren's SS-A Antibody Measurement
SJSSBABC92237La Antibody;Sjogrens SS-B AntibodyA measurement of the Sjogrens SS-B antibody in a biological specimen.Sjogren's SS-B Antibody Measurement
SMTHABC92281Smith AntibodyA measurement of the Smith antibody in a biological specimen.Smith Antibody Measurement
STRPLOABC92282Streptolysin O Antibody;Antistreptolysin OA measurement of Streptolysin O Antibody in a biological specimen.Streptolysin O Antibody Measurement
EPITCEC92251Transitional Epithelial CellsA measurement of the transitional epithelial cells present in a biological specimen.Transitional Epithelial Cells Measurement
TRICHC92238TrichomonasExamination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.Trichomonas Screening
TRYPTASEC92292TryptaseA measurement of the tryptase in a biological specimen.Tryptase Measurement
MYBLAT1C92283Type I MyeloblastsA measurement of type I myeloblast cells per unit of a biological specimen.Type I Myeloblasts Measurement
MYBLAT2C92284Type II MyeloblastsA measurement of type II myeloblast cells per unit of a biological specimen.Type II Myeloblasts Measurement
MYBLAT3C92285Type III MyeloblastsA measurement of type III myeloblast cells per unit of a biological specimen.Type III Myeloblasts Measurement
YEASTHYPC92239Yeast HyphaeExamination of a biological specimen to detect the presence of any yeast cells that are in the long, filamentous and branching phase of growth.Yeast Hyphae Screening
SVCAM1C92533Soluble Vascular Cell Adhesion Molecule 1A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.Soluble Vascular Cell Adhesion Molecule 1
AFPL3AFPC96565A Fetoprotein L3/A FetoproteinA relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement
ACHRABC96559Acetylcholine Receptor AntibodyA measurement of the acetylcholine receptor antibody in a biological specimen.Acetylcholine Receptor Antibody Measurement
ACHEC96560AcetylcholinesteraseA measurement of the acetylcholinesterase in a biological specimen.Acetylcholinesterase Measurement
AFPL1C96562Alpha Fetoprotein L1A measurement of the alpha fetoprotein L1 in a biological specimen.Alpha Fetoprotein L1 Measurement
AFPL2C96563Alpha Fetoprotein L2A measurement of the alpha fetoprotein L2 in a biological specimen.Alpha Fetoprotein L2 Measurement
AFPL3C96564Alpha Fetoprotein L3A measurement of the alpha fetoprotein L3 in a biological specimen.Alpha Fetoprotein L3 Measurement
STIPBASOC96567Basophilic StipplingA measurement of the basophilic stippling in a biological specimen.Basophilic Stippling Measurement
BNZLCGNC75350Benzoylecgonine;Cocaine MetaboliteA measurement of the benzoylecgonine in a biological specimen.Benzoylecgonine Measurement
BHYXBTRC96568Beta-Hydroxybutyrate;B-Hydroxybutyrate;3-HydroxybutyrateA measurement of the total Beta-hydroxybutyrate in a biological specimen.Beta-Hydroxybutyrate Measurement
CSBROADC96588Broad CastsA measurement of the broad casts in a biological specimen.Broad Casts Measurement
CACLRC96589Calcium ClearanceA measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).Calcium Clearance Measurement
CASULPHC96590Calcium SulphateA measurement of the calcium sulphate in a biological specimen.Calcium Sulphate Measurement
CARBXHGBC96591CarboxyhemoglobinA measurement of the carboxyhemoglobin in a biological specimen.Carboxyhemoglobin Measurement
CECC96592Circulating Endothelial CellsA measurement of the circulating endothelial cells in a biological specimen.Circulating Endothelial Cell Count
CTCC96593Circulating Tumor CellsA measurement of the circulating tumor cells in a biological specimen.Circulating Tumor Cell Count
CLARITYC96594ClarityA measurement of the transparency of a biological specimen.Clarity Measurement
CCPABC96595Cyclic Citrullinated Peptide AntibodyA measurement of the cyclic citrullinated peptide antibody in a biological specimen.Cyclic Citrullinated Peptide Antibody Measurement
CMVIGGABC96596Cytomegalovirus IgG AntibodyA measurement of the cytomegalovirus IgG antibody in a biological specimen.Cytomegalovirus IgG Antibody Measurement
CMVIGMABC96597Cytomegalovirus IgM AntibodyA measurement of the cytomegalovirus IgM antibody in a biological specimen.Cytomegalovirus IgM Antibody Measurement
DHEASC96629Dehydroepiandrosterone Sulfate;DHEA-S;sDHEA;DHEA SulfateA measurement of the sulfated Dehydroepiandrosterone in a biological specimen.Sulfated DHEA Measurement
DRVVTC96696Dilute Russell's Viper Venom TimeA measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom.Dilute Russell's Viper Venom Time Measurement
ECCENTCYC96598EccentrocytesA measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.Eccentrocyte Count
EBCIGGABC96600Epstein-Barr Capsid IgG AntibodyA measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.Epstein-Barr Capsid IgG Antibody Measurement
EBCIGMABC96601Epstein-Barr Capsid IgM AntibodyA measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.Epstein-Barr Capsid IgM Antibody Measurement
EBEAGC96602Epstein-Barr Early AntigenA measurement of the Epstein-Barr early antigen in a biological specimen.Epstein-Barr Early Antigen Measurement
EBNABC96603Epstein-Barr Nuclear AntibodyA measurement of the Epstein-Barr nuclear antibody in a biological specimen.Epstein-Barr Nuclear Antibody Measurement
EBNAGC96604Epstein-Barr Nuclear AntigenA measurement of the Epstein-Barr nuclear antigen in a biological specimen.Epstein-Barr Nuclear Antigen Measurement
RBCGHOSTC96605Erythrocyte Ghosts;RBC GhostsA measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.Erythrocyte Ghost Count
FACTIIC96626Factor II;ProthrombinA measurement of the Factor II in a biological specimen.Prothrombin Measurement
FATC96648FatA measurement of the fat in a biological specimen.Fat Measurement
FGF23C96650Fibroblast Growth Factor 23;PhosphatoninA measurement of the fibroblast growth factor 23 in a biological specimen.Fibroblast Growth Factor 23 Measurement
NEUTGTC96651Giant NeutrophilsA measurement of the giant neutrophils in a biological specimen.Giant Neutrophil Count
GLUCCLRC96652Glucose ClearanceA measurement of the glucose clearance in a biological specimen.Glucose Clearance Measurement
GADABC96653Glutamic Acid Decarboxylase Antibody;GAD AntibodyA measurement of the glutamic acid decarboxylase antibody in a biological specimen.Glutamic Acid Decarboxylase Antibody Measurement
GRANC96654GranulocytesA measurement of the granulocytes in a biological specimen.Granulocyte Count
HBCABC96660Hepatitis B Virus Core AntibodyA measurement of the hepatitis B virus core antibody in a biological specimen.Hepatitis B Virus Core Antibody Measurement
HBCIGMABC96661Hepatitis B Virus Core IgM AntibodyA measurement of the hepatitis B virus core IgM antibody in a biological specimen.Hepatitis B Virus Core IgM Antibody Measurement
HBEABC96662Hepatitis B Virus e AntibodyA measurement of the hepatitis B e antibody in a biological specimen.Hepatitis B Virus e Antibody Measurement
HBEAGC96663Hepatitis B Virus e AntigenA measurement of the hepatitis B e antigen in a biological specimen.Hepatitis B Virus e Antigen Measurement
HDABC96664Hepatitis D Virus Antibody;Hepatitis Delta AntibodyA measurement of the hepatitis D virus antibody in a biological specimen.Hepatitis D Virus Antibody Measurement
HEIGMABC96665Hepatitis E Virus IgM AntibodyA measurement of the hepatitis E virus IgM antibody in a biological specimen.Hepatitis E Virus IgM Antibody Measurement
HS1IGGABC96697Herpes Simplex Virus 1 IgG Antibody;HSV-1 IgG AntibodyA measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.Herpes Simplex Virus 1 IgG Antibody Measurement
HS12GGABC96698Herpes Simplex Virus 1/2 IgG Antibody;HSV-1/2 IgG AbA measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.Herpes Simplex Virus 1/2 IgG Antibody Measurement
HS12GMABC96666Herpes Simplex Virus 1/2 IgM Antibody;HSV-1/2 IgM AbA measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.Herpes Simplex Virus 1/2 IgM Antibody Measurement
HS2IGGABC96667Herpes Simplex Virus 2 IgG Antibody;HSV-2 IgG AntibodyA measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.Herpes Simplex Virus 2 IgG Antibody Measurement
HEXKC96668HexokinaseA measurement of the hexokinase in a biological specimen.Hexokinase Measurement
HYPERCHRC96669HyperchromiaA measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.Hyperchromia Measurement
BASOIMC96670Immature BasophilsA measurement of the immature basophils in a biological specimen.Immature Basophil Count
BASOIMLEC96671Immature Basophils/LeukocytesA relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.Immature Basophil to Leukocyte Ratio Measurement
CELLSIMC96672Immature CellsA measurement of the total immature cells in a blood specimen.Immature Cell Count
EOSIMC96673Immature EosinophilsA measurement of the immature eosinophils in a biological specimen.Immature Eosinophil Count
EOSIMLEC96674Immature Eosinophils/LeukocytesA relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.Immature Eosinophil to Leukocyte Ratio Measurement
GRANIMC96675Immature GranulocytesA measurement of the total immature granulocytes in a biological specimen.Immature Granulocyte Count
MONOIMC96676Immature MonocytesA measurement of the immature monocytes in a biological specimen.Immature Monocyte Count
MONOIMLEC96677Immature Monocytes/LeukocytesA relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.Immature Monocyte to Leukocyte Ratio Measurement
NEUTIMC96678Immature NeutrophilsA measurement of the total immature neutrophils in a biological specimen.Immature Neutrophil Count
PLSIMCEC96679Immature Plasma CellsA measurement of the immature plasma cells in a biological specimen.Immature Plasma Cell Count
PLSIMCLYC96680Immature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.Immature Plasma Cell to Lymphocyte Ratio Measurement
INHIBINBC96681Inhibin BA measurement of the inhibin B in a biological specimen.Inhibin B Measurement
KURLOFCEC96682Kurloff CellsA measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.Kurloff Cells Measurement
LKM1ABC96683Liver Kidney Microsomal Type 1 Antibody;LKM-1A measurement of the liver kidney microsomal type 1 antibody in a biological specimen.Liver Kidney Microsomal Type 1 Antibody Measurement
MPCC96686Mean Platelet ComponentA measurement of the mean platelet component (platelet activity) in a blood specimen.Mean Platelet Component Measurement
KRCYMGC96688MegakaryocytesA measurement of the megakaryocytes per unit of a biological specimen.Megakaryocyte Count
HGBMETC96689MethemoglobinA measurement of the methemoglobin in a biological specimen.Methemoglobin Measurement
MMAC96690Methylmalonic AcidA measurement of the methylmalonic acid in a biological specimen.Methylmalonic Acid Measurement
BNPPRONTC96610N-Terminal ProB-type Natriuretic Peptide;NT proBNP II;N-terminal pro-Brain Natriuretic PeptideA measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.N-Terminal ProB-type Natriuretic Peptide Measurement
OXYCAPC96614Oxygen CapacityA measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.Oxygen Capacity Measurement
OXYSATC68032Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
HGBOXYC96616OxyhemoglobinA measurement of the oxyhemoglobin in a biological specimen.Oxyhemoglobin Measurement
PB19GGABC96617Parvovirus B19 IgG AntibodyA measurement of the Parvovirus B19 IgG antibody in a biological specimen.Parvovirus B19 IgG Antibody Measurement
PB19GMABC96618Parvovirus B19 IgM AntibodyA measurement of the Parvovirus B19 IgM antibody in a biological specimen.Parvovirus B19 IgM Antibody Measurement
PHOSLPDC96623PhospholipidA measurement of the phospholipids in a biological specimen.Phospholipid Measurement
PLATCLMPC96624Platelet Clumps;PLT ClumpsA measurement of the platelet clumps in a biological specimen.Platelet Clumps Count
P1NPC96625Procollagen 1 N-Terminal Propeptide;Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1A measurement of the procollagen 1 N-terminal propeptide in a biological specimen.Procollagen 1 N-Terminal Propeptide Measurement
RPTLTIMEC96628Reptilase TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.Reptilase Time Measurement
TRGTCEC96636Leptocytes;Target CellsA measurement of the target cells in a biological specimen.Target Cell Count
THYPXDC96639Thyroperoxidase;Thyroid PeroxidaseA measurement of the thyroperoxidase in a biological specimen.Thyroperoxidase Measurement
THYPXDABC96638Thyroperoxidase AntibodyA measurement of the thyroperoxidase antibody in a biological specimen.Thyroperoxidase Antibody Measurement
TOXGRANC96641Toxic GranulationA measurement of the toxic granulation in neutrophilic blood cells.Toxic Granulation Measurement
UREACRTC96645Urea/CreatinineA relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.Urea to Creatinine Ratio Measurement
ADVVLDC98705ADV Viral LoadA measurement of the adenovirus viral load in a biological specimen.Adenovirus Viral Load Measurement
AFACTXAAC98706Anti-Factor Xa ActivityA measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.Anti-Factor Xa Activity Measurement
AMYLASEPC98767Amylase, PancreaticA measurement of the pancreatic enzyme amylase in a biological specimen.Pancreatic Amylase Measurement
AMYLASESC98780Amylase, SalivaryA measurement of the salivary enzyme amylase in a biological specimen.Salivary Amylase Measurement
APTTSTNDC98862Activated PTT/StandardA relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT/Standard Ratio Measurement
BASOCEC98865Basophils/Total CellsA relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).Basophil to Total CellRatio Measurement
BKVVLDC98710BKV Viral LoadA measurement of the BK virus viral load in a biological specimen.BK Virus Viral Load Measurement
BLSTMBCEC98761Myeloblasts/Total CellsA relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).Myeloblast to Total Cell Ratio Measurement
BLSTMGKC98752MegakaryoblastsA measurement of the megakaryoblasts in a biological specimen.Megakaryoblast Cell Count
BLSTMKCEC98753Megakaryoblasts/Total CellsA relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).Megakaryoblast to Total Cell Ratio Measurement
BLSTNMCEC98764Normoblasts/Total CellsA relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).Normoblast to Total Cell Ratio Measurement
BLSTPNCEC98870Pronormoblasts/Total CellsA relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).Pronormoblast to Total CellRatio Measurement
CMVVLDC98716CMV Viral LoadA measurement of the cytomegalovirus viral load in a biological specimen.Cytomegalovirus Viral Load Measurement
EBVVLDC98721EBV Viral LoadA measurement of the Epstein-Barr virus viral load in a biological specimen.Epstein-Barr Virus Viral Load Measurement
EOSCEC98720Eosinophils/Total CellsA relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).Eosinophils to Total Cell Ratio Measurement
FACTIXC98725Factor IXA measurement of the factor IX in a biological specimen.Factor IX Measurement
FACTVC98726Factor VA measurement of the factor V in a biological specimen.Factor V Measurement
FACTVWC98799von Willebrand FactorA measurement of the von Willebrand factor in a biological specimen.von Willebrand Factor Measurement
FACTXC98727Factor XA measurement of the factor X in a biological specimen.Factor X Measurement
FATDROPC98728Fat DropletA measurement of the triglyceride aggregates within a biological specimen.Fat Droplet Measurement
GFRBSAC98734Glomerular Filtration Rate Adj for BSAA measurement of the glomerular filtration rate adjusted for body size.Glomerular Filtration Rate Adjusted for BSA
GFRBSCRTC98735GFR from Creatinine Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on creatinine.Glomerular Filtration Rate from Creatinine Adjusted for BSA
GFRBSCYCC98736GFR from Cystatin C Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on cystatin C.Glomerular Filtration Rate from Cystatin C Adjusted for BSA
GRANCEC98866Granulocytes/Total CellsA relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).Granulocyte to Total CellRatio Measurement
HASIGEABC98740Human Anti-Sheep IgE AntibodyA measurement of the human anti-sheep IgE antibodies in a biological specimen.Human Anti-Sheep IgE Antibody Measurement
HASIGGABC98741Human Anti-Sheep IgG AntibodyA measurement of the human anti-sheep IgG antibodies in a biological specimen.Human Anti-Sheep IgG Antibody Measurement
HASIGMABC98742Human Anti-Sheep IgM AntibodyA measurement of the human anti-sheep IgM antibodies in a biological specimen.Human Anti-Sheep IgM Antibody Measurement
HMOSIDRNC96659HemosiderinA measurement of the hemosiderin complex in a biological specimen.- - -
HS1IGMABC98738Herpes Simplex Virus 1 IgM AntibodyA measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.Herpes Simplex Virus 1 IgM Antibody Measurement
HS2IGMABC98739Herpes Simplex Virus 2 IgM AntibodyA measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.Herpes Simplex Virus 2 IgM Antibody Measurement
IGDC98745Immunoglobulin DA measurement of the Immunoglobulin D in a biological specimen.Immunoglobulin D Measurement
INLCLRC98748Inulin ClearanceA measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).Inulin Clearance
IOTCLRC98749Iothalamate ClearanceA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).Iothalamate Clearance
IOTCLRBSC98750Iothalamate Clearance Adjusted for BSAA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.Iothalamate Clearance Adjusted for BSA
KLCFRC98730Kappa Light Chain, FreeA measurement of the free kappa light chain in a biological specimen.Free Kappa Light Chain Measurement
KLCLLCFRC98731Kappa Lt Chain,Free/Lambda Lt Chain,FreeA relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement
KRCYMGCEC98867Megakaryocytes/Total CellsA relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).Megakaryocyte to Total CellRatio Measurement
LLCFRC98732Lambda Light Chain, FreeA measurement of the free lambda light chain in a biological specimen.Free Lambda Light Chain Measurement
LYMCEC98751Lymphocytes/Total CellsA relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).Lymphocyte to Total Cell Ratio Measurement
METAMYCEC98754Metamyelocytes/Total CellsA relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).Metamyelocyte to Total Cell Ratio Measurement
MONOCEC98872Monocytes/Total CellsA relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).Monocytes to Total CellRatioMeasurement
MYCYCEC98868Myelocytes/Total CellsA relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).Myelocyte to Total CellRatio Measurement
NEUTCEC98763Neutrophils/Total CellsA relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).Neutrophil to Total Cell Ratio Measurement
NKCEC98762Natural Killer CellsA measurement of the total natural killer cells in a biological specimen.Natural Killer Cell Count
PLSMCECEC98869Plasma Cells/Total CellsA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).Plasma Cell to Total CellRatio Measurement
PROMYCEC98773Promyelocytes/Total CellsA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).Promyelocyte to Total Cell Ratio Measurement
PTAC98774Prothrombin ActivityA measurement of the biological activity of prothrombin in a biological specimen.Prothrombin Activity Measurement
RETIHGBC98776Reticulocyte HemoglobinA measurement of the amount of hemoglobin in reticulocytes.Reticulocyte Hemoglobin Measurement
TFRRNSATC98792Transferrin SaturationA measurement of the iron bound to transferrin in a biological specimen.Transferrin Saturation Measurement
VZVIGAABC98795Varicella Zoster Virus IgA AntibodyA measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.Varicella Zoster Virus IgA Antibody Measurement
VZVIGGABC98796Varicella Zoster Virus IgG AntibodyA measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.Varicella Zoster Virus IgG Antibody Measurement
VZVIGMABC98797Varicella Zoster Virus IgM AntibodyA measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.Varicella Zoster Virus IgM Antibody Measurement
DHPGC1010173,4-Dihydroxyphenylglycol;3.4 DihydroxyphenylglycolA measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.3,4-Dihydroxyphenylglycol Measurement
APROTCRSC100471Activated Protein C Resistance;Factor V Leiden ScreenA measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.Activated Protein C Resistance Measurement
APTTSPTTC100421Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin TimeA relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT to Standard PTT Ratio Measurement
AAPC100430Alanine AminopeptidaseA measurement of the alanine aminopeptidase in a biological specimen.Alanine Aminopeptidase Measurement
A1AGLPC100429Alpha-1 Acid GlycoproteinA measurement of the alpha-1 acid glycoprotein in a biological specimen.Alpha-1 Acid Glycoprotein Measurement
A1MICGC100461Alpha-1 Microglobulin;Protein HCA measurement of the alpha-1 microglobulin in a biological specimen.Alpha-1 Microglobulin Measurement
A1MCREATC100462Alpha-1 Microglobulin/CreatinineA relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.Alpha-1 Microglobulin to Creatinine Ratio Measurement
APOC2C100427Apolipoprotein C2;Apolipoprotein CIIA measurement of the apolipoprotein C2 in a biological specimen.Apolipoprotein C2 Measurement
APOJC100428Apolipoprotein J;ClusterinA measurement of the apolipoprotein J in a biological specimen.Apolipoprotein J Measurement
BETACRTNC100472Beta Carotene;b-Carotene;Beta CarotinA measurement of the beta carotene in a biological specimen.Beta Carotene Measurement
BTPC100426Beta-Trace ProteinA measurement of the beta-trace protein in a biological specimen.Beta-Trace Protein Measurement
CDTC101016Carbohydrate-Deficient TransferrinA measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.Carbohydrate-Deficient Transferrin Measurement
CRLPLSMNC100432Ceruloplasmin;CaeruloplasminA measurement of ceruloplasmin in a biological specimen.Ceruloplasmin Measurement
CH50C100423Complement CH50;Total Hemolytic Complement;CH50A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.CH50 Measurement
CXCR3C100431Chemokine (C-X-C Motif) Receptor 3;GPR9, CD183, CXCR3A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.Chemokine Receptor CXCR3 Measurement
CTRIGAABC100464Chlamydia trachomatis IgA AntibodyA measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.Chlamydia trachomatis IgA Antibody Measurement
CTRIGGABC100466Chlamydia trachomatis IgG AntibodyA measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.Chlamydia trachomatis IgG Antibody Measurement
CTRIGMABC100465Chlamydia trachomatis IgM AntibodyA measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.Chlamydia trachomatis IgM Antibody Measurement
DTPACLRC100441DTPA ClearanceA measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.Diethylene Triamine Pentaacetic Acid Clearance
DNASEBABC100463DNase-B Antibody;Anti-Dnase BA measurement of Dnase-B antibody in a biological specimen.DNase-B Antibody Measurement
ECTC100422Ecarin Clotting TimeA measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.Ecarin Clotting Time Measurement
EDTACLRC100440EDTA ClearanceA measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.EDTA Clearance
GLYCRLFRC100448Free Glycerol;Free GlycerinA measurement of the amount of unbound glycerol in a biological specimen.Free Glycerol Measurement
GFRBSB2MC100450GFR from B-2 Microglobulin Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement
GFRBSBTPC100449GFR from Beta-Trace Protein Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement
HDLCLDLCC100425HDL Cholesterol/LDL Cholesterol RatioA relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.HDL Cholesterol to LDL Cholesterol Ratio Measurement
HLAB27AGC100460HLA-B27 Antigen;Human Leukocyte Antigen B27A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.HLA-B27 Antigen Measurement
HOMAIRC100447Homostat Model Assess of Insulin Rstn;Homeostatic Model Assessment of Insulin ResistanceAn assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.Homeostatic Model Assessment of Insulin Resistance
GRANIMLEC100445Immature Granulocytes/LeukocytesA relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).Immature Granulocytes to Leukocytes Ratio Measurement
LYMIMC100444Immature LymphocytesA measurement of the immature lymphocytes in a biological specimen.Immature Lymphocytes Measurement
LYMIMLEC100443Immature Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.Immature Lymphocytes to Leukocytes Ratio Measurement
NEUTIMLEC100442Immature Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.Immature Neutrophils to Leukocytes Ratio Measurement
IOHEXCLRC100439Iohexol ClearanceA measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.Iohexol Clearance
JO1ABC100459Jo-1 AntibodyA measurement of the Jo-1 antibody in a biological specimen.Jo-1 Antibody Measurement
KIM1C100433Kidney Injury Molecule-1;KIM-1;Hepatitis A Virus Cellular Receptor 1A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.Kidney Injury Molecule-1 Measurement
LKM1IAABC100456Liver Kidney Microsomal Type 1 IgA AbA measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgA Antibody Measurement
LKM1IGABC100454Liver Kidney Microsomal Type 1 IgG AbA measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgG Antibody Measurement
LKM1IMABC100455Liver Kidney Microsomal Type 1 IgM AbA measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgM Antibody Measurement
NPAPC100434Non-Prostatic Acid PhosphataseA measurement of the non-prostatic acid phosphatase in a biological specimen.Non-Prostatic Acid Phosphatase Measurement
OVAPARSC100452Ova and ParasiteA measurement of the parasites and ova in a biological specimen.Ova and Parasite Measurement
PEPSNGAC100469Pepsinogen A;PGAA measurement of the pepsinogen A in a biological specimen.Pepsinogen A Measurement
PEPSNGCC100470Pepsinogen C;PGCA measurement of the pepsinogen C in a biological specimen.Pepsinogen C Measurement
PEPSNGIC100467Pepsinogen I;PGIA measurement of the pepsinogen I in a biological specimen.Pepsinogen I Measurement
PEPSNGIIC100468Pepsinogen II;PGIIA measurement of the pepsinogen II in a biological specimen.Pepsinogen II Measurement
PEPSNGC100122PepsinogenA measurement of the pepsinogen in a biological specimen.Pepsinogen Measurement
PLSMDMC100453PlasmodiumExamination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.Plasmodium Measurement
PLATHCTC100424Platelet Hematocrit;ThrombocytocritA relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.Platelet Hematocrit Measurement
PREALBC100435PrealbuminA measurement of the prealbumin in a biological specimen.Prealbumin Measurement
PERTHRBLC100446ProerythroblastA measurement of the proerythroblasts in a biological specimen.Proerythroblast Measurement
PROTSC100436Protein SA measurement of the protein S in a biological specimen.Protein S Measurement
RBPC100437Retinol Binding ProteinA measurement of the total retinol binding protein in a biological specimen.Retinol Binding Protein Measurement
RNPABC100457Ribonucleoprotein Antibody;RNP AntibodyA measurement of the ribonucleoprotein antibody in a biological specimen.Ribonucleoprotein Antibody Measurement
BLSTRSIDC100419Ringed SideroblastsA measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.Ringed Sideroblast Measurement
SCL70ABC100458Scl-70 Antibody;Scleroderma-70 AntibodyA measurement of the Scl-70 antibody in a biological specimen.Scl-70 Antibody Measurement
BLSTSIDC100418SideroblastA measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.Sideroblast Measurement
SLTFRNRCC100438Soluble Transferrin ReceptorA measurement of the soluble transferrin receptor in a biological specimen.Soluble Transferrin Receptor Measurement
TRCYANDPC100420Tricyclic AntidepressantsA measurement of tricyclic antidepressants in a biological specimen.Tricyclic Antidepressant Measurement
Back to top
CL.C67154.LBTESTLaboratory Test Name
(LBTEST)
text
Extensible: Yes
C67154Laboratory Test NameTerminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.CDISC SDTM Laboratory Test Terminology by Name
AnisocytesC74797AnisocytesA measurement of the inequality in the size of the red blood cells in a whole blood specimen.Anisocyte Measurement
PoikilocytesC79602PoikilocytesA measurement of the odd-shaped erythrocytes in a whole blood specimen.Poikilocyte Measurement
BilirubinC38037Bilirubin;Total BilirubinA measurement of the total bilirubin in a biological specimen.Total Bilirubin Measurement
Activated Partial Thromboplastin TimeC38462Activated Partial Thromboplastin TimeA measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.Partial Thromboplastin Time
GlucoseC41376GlucoseA measurement of the glucose in a biological specimen.Plasma Glucose Measurement
pHC45997pHA measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.pH
ErythrocytesC51946Erythrocytes;Red Blood CellsA measurement of the total erythrocytes in a biological specimen.Erythrocyte Count
ReticulocytesC51947ReticulocytesA measurement of the reticulocytes in a biological specimen.Reticulocyte Count
LeukocytesC51948Leukocytes;White Blood CellsA measurement of the leukocytes in a biological specimen.Leukocyte Count
LymphocytesC51949LymphocytesA measurement of the lymphocytes in a biological specimen.Lymphocyte Count
PlateletsC51951PlateletsA measurement of the platelets in a biological specimen.Platelet Count
Blood Urea NitrogenC61019Blood Urea NitrogenA measurement of the urea nitrogen in a blood specimen.Blood Urea Nitrogen Measurement
CholesterolC61032Cholesterol;Total CholesterolA measurement of the cholesterol in a biological specimen.Serum Total Cholesterol Measurement
HDL CholesterolC61041HDL CholesterolA measurement of the high density lipoprotein cholesterol in a biological specimen.Serum HDL Cholesterol Measurement
LDL CholesterolC61042LDL CholesterolA measurement of the low density lipoprotein cholesterol in a biological specimen.Serum LDL Cholesterol Measurement
Prothrombin TimeC62656Prothrombin TimeA blood clotting measurement that evaluates the extrinsic pathway of coagulation.Prothrombin Time
NeutrophilsC63321NeutrophilsA measurement of the neutrophils in a biological specimen.Absolute Neutrophil Count
AlbuminC64431Albumin;MicroalbuminA measurement of the albumin protein in a biological specimen.Albumin Measurement
Alkaline PhosphataseC64432Alkaline PhosphataseA measurement of the alkaline phosphatase in a biological specimen.Alkaline Phosphatase Measurement
Alanine AminotransferaseC64433Alanine Aminotransferase;SGPTA measurement of the alanine aminotransferase in a biological specimen.Alanine Aminotransferase Measurement
AmylaseC64434AmylaseA measurement of the total enzyme amylase in a biological specimen.Amylase Measurement
Aspartate AminotransferaseC64467Aspartate Aminotransferase;SGOTA measurement of the aspartate aminotransferase in a biological specimen.Aspartate Aminotransferase Measurement
BacteriaC64469BacteriaA measurement of the bacteria in a biological specimen.Bacterial Count
BasophilsC64470BasophilsA measurement of the basophils in a biological specimen.Total Basophil Count
Basophils/LeukocytesC64471Basophils/LeukocytesA relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.Basophil To Leukocyte Ratio
Direct BilirubinC64481Direct BilirubinA measurement of the conjugated or water-soluble bilirubin in a biological specimen.Direct Bilirubin Measurement
Indirect BilirubinC64483Indirect BilirubinA measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.Indirect Bilirubin Measurement
Blasts/LeukocytesC64487Blasts/LeukocytesA relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.Blast To Leukocyte Ratio
CalciumC64488CalciumA measurement of the calcium in a biological specimen.Calcium Measurement
Creatine KinaseC64489Creatine KinaseA measurement of the total creatine kinase in a biological specimen.Creatine Kinase Measurement
Creatine Kinase BBC64490Creatine Kinase BBA measurement of the homozygous B-type creatine kinase in a biological specimen.Creatine Kinase BB Measurement
Creatine Kinase MBC64491Creatine Kinase MBA measurement of the heterozygous MB-type creatine kinase in a biological specimen.Creatine Kinase MB Measurement
Creatine Kinase MMC64494Creatine Kinase MMA measurement of the homozygous M-type creatine kinase in a biological specimen.Creatine Kinase MM Measurement
ChlorideC64495ChlorideA measurement of the chloride in a biological specimen.Chloride Measurement
Carbon DioxideC64545Carbon DioxideA measurement of the carbon dioxide gas in a biological specimen.Carbon Dioxide Measurement
ColorC64546ColorA measurement of the color of a biological specimen.Color Assessment
CreatinineC64547CreatinineA measurement of the creatinine in a biological specimen.Creatinine Measurement
C Reactive ProteinC64548C Reactive ProteinA measurement of the C reactive protein in a biological specimen.C-Reactive Protein Measurement
ElliptocytesC64549Elliptocytes;OvalocytesA measurement of the elliptically shaped erythrocytes in a biological specimen.Elliptocyte Count
EosinophilsC64550EosinophilsA measurement of the eosinophils in a biological specimen.Eosinophil Count
Eosinophils/LeukocytesC64604Eosinophils/LeukocytesA relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.Eosinophil To Leukocyte Ratio
Epithelial CellsC64605Epithelial CellsA measurement of the epithelial cells in a biological specimen.Epithelial Cell Count
FibrinogenC64606FibrinogenA measurement of the fibrinogen in a biological specimen.Fibrinogen Measurement
HematocritC64796HematocritThe percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).Hematocrit
Ery. Mean Corpuscular HemoglobinC64797Ery. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin
Ery. Mean Corpuscular HGB ConcentrationC64798Ery. Mean Corpuscular HGB ConcentrationA quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin Concentration
Ery. Mean Corpuscular VolumeC64799Ery. Mean Corpuscular VolumeA quantitative measurement of the mean volume of erythrocytes in a biological specimen.Erythrocyte Mean Corpuscular Volume
Erythrocytes Distribution WidthC64800Erythrocytes Distribution WidthA value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.Erythrocyte Distribution Width Measurement
DacryocytesC64801Dacryocytes;Tear Shaped Erythrocytes;Teardrop CellsA measurement of dacryocytes in a biological specimen.Dacryocyte Analysis
HypochromiaC64802HypochromiaAn observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.Hypochromia
PolychromasiaC64803PolychromasiaA measurement of the blue-staining characteristic of newly generated erythrocytes.Polychromasia
Prothrombin Intl. Normalized RatioC64805Prothrombin Intl. Normalized RatioA ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.International Normalized Ratio of Prothrombin Time
VLDL CholesterolC64806VLDL CholesterolA measurement of the very low density lipoprotein cholesterol in a biological specimen.Serum VLDL Cholesterol Measurement
Triacylglycerol LipaseC64807Triacylglycerol LipaseA measurement of the pancreatic lipase in a biological specimen.Triacylglycerol Lipase Measurement
SodiumC64809SodiumA measurement of the sodium in a biological specimen.Sodium Measurement
NitriteC64810NitriteA measurement of the nitrite in a urine specimen.Nitrite Measurement
TriglyceridesC64812TriglyceridesA measurement of the triglycerides in a biological specimen.Triglyceride Measurement
ThyrotropinC64813ThyrotropinA measurement of the thyrotropin in a biological specimen.Thyrotropin Measurement
UrateC64814Urate;Uric AcidA measurement of the urate in a biological specimen.Urate Measurement
UreaC64815UreaA measurement of the urea in a biological specimen.Urea Measurement
UrobilinogenC64816UrobilinogenA measurement of the urobilinogen in a biological specimen.Urobilinogen Measurement
Vitamin B12C64817Vitamin B12A measurement of the Vitamin B12 in a serum specimen.Vitamin B12 Measurement
Lymphocytes AtypicalC64818Lymphocytes AtypicalA measurement of the atypical lymphocytes in a biological specimen.Atypical Lymphocyte Count
Lymphocytes Atypical/LeukocytesC64819Lymphocytes Atypical/LeukocytesA relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.Atypical Lymphocyte To Leukocyte Ratio
Lymphocytes/LeukocytesC64820Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.Lymphocyte To Leukocyte Ratio
MacrocytesC64821MacrocytesA measurement of the macrocytes in a biological specimen.Macrocyte Count
MicrocytesC64822MicrocytesA measurement of the microcytes in a biological specimen.Microcyte Count
MonocytesC64823MonocytesA measurement of the monocytes in a biological specimen.Monocyte Count
Monocytes/LeukocytesC64824Monocytes/LeukocytesA relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.Monocyte To Leukocyte Ratio
Myeloblasts/LeukocytesC64825Myeloblasts/LeukocytesA relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.Myeloblast To Leukocyte Ratio
Myelocytes/LeukocytesC64826Myelocytes/LeukocytesA relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.Myelocyte To Leukocyte Ratio
Neutrophils/LeukocytesC64827Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.Neutrophil To Leukocyte Ratio
Reticulocytes/ErythrocytesC64828Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.Reticulocyte To Erythrocyte Ratio
Prolymphocytes/LeukocytesC64829Prolymphocytes/LeukocytesA relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.Prolymphocyte To Leukocyte Ratio
Neutrophils Band FormC64830Neutrophils Band FormA measurement of the banded neutrophils in a biological specimen.Neutrophil Band Form Count
Neutrophils Band Form/LeukocytesC64831Neutrophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.Neutrophil Band Form To Leukocyte Ratio
Specific GravityC64832Specific GravityA ratio of the density of a fluid to the density of water.Specific Gravity
MagnesiumC64840MagnesiumA measurement of the magnesium in a biological specimen.Magnesium Measurement
Gamma Glutamyl TransferaseC64847Gamma Glutamyl TransferaseA measurement of the gamma glutamyl transferase in a biological specimen.Gamma Glutamyl Transpeptidase Measurement
HemoglobinC64848HemoglobinA measurement of the hemoglobin in a biological specimen.Hemoglobin Measurement
Hemoglobin A1CC64849Hemoglobin A1CA measurement of the glycosylated hemoglobin in a biological specimen.Glycosylated Hemoglobin Measurement
Hepatitis B Virus Surface AntigenC64850HBsAg;Hepatitis B Virus Surface AntigenA measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Virus Surface Antigen Measurement
Choriogonadotropin BetaC64851Choriogonadotropin Beta;Pregnancy TestA measurement of the Choriogonadotropin Beta in a biological specimen.Choriogonadotropin Beta Measurement
PotassiumC64853PotassiumA measurement of the potassium in a biological specimen.Potassium Measurement
KetonesC64854KetonesA measurement of the ketones in a biological specimen.Ketone Measurement
Lactate DehydrogenaseC64855Lactate DehydrogenaseA measurement of the lactate dehydrogenase in a biological specimen.Lactate Dehydrogenase Measurement
Leukocyte EsteraseC64856Leukocyte EsteraseA measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.Leukocyte Esterase Measurement
PhosphateC64857Phosphate;Phosphorus;Inorganic PhosphateA measurement of the phosphate in a biological specimen.Phosphate Measurement
ProteinC64858ProteinA measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.Total Protein Measurement
Prostate Specific AntigenC17634Prostate Specific AntigenA measurement of the prostate specific antigen in a biological specimen.Prostate Specific Antigen Measurement
Creatinine ClearanceC25747Creatinine ClearanceA measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).Creatinine Clearance
Hairy CellsC74604Hairy CellsA measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.Hairy Cell Count
BlastsC74605BlastsA measurement of the blast cells in a biological specimen.Blast Count
CD19C74606CD19A measurement of the CD19 B cells in a biological specimen.CD19 Expressing B Cell Count
CD3C74607CD3A measurement of the CD3 T cells in a biological specimen.CD3 Expressing T Cell Count
CD4C74608CD4A measurement of the CD4 T cells in a biological specimen.CD4 Expressing T Cell Count
CD8C74609CD8A measurement of the CD8 T cells in a biological specimen.CD8 Expressing T Cell Count
Dohle BodiesC74610Dohle BodiesA measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.Dohle Body Measurement
Erythrocyte Sedimentation RateC74611Erythrocyte Sedimentation Rate;Biernacki ReactionThe distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).Erythrocyte Sedimentation Rate Measurement
Hypersegmented CellsC74612Hypersegmented CellsA measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.Hypersegmented Neutrophil Measurement
Lymphoma CellsC74613Lymphoma CellsA measurement of the malignant lymphocytes in a biological specimen.Lymphoma Cell Count
May-Hegglin AnomalyC74614May-Hegglin AnomalyA measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.May-Hegglin Anomaly Measurement
MetamyelocytesC74615MetamyelocytesA measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.Metamyelocyte Count
Pappenheimer BodiesC74616Pappenheimer BodiesA measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.Pappenheimer Body Count
Pelger Huet AnomalyC74617Pelger Huet AnomalyA measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.Pelger Huet Anomaly Measurement
Plasmacytoid LymphocytesC74618Plasmacytoid Lymphocytes;PlymphocytesA measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.Plasmacytoid Lymphocyte Count
Precursor Plasma CellsC74619Precursor Plasma Cells;PlasmablastA measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.Precursor Plasma Cell Count
ProlymphocytesC74620ProlymphocytesA measurement of the prolymphocytes in a biological specimen.Prolymphocyte Count
PromonocytesC74621PromonocytesA measurement of the promonocytes in a biological specimen.Promonocyte Count
PromyelocytesC74622PromyelocytesA measurement of the promyelocytes (immature myelocytes) in a biological specimen.Promyelocyte Count
Rouleaux FormationC74624Rouleaux FormationA measurement of the number of stacking red blood cells within a biological specimen.Rouleaux Formation Count
Sezary CellsC74625Sezary CellsA measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.Sezary Cell Count
Sickle CellsC74626Sickle CellsA measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.Sickle Cell Count
Smudge CellsC74627Smudge Cells;Basket CellsA measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.Smudge Cell Count
Vacuolated NeutrophilsC74628Vacuolated NeutrophilsA measurement of the neutrophils containing small vacuoles in a biological specimen.Vacuolated Neutrophil Count
Leukemic BlastsC74630Leukemic Blasts;Leukemic Lymphoblasts;Immunoblastic LymphocytesA measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.Leukemic Blast Count
MonoblastsC74631MonoblastsA measurement of the monoblast cells in a biological specimen.Monoblast Count
MyeloblastsC74632MyeloblastsA measurement of the myeloblast cells in a biological specimen.Myeloblast Count
Acanthocytes/ErythrocytesC74633Acanthocytes/ErythrocytesA relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.Acanthocyte to Erythrocyte Ratio Measurement
Bite Cells/ErythrocytesC74634Bite Cells/ErythrocytesA relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen .Bite Cell to Erythrocyte Ratio Measurement
CD19/LymphocytesC74635CD19/LymphocytesA relative measurement (ratio or percentage) of CD19 B cells to all lymphocytes in a biological specimen.CD19 B Cell to Lymphocyte Ratio Measurement
CD3/LymphocytesC74636CD3/LymphocytesA relative measurement (ratio or percentage) of CD3 T cells to all lymphocytes in a biological specimen.CD3 T Cell to Lymphocyte Ratio Measurement
CD4/CD8C74637CD4/CD8A relative measurement (ratio or percentage) of CD4 T cells to the CD8 T cells in a biological specimen.CD4 T Cell to CD8 T Cell Ratio Measurement
CD4/LymphocytesC74638CD4/LymphocytesA relative measurement (ratio or percentage) of CD4 T cells to all lymphocytes in a biological specimen.CD4 T Cell to Lymphocyte Ratio Measurement
CD8/LymphocytesC74639CD8/LymphocytesA relative measurement (ratio or percentage) of CD8 T cells to all lymphocytes in a biological specimen.CD8 T Cell to Lymphocyte Ratio Measurement
Hairy Cells/LymphocytesC74640Hairy Cells/LymphocytesA relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .Hairy Cell to Lymphocyte Ratio Measurement
Leukemic Blasts/LymphocytesC74641Leukemic Blasts/LymphocytesA relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.Leukemic Blast to Lymphocyte Ratio Measurement
Malignant Cells, NOS/Blood CellsC74643Malignant Cells, NOS/Blood CellsA relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.Malignant Cell to Blood Cell Ratio Measurement
Metamyelocytes/LeukocytesC74645Metamyelocytes/LeukocytesA relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.Metamyelocyte to Leukocyte Ratio Measurement
Monoblasts/LeukocytesC74646Monoblasts/LeukocytesA relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.Monoblast to Leukocyte Ratio Measurement
Nucleated Erythrocytes/ErythrocytesC74647Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/ErythrocytesA relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.Nucleated Red Blood Cell to Erythrocyte Ratio Measurement
Plasmacytoid Lymphocytes/LymphocytesC74648Plasmacytoid Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement
Poikilocytes/ErythrocytesC74649Poikilocytes/ErythrocytesA relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.Poikilocyte to Erythrocyte Ratio Measurement
Precursor Plasma Cells/LymphocytesC74650Precursor Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.Precursor Plasma Cell to Lymphocyte Ratio Measurement
Prolymphocytes/LymphocytesC74651Prolymphocytes/LymphocytesA relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.Prolymphocyte to Lymphocyte Ratio Measurement
Promonocytes/LeukocytesC74652Promonocytes/LeukocytesA relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.Promonocyte to Lymphocyte Ratio Measurement
Promyelocytes/LeukocytesC74653Promyelocytes/LeukocytesA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.Promyelocyte to Lymphocyte Ratio Measurement
Reactive Lymphocytes/LymphocytesC74654Reactive Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.Reactive Lymphocyte to Lymphocyte Ratio Measurement
Sezary Cells/LymphocytesC74655Sezary Cells/LymphocytesA relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.Sezary Cell to Lymphocyte Ratio Measurement
Sickle Cells/ErythrocytesC74656Sickle Cells/ErythrocytesA relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.Sickle Cell to Erythrocyte Ratio Measurement
Auer RodsC74657Auer RodsA measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.Auer Rod Measurement
Helmet CellsC74658Helmet CellsA measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.Helmet Cell Count
Large Unstained CellsC74659Large Unstained CellsA measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.Large Unstained Cell Count
Malignant Cells, NOSC74660Malignant Cells, NOSA measurement of the malignant cells of all types in a biological specimen.Malignant Cell Count
Mature Plasma CellsC74661Mature Plasma Cells;PlasmacytesA measurement of the mature plasma cells (plasmacytes) in a biological specimen.Mature Plasma Cell Count
MyelocytesC74662MyelocytesA measurement of the myelocytes in a biological specimen.Myelocyte Count
SpermatozoaC74663SpermatozoaA measurement of the spermatozoa cells present in a biological specimen.Spermatozoa Cell Count
Yeast CellsC74664Yeast CellsA measurement of the yeast cells present in a biological specimen.Yeast Cell Measurement
Amorphous CrystalsC74665Amorphous CrystalsA measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.Amorphous Crystal Measurement
Amorphous SedimentC74666Amorphous Sediment;Amorphous DebrisA measurement of the amorphous sediment present in a biological specimen.Amorphous Sediment Measurement
BicarbonateC74667Bicarbonate;HCO3A measurement of the bicarbonate in a biological specimen.Bicarbonate Measurement
Bilirubin CrystalsC74668Bilirubin CrystalsA measurement of the bilirubin crystals present in a biological specimen.Bilirubin Crystal Measurement
Calcium Carbonate CrystalsC74669Calcium Carbonate CrystalsA measurement of the calcium carbonate crystals present in a biological specimen.Calcium Carbonate Crystal Measurement
Calcium Oxalate CrystalsC74670Calcium Oxalate CrystalsA measurement of the calcium oxalate crystals present in a biological specimen.Calcium Oxalate Crystal Measurement
Calcium Phosphate CrystalsC74671Calcium Phosphate CrystalsA measurement of the calcium phosphate crystals present in a biological specimen.Calcium Phosphate Crystal Measurement
Cholesterol CrystalsC74672Cholesterol CrystalsA measurement of the cholesterol crystals present in a biological specimen.Cholesterol Crystal Measurement
CrystalsC74673CrystalsA statement that indicates crystals were looked for and not found in a biological specimen.Crystal Present Or Absent
Cystine CrystalsC74674Cystine CrystalsA measurement of the cystine crystals present in a biological specimen.Cystine Crystal Measurement
Vitamin B9C74676Folic Acid;Vitamin B9A measurement of the folic acid in a biological specimen.Folic Acid Measurement
Carnitine, FreeC74677Carnitine, FreeA measurement of the free carnitine in a biological specimen.Free Carnitine Measurement
FructosamineC74678Fructosamine;Glycated Serum ProteinA measurement of the fructosamine in a biological specimen.Fructosamine Measurement
IronC74679Iron;FEA measurement of the iron in a biological specimen.Iron Measurement
Leucine CrystalsC74680Leucine CrystalsA measurement of the leucine crystals present in a biological specimen.Leucine Crystal Measurement
Monosodium Urate CrystalsC74681Monosodium Urate CrystalsA measurement of the monosodium urate crystals present in a biological specimen.Monosodium Urate Crystal Measurement
CarnitineC74682CarnitineA measurement of the total carnitine in a biological specimen.Total Carnitine Measurement
Tyrosine CrystalsC74683Tyrosine CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Tyrosine Crystal Measurement
Uric Acid CrystalsC74684Uric Acid CrystalsA measurement of the uric acid crystals present in a biological specimen.Uric Acid Crystal Measurement
Anion GapC74685Anion GapA computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.Anion Gap Measurement
Occult BloodC74686Occult BloodA measurement of the blood in body products such as a stool sample, not detectable on gross examination.Occult Blood Measurement
AmphetamineC74687AmphetamineA measurement of any amphetamine class drug present in a biological specimen.Amphetamine Drug Class Measurement
BarbituratesC74688BarbituratesA measurement of any barbiturate class drug present in a biological specimen.Barbiturate Drug Class Measurement
CannabinoidsC74689CannabinoidsA measurement of any cannabinoid class drug present in a biological specimen.Cannabinoid Drug Class Measurement
CocaineC74690CocaineA measurement of the cocaine present in a biological specimen.Cocaine Measurement
Round Epithelial CellsC74698Round Epithelial CellsA measurement of the round epithelial cells present in a biological specimen.Round Epithelial Cell Count
AcanthocytesC74699AcanthocytesA measurement of the acanthocytes in a biological specimen.Acanthocyte Count
Bite CellsC74700Bite CellsA measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen .Bite Cell Count
Burr CellsC74701Burr Cells;KeratocytesA measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.Burr Cell Count
Cabot RingsC74702Cabot RingsA measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.Cabot Ring Count
Crenated CellsC74703Crenated Cells;EchinocytesA measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.Crenated Cell Measurement
Howell-Jolly BodiesC74704Howell-Jolly BodiesA measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.Howell-Jolly Body Measurement
Nucleated ErythrocytesC74705Nucleated Erythrocytes;Nucleated Red Blood CellsA measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.Nucleated Red Blood Cell Count
SchistocytesC74706SchistocytesA measurement of the schistocytes (fragmented red blood cells) in a biological specimen.Schistocyte Count
SpherocytesC74707SpherocytesA measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.Spherocyte Count
StomatocytesC74708StomatocytesA measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.Stomatocyte Count
Heinz BodiesC74709Heinz Bodies;Heinz-Erhlich BodiesA measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.Heinz-Ehrlich Body Measurement
Hepatitis A Virus AntibodyC92534Hepatitis A Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.Hepatitis A Antibody Measurement
Hepatitis B Virus Surface AntibodyC74711Anti-HBs;HBsAb;Hepatitis B Virus Surface AntibodyA measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Surface Antibody Measurement
Hepatitis C Virus AntibodyC92535Hepatitis C Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.Hepatitis C Antibody Measurement
HIV-1 AntibodyC74713HIV-1 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-1 virus.HIV-1 Antibody Measurement
HIV-1/2 AntibodyC74714HIV-1/2 AntibodyA measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.HIV-1 HIV-2 Antibody Measurement
HIV-2 AntibodyC74715HIV-2 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-2 virus.HIV-2 Antibody Measurement
Rapid Plasma ReaginC74716Rapid Plasma ReaginA measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.Rapid Plasma Reagin Measurement
Rheumatoid FactorC74717Rheumatoid FactorA measurement of the rheumatoid factor antibody in a biological specimen.Rheumatoid Factor Measurement
Total Iron Binding CapacityC74718Total Iron Binding CapacityA measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.Total Iron Binding Capacity
Unsaturated Iron Binding CapacityC74719Unsaturated Iron Binding CapacityA measurement of the binding capacity of unsaturated iron in a biological specimen.Unsaturated Iron Binding Capacity Measurement
Mucous ThreadsC74721Mucous ThreadsA measurement of the mucous threads present in a biological specimen.Mucous Thread Measurement
TurbidityC74723TurbidityA measurement of the opacity of a biological specimen.Turbidity Measurement
HAV Viral LoadC92541HAV Viral LoadA measurement of the hepatitis A viral load in a biological specimen.Hepatitis A Viral Load Measurement
HBV Viral LoadC92542HBV Viral LoadA measurement of the hepatitis B viral load in a biological specimen.Hepatitis B Viral Load Measurement
HCV Viral LoadC92543HCV Viral LoadA measurement of the hepatitis C viral load in a biological specimen.Hepatitis C Viral Load Measurement
HIV Viral LoadC92544HIV Viral LoadA measurement of the HIV viral load in a biological specimen.HIV Viral Load Measurement
Giant PlateletsC74728Giant PlateletsA measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.Giant Platelet Count
Large PlateletsC74729Large PlateletsA measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.Large Platelet Count
Mean Platelet VolumeC74730Mean Platelet VolumeA measurement of the average size of the platelets present in a blood sample.Mean Platelet Volume Measurement
AldolaseC74731AldolaseA measurement of the aldolase enzyme in a biological specimen.Aldolase Measurement
Alpha FetoproteinC74732Alpha FetoproteinA measurement of the alpha fetoprotein in a biological specimen.Alpha-fetoprotein Measurement
Apolipoprotein A1C74733Apolipoprotein A1A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.Apolipoprotein A1 Measurement
Apolipoprotein BC74734Apolipoprotein BA measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.Apolipoprotein B Measurement
Brain Natriuretic PeptideC74735Brain Natriuretic Peptide;B-Type Natriuretic PeptideA measurement of the brain (B-type) natriuretic peptide in a biological specimen.Brain Natriuretic Peptide Measurement
C-peptideC74736C-peptideA measurement of the C (connecting) peptide of insulin in a biological specimen.C-peptide Measurement
FerritinC74737FerritinA measurement of the ferritin in a biological specimen.Ferritin Measurement
GlobulinC74738GlobulinA measurement of the globulin protein in a biological specimen.Globulin Protein Measurement
GlutamateC74739Glutamate;Glutamic AcidA measurement of the glutamate in a biological specimen.Glutamate Measurement
HaptoglobinC74740HaptoglobinA measurement of the haptoglobin protein in a biological specimen.Haptoglobin Protein Measurement
HomocysteineC74741HomocysteineA measurement of the homocysteine amino acid in a biological specimen.Homocysteine Acid Measurement
N-telopeptideC74743N-telopeptideA measurement of the N-telopeptide in a biological specimen.N-telopeptide Measurement
OsteocalcinC74744OsteocalcinA measurement of the osteocalcin in a biological specimen.Osteocalcin Measurement
Sex Hormone Binding GlobulinC74745Sex Hormone Binding Globulin;Sex Hormone Binding ProteinA measurement of the sex hormone binding (globulin) protein in a biological specimen.Sex Hormone Binding Protein Measurement
Thyroxine Binding GlobulinC74746Thyroxine Binding GlobulinA measurement of the thyroxine binding globulin protein in a biological specimen.Thyroxine Binding Globulin Protein Measurement
TriiodothyronineC74747Triiodothyronine;Total T3A measurement of the total (free and bound) triiodothyronine in a biological specimen.Triiodothyronine Measurement
Triiodothyronine UptakeC74748Triiodothyronine UptakeA measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.Triiodothyronine Uptake Measurement
Troponin IC74749Troponin IA measurement of the actin binding troponin in a biological specimen.Troponin I Measurement
Troponin TC74750Troponin TA measurement of the tropomyosin binding troponin in a biological specimen.Troponin T Measurement
Tumor Necrosis FactorC74751Tumor Necrosis Factor;Tumor Necrosis Factor alphaA measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.Tumor Necrosis Factor Measurement
BUN/CreatinineC74753BUN/CreatinineA relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.Blood Urea Nitrogen To Creatinine Ratio Measurement
Hippuric Acid CrystalsC74754Hippuric Acid CrystalsA measurement of the hippuric acid crystals present in a biological specimen.Hippuric Acid Crystal Measurement
Sulfa CrystalsC74755Sulfa CrystalsA measurement of the sulfa crystals present in a biological specimen.Sulfa Crystal Measurement
Triple Phosphate CrystalsC74756Triple Phosphate CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Triple Phosphate Crystal Measurement
Unclassified CrystalsC74757Unclassified CrystalsA measurement of the unclassifiable crystals present in a biological specimen.Unclassified Crystal Measurement
Ammonium Biurate CrystalsC74758Ammonium Biurate CrystalsA measurement of the ammonium biurate crystals present in a biological specimen.Urine Ammonium Biurate Crystal Measurement
Ammonium Oxalate CrystalsC74759Ammonium Oxalate CrystalsA measurement of the ammonium oxalate crystals present in a urine specimen.Urine Ammonium Oxalate Crystal Measurement
Albumin/CreatinineC74761Albumin/Creatinine;Microalbumin/Creatinine RatioA relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.Albumin To Creatinine Protein Ratio Measurement
Bacterial CastsC74762Bacterial CastsA measurement of the bacterial casts present in a biological specimen.Bacterial Cast Measurement
CastsC74763CastsA statement that indicates casts were looked for and not found in a biological specimen.Cast Present Or Absent
Cellular CastsC74764Cellular CastsA measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.Cellular Cast Measurement
Granular Coarse CastsC74765Granular Coarse CastsA measurement of the coarse granular casts present in a biological specimen.Coarse Granular Cast Measurement
Fatty CastsC74766Fatty CastsA measurement of the fatty casts present in a biological specimen.Fatty Cast Measurement
Granular CastsC74768Granular CastsA measurement of the granular (coarse and fine) casts present in a biological specimen.Granular Cast Measurement
Granular Fine CastsC74769Granular Fine CastsA measurement of the fine granular casts present in a biological specimen.Granular Fine Cast Measurement
Hyaline CastsC74770Hyaline CastsA measurement of the hyaline casts present in a biological specimen.Hyaline Cast Measurement
Mixed CastsC74771Mixed CastsA measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.Mixed Cast Count
RBC CastsC74772RBC CastsA measurement of the red blood cell casts present in a biological specimen.Red Blood Cell Cast Measurement
Squamous Epithelial CellsC74773Squamous Epithelial CellsA measurement of the squamous epithelial cells present in a biological specimen.Squamous Epithelial Cell Count
Squamous Transitional Epithelial CellsC74774Squamous Transitional Epithelial Cells;Epithelial CellsA measurement of the squamous transitional epithelial cells present in a biological specimen.Squamous Transitional Epithelial Cell Count
Tubular Epithelial CellsC74775Tubular Epithelial Cells;Renal Tubular Epithelial CellsA measurement of the tubular epithelial cells present in a biological specimen.Tubular Epithelial Cell Count
Unclassified CastsC74776Unclassified CastsA measurement of the unclassifiable casts present in a biological specimen.Unclassified Cast Measurement
Waxy CastsC74777Waxy CastsA measurement of the waxy casts present in a biological specimen.Waxy Cell Cast Measurement
WBC CastsC74778WBC CastsA measurement of the white blood cell casts present in a biological specimen.White Blood Cell Cast Measurement
Epithelial CastsC74779Epithelial CastsA measurement of the epithelial cell casts present in a biological specimen.Epithelial-Cast Measurement
Adrenocorticotropic HormoneC74780Adrenocorticotropic HormoneA measurement of the adrenocorticotropic hormone in a biological specimen.Adrenocorticotropic Hormone Measurement
CortisolC74781Cortisol;Total CortisolA measurement of the cortisol in a biological specimen.Cortisol Measurement
EstradiolC74782Estradiol;OestradiolA measurement of the estradiol in a biological specimen.Estradiol Measurement
Follicle Stimulating HormoneC74783Follicle Stimulating HormoneA measurement of the follicle stimulating hormone (FSH) in a biological specimen.Follicle Stimulating Hormone Measurement
Parathyroid Hormone, FragmentedC74784Parathyroid Hormone, FragmentedA measurement of the fragmented parathyroid hormone in a biological specimen.Fragmented Parathyroid Hormone Measurement
Testosterone, FreeC74785Testosterone, FreeA measurement of the free testosterone in a biological specimen.Free Testosterone Measurement
Thyroxine, FreeC74786Thyroxine, Free;Free T4A measurement of the free thyroxine in a biological specimen.Free Thyroxine Measurement
Triiodothyronine, FreeC74787Triiodothyronine, Free;Free T3A measurement of the free triiodothyronine in a biological specimen.Free Triiodothyronine Measurement
InsulinC74788InsulinA measurement of the insulin in a biological specimen.Insulin Measurement
Parathyroid Hormone, IntactC74789Parathyroid Hormone, IntactA measurement of the intact parathyroid hormone in a biological specimen.Intact Parathyroid Hormone Measurement
Luteinizing HormoneC74790Luteinizing HormoneA measurement of the luteinizing hormone in a biological specimen.Luteinizing Hormone Measurement
ProgesteroneC74791ProgesteroneA measurement of the progesterone hormone in a biological specimen.Progesterone Measurement
SomatotrophinC80360Somatotrophin;Growth HormoneA measurement of the somatotrophin (growth) hormone in a biological specimen.Somatotropin Measurement
TestosteroneC74793Testosterone;Total TestosteroneA measurement of the total (free and bound) testosterone in a biological specimen.Total Testosterone Measurement
ThyroxineC74794Thyroxine;Total T4A measurement of the total (free and bound) thyroxine in a biological specimen.Total Thyroxine Measurement
OpiateC74796OpiateA measurement of any opiate class drug present in a biological specimen.Opiate Measurement
Lymphoma Cells/LymphocytesC74910Lymphoma Cells/LymphocytesA relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.Lymphoma Cell to Lymphocyte Ratio Measurement
Mature Plasma Cells/LymphocytesC74911Mature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.Mature Plasma Cell to Lymphocyte Ratio Measurement
Acid Urate CrystalsC74912Acid Urate CrystalsA measurement of the ammonium acid urate crystals present in a biological specimen.Acid Urate Crystal Measurement
Anti-Double Stranded DNAC74913Anti-Double Stranded DNAA measurement of the anti-double stranded DNA antibody in a biological specimen.Anti-Double Stranded DNA Measurement
Antinuclear AntibodiesC74916Antinuclear AntibodiesA measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.Antinuclear Antibody Measurement
5 Prime NucleotidaseC794375 Prime Nucleotidase;5'-Ribonucleotide PhosphohydrolaseA measurement of the 5'-nucleotidase in a biological specimen.5 Prime Nucleotidase Measurement
6-MonoacetylmorphineC748766-MonoacetylmorphineA measurement of the 6-monoacetylmorphine present in a biological specimen.6-Monoacetylmorphine Measurement
AcetylcholineC74838AcetylcholineA measurement of the acetylcholine hormone in a biological specimen.Acetylcholine Measurement
AdiponectinC74839AdiponectinA measurement of the adiponectin hormone in a biological specimen.Adiponectin Measurement
Albumin/GlobulinC74894Albumin/GlobulinThe ratio of albumin to globulin in a biological specimen.Albumin to Globulin Ratio Measurement
AldosteroneC74841AldosteroneA measurement of the aldosterone hormone in a biological specimen.Aldosterone Measurement
Alkaline Phosphatase/CreatinineC79438Alkaline Phosphatase/CreatinineA relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.Alkaline Phosphatase to Creatinine Ratio Measurement
Alpha Glutathione-S-TransferaseC79433Alpha Glutathione-S-TransferaseA measurement of the alpha form of glutathione S-transferase in a biological specimen.Alpha Glutathione-S-Transferase Measurement
AmmoniaC74799Ammonia;NH3A measurement of the ammonia in a biological specimen.Ammonia Measurement
AndrostenediolC74842AndrostenediolA measurement of the androstenediol metabolite in a biological specimen.Androstenediol Metabolite Measurement
AndrostenedioneC74843Androstenedione;4-AndrostenedioneA measurement of the androstenedione hormone in a biological specimen.Androstenedione Measurement
Angiotensin IC74844Angiotensin IA measurement of the angiotensin I hormone in a biological specimen.Angiotensin I Measurement
Angiotensin IIC74845Angiotensin IIA measurement of the angiotensin II hormone in a biological specimen.Angiotensin II Measurement
AngiotensinogenC74846Angiotensinogen;Angiotensin PrecursorA measurement of the angiotensinogen hormone in a biological specimen.Angiotensinogen Measurement
AntidepressantsC74691AntidepressantsA measurement of any antidepressant class drug present in a biological specimen.Antidepressant Measurement
Antidiuretic HormoneC74847Antidiuretic Hormone;VasopressinA measurement of the antidiuretic hormone in a biological specimen.Antidiuretic Hormone Measurement
Atrial Natriuretic PeptideC74886Atrial Natriuretic Peptide;AtriopeptinA measurement of the atrial natriuretic peptide in a biological specimen.Atrial Natriuretic Peptide Measurement
BenzodiazepineC74692BenzodiazepineA measurement of any benzodiazepine class drug present in a biological specimen.Benzodiazepine Measurement
Bile AcidC74800Bile Acid;Bile Salts;Bile Acids;Bile SaltA measurement of the total bile acids in a biological specimen.Bile Acid Measurement
CalcitoninC74848CalcitoninA measurement of the calcitonin hormone in a biological specimen.Calcitonin Measurement
CalcitriolC74849CalcitriolA measurement of the calcitriol hormone in a biological specimen.Calcitriol Measurement
Calcium/CreatinineC79439Calcium/CreatinineA relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.Calcium to Creatinine Ratio Measurement
Chloride/CreatinineC79440Chloride/CreatinineA relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.Chloride to Creatinine Ratio Measurement
CholecystokininC74850Cholecystokinin;PancreozyminA measurement of the cholecystokinin hormone in a biological specimen.Cholecystokinin Measurement
CodeineC74877CodeineA measurement of the codeine present in a biological specimen.Codeine Measurement
CorticosteroneC79434CorticosteroneA measurement of corticosterone in a biological specimen.Corticosterone Measurement
Corticotropin Releasing HormoneC74851Corticotropin Releasing Hormone;Corticotropin Releasing FactorA measurement of the corticotropin releasing hormone in a biological specimen.Corticotropin Releasing Hormone Measurement
Creatine Kinase BB/Total Creatine KinaseC79466Creatine Kinase BB/Total Creatine KinaseA relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase BB to Total Creatine Kinase Ratio Measurement
Creatine Kinase MB/Total Creatine KinaseC79441Creatine Kinase MB/Total Creatine KinaseA relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MB to Total Creatine Kinase Ratio Measurement
Creatine Kinase MM/Total Creatine KinaseC79442Creatine Kinase MM/Total Creatine KinaseA relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MM to Total Creatine Kinase Ratio Measurement
DehydroepiandrosteroneC74852Dehydroepiandrosterone;DehydroisoandrosteroneA measurement of the dehydroepiandrosterone hormone in a biological specimen.Dehydroepiandrosterone Measurement
DeoxypyridinolineC79443DeoxypyridinolineA measurement of the deoxypyridinoline in a biological specimen.Deoxypyridinoline Measurement
Deoxypyridinoline/CreatinineC79444Deoxypyridinoline/CreatinineA relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.Deoxypyridinoline to Creatinine Ratio Measurement
DihydrocodeineC74878DihydrocodeineA measurement of the dihydrocodeine present in a biological specimen.Dihydrocodeine Measurement
DihydrotestosteroneC74853Dihydrotestosterone;AndrostanaloneA measurement of the dihydrotestosterone hormone in a biological specimen.Dihydrotestosterone Measurement
DopamineC74854DopamineA measurement of the dopamine hormone in a biological specimen.Dopamine Measurement
EpinephrineC79445Epinephrine;AdrenalineA measurement of the epinephrine hormone in a biological specimen.Epinephrine Measurement
ErythropoietinC74855Erythropoietin;HematopoietinA measurement of the erythropoietin hormone in a biological specimen.Erythropoietin Measurement
EstriolC74856Estriol;OestriolA measurement of the estriol hormone in a biological specimen.Estriol Measurement
EstroneC74857Estrone;OestroneA measurement of the estrone hormone in a biological specimen.Estrone Measurement
EthanolC74693Ethanol;AlcoholA measurement of the ethanol present in a biological specimen.Ethanol Measurement
Gamma Glutamyl Transferase/CreatinineC79446Gamma Glutamyl Transferase/CreatinineA relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.Gamma Glutamyl Transferase to Creatinine Ratio Measurement
GastrinC74858GastrinA measurement of the gastrin hormone in a biological specimen.Gastrin Measurement
GlucagonC74859GlucagonA measurement of the glucagon hormone in a biological specimen.Glucagon Measurement
Glucose/CreatinineC79447Glucose/CreatinineA relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.Glucose to Creatinine Ratio Measurement
Glutamate DehydrogenaseC79448Glutamate DehydrogenaseA measurement of the glutamate dehydrogenase in a biological specimen.Glutamate Dehydrogenase Measurement
Glutathione-S-Transferase/CreatinineC79435Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.Glutathione-S-Transferase to Creatinine Ratio Measurement
Gonadotropin Releasing HormoneC74860Gonadotropin Releasing Hormone;Luteinising Hormone Releasing HormoneA measurement of the gonadotropin releasing hormone in a biological specimen.Gonadotropin Releasing Hormone Measurement
Growth Hormone Inhibiting HormoneC74861Growth Hormone Inhibiting Hormone;SomatostatinA measurement of the growth hormone inhibiting hormone in a biological specimen.Growth Hormone Inhibiting Hormone Measurement
Growth Hormone Releasing HormoneC74862Growth Hormone Releasing Hormone;SomatocrininA measurement of the growth hormone releasing hormone in a biological specimen.Growth Hormone Releasing Hormone Measurement
Homovanillic AcidC74863Homovanillic AcidA measurement of the homovanillic acid metabolite in a biological specimen.Homovanillic Acid Measurement
HydrocodoneC74879HydrocodoneA measurement of the hydrocodone present in a biological specimen.Hydrocodone Measurement
HydromorphoneC74880HydromorphoneA measurement of the hydromorphone present in a biological specimen.Hydromorphone Measurement
Insulin-like Growth Factor-1C74864Insulin-like Growth Factor-1A measurement of the insulin-like growth factor-1 in a biological specimen.Insulin Like Growth Factor-1 Measurement
Insulin-like Growth Factor-2C74865Insulin-like Growth Factor-2A measurement of the insulin-like growth factor-2 in a biological specimen.Insulin Like Growth Factor-2 Measurement
Interleukin 1C74805Interleukin 1A measurement of the interleukin 1 in a biological specimen.Interleukin 1 Measurement
Interleukin 10C74806Interleukin 10A measurement of the interleukin 10 in a biological specimen.Interleukin 10 Measurement
Interleukin 11C74807Interleukin 11A measurement of the interleukin 11 in a biological specimen.Interleukin 11 Measurement
Interleukin 12C74808Interleukin 12A measurement of the interleukin 12 in a biological specimen.Interleukin 12 Measurement
Interleukin 13C74809Interleukin 13A measurement of the interleukin 13 in a biological specimen.Interleukin 13 Measurement
Interleukin 14C74810Interleukin 14A measurement of the interleukin 14 in a biological specimen.Interleukin 14 Measurement
Interleukin 15C74811Interleukin 15A measurement of the interleukin 15 in a biological specimen.Interleukin 15 Measurement
Interleukin 16C74812Interleukin 16A measurement of the interleukin 16 in a biological specimen.Interleukin 16 Measurement
Interleukin 17C74813Interleukin 17A measurement of the interleukin 17 in a biological specimen.Interleukin 17 Measurement
Interleukin 18C74814Interleukin 18A measurement of the interleukin 18 in a biological specimen.Interleukin 18 Measurement
Interleukin 19C74815Interleukin 19A measurement of the interleukin 19 in a biological specimen.Interleukin 19 Measurement
Interleukin 2C74816Interleukin 2A measurement of the interleukin 2 in a biological specimen.Interleukin 2 Measurement
Interleukin 20C74817Interleukin 20A measurement of the interleukin 20 in a biological specimen.Interleukin 20 Measurement
Interleukin 21C74818Interleukin 21A measurement of the interleukin 21 in a biological specimen.Interleukin 21 Measurement
Interleukin 22C74819Interleukin 22A measurement of the interleukin 22 in a biological specimen.Interleukin 22 Measurement
Interleukin 23C74820Interleukin 23A measurement of the interleukin 23 in a biological specimen.Interleukin 23 Measurement
Interleukin 24C74821Interleukin 24A measurement of the interleukin 24 in a biological specimen.Interleukin 24 Measurement
Interleukin 25C74822Interleukin 25A measurement of the interleukin 25 in a biological specimen.Interleukin 25 Measurement
Interleukin 26C74823Interleukin 26A measurement of the interleukin 26 in a biological specimen.Interleukin 26 Measurement
Interleukin 27C74824Interleukin 27A measurement of the interleukin 27 in a biological specimen.Interleukin 27 Measurement
Interleukin 28C74825Interleukin 28A measurement of the interleukin 28 in a biological specimen.Interleukin 28 Measurement
Interleukin 29C74826Interleukin 29A measurement of the interleukin 29 in a biological specimen.Interleukin 29 Measurement
Interleukin 3C74827Interleukin 3A measurement of the interleukin 3 in a biological specimen.Interleukin 3 Measurement
Interleukin 30C74828Interleukin 30A measurement of the interleukin 30 in a biological specimen.Interleukin 30 Measurement
Interleukin 31C74829Interleukin 31A measurement of the interleukin 31 in a biological specimen.Interleukin 31 Measurement
Interleukin 32C74830Interleukin 32A measurement of the interleukin 32 in a biological specimen.Interleukin 32 Measurement
Interleukin 33C74831Interleukin 33A measurement of the interleukin 33 in a biological specimen.Interleukin 33 Measurement
Interleukin 4C74832Interleukin 4A measurement of the interleukin 4 in a biological specimen.Interleukin 4 Measurement
Interleukin 5C74833Interleukin 5A measurement of the interleukin 5 in a biological specimen.Interleukin 5 Measurement
Interleukin 6C74834Interleukin 6A measurement of the interleukin 6 in a biological specimen.Interleukin 6 Measurement
Interleukin 7C74835Interleukin 7A measurement of the interleukin 7 in a biological specimen.Interleukin 7 Measurement
Interleukin 8C74836Interleukin 8A measurement of the interleukin 8 in a biological specimen.Interleukin 8 Measurement
Interleukin 9C74837Interleukin 9A measurement of the interleukin 9 in a biological specimen.Interleukin 9 Measurement
LDH Isoenzyme 1C74887LDH Isoenzyme 1A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.Lactate Dehydrogenase Isoenzyme 1 Measurement
LDH Isoenzyme 2C74888LDH Isoenzyme 2A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.Lactate Dehydrogenase Isoenzyme 2 Measurement
LDH Isoenzyme 3C74889LDH Isoenzyme 3A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.Lactate Dehydrogenase Isoenzyme 3 Measurement
LDH Isoenzyme 4C74890LDH Isoenzyme 4A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.Lactate Dehydrogenase Isoenzyme 4 Measurement
LDH Isoenzyme 5C74891LDH Isoenzyme 5A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.Lactate Dehydrogenase Isoenzyme 5 Measurement
Lactate Dehydrogenase/CreatinineC79449Lactate Dehydrogenase/CreatinineA relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.Lactate Dehydrogenase to Creatinine Ratio Measurement
Lactic AcidC79450Lactic Acid;2-hydroxypropanoic acid;LactateA measurement of the lactic acid in a biological specimen.Lactic Acid Measurement
Large Unstained Cells/LeukocytesC79467Large Unstained Cells/LeukocytesA relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.Large Unstained Cells to Leukocytes Ratio Measurement
LDH Isoenzyme 1/LDHC79451LDH Isoenzyme 1/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 1 to LDH Ratio Measurement
LDH Isoenzyme 2/LDHC79452LDH Isoenzyme 2/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 2 to LDH Ratio Measurement
LDH Isoenzyme 3/LDHC79453LDH Isoenzyme 3/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 3 to LDH Ratio Measurement
LDH Isoenzyme 4/LDHC79454LDH Isoenzyme 4/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 4 to LDH Ratio Measurement
LDH Isoenzyme 5/LDHC79455LDH Isoenzyme 5/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 5 to LDH Ratio Measurement
LeptinC74866LeptinA measurement of the leptin hormone in a biological specimen.Leptin Measurement
Magnesium/CreatinineC79456Magnesium/CreatinineA relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.Magnesium to Creatinine Ratio Measurement
MelatoninC74867MelatoninA measurement of the melatonin hormone in a biological specimen.Melatonin Measurement
MethadoneC74881MethadoneA measurement of the methadone present in a biological specimen.Methadone Measurement
MethaqualoneC74882MethaqualoneA measurement of the methaqualone present in a biological specimen.Methaqualone Measurement
MorphineC74883MorphineA measurement of the morphine present in a biological specimen.Morphine Measurement
Mu Glutathione-S-TransferaseC79457Mu Glutathione-S-TransferaseA measurement of the mu form of glutathione S-transferase in a biological specimen.Mu Glutathione-S-Transferase Measurement
Mu Glutathione-S-Transferase/CreatinineC79458Mu Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.Mu Glutathione-S-Transferase to Creatinine Ratio Measurement
MyoglobinC79436MyoglobinA measurement of myoglobin in a biological specimen.Myoglobin Measurement
N-Acetyl GlucosamideC79459N-Acetyl Glucosamide;N-Acetyl GlucosamineA measurement of N-acetyl glucosamide in a biological specimen.N-Acetyl Glucosamide Measurement
N-Acetyl Glucosamide/CreatinineC79460N-Acetyl Glucosamide/CreatinineA relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.N-Acetyl Glucosamide to Creatinine Ratio Measurement
Neuropeptide YC74892Neuropeptide YA measurement of the neuropeptide Y in a biological specimen.Neuropeptide Y Measurement
NorepinephrineC74868Noradrenaline;NorepinephrineA measurement of the norepinephrine hormone in a biological specimen.Noradrenaline Measurement
OsmolalityC74801OsmolalityA measurement of the osmoles of solute per unit of biological specimen.Osmolality Measurement
OxycodoneC74884Oxycodone;OxycontinA measurement of the oxycodone present in a biological specimen.Oxycodone Measurement
OxytocinC74869Oxytocin;OxytoxinA measurement of the oxytocin hormone in a biological specimen.Oxytocin Measurement
PhencyclidineC74694Phencyclidine;PhenylcyclohexylpiperidineA measurement of the phencyclidine present in a biological specimen.Phencyclidine Measurement
PhenothiazineC74695Phenothiazine;DibenzothiazineA measurement of the phenothiazine present in a biological specimen.Phenothiazine Measurement
Phosphate/CreatinineC79461Phosphate/CreatinineA relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.Phosphate to Creatinine Ratio Measurement
Potassium/CreatinineC79462Potassium/CreatinineA relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.Potassium to Creatinine Ratio Measurement
ProlactinC74870ProlactinA measurement of the prolactin hormone in a biological specimen.Prolactin Measurement
PropoxypheneC74885PropoxypheneA measurement of the propoxyphene present in a biological specimen.Propoxyphene Measurement
Protein/CreatinineC79463Protein/CreatinineA relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.Protein to Creatinine Ratio Measurement
PseudoephedrineC74696PseudoephedrineA measurement of the pseudoephedrine present in a biological specimen.Pseudoephedrine Measurement
Reactive LymphocytesC74629Reactive LymphocytesA measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.Reactive Lymphocyte Count Measurement
ReninC74893Renin;AngiotensinogenaseA measurement of the renin in a biological specimen.Renin Measurement
SecretinC74871SecretinA measurement of the secretin hormone in a biological specimen.Secretin Measurement
SerotoninC74872SerotoninA measurement of the serotonin hormone in a biological specimen.Serotonin Measurement
Sodium/CreatinineC79464Sodium/CreatinineA relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.Sodium to Creatinine Ratio Measurement
Sorbitol DehydrogenaseC79465Sorbitol DehydrogenaseA measurement of the sorbitol dehydrogenase in a biological specimen.Sorbitol Dehydrogenase Measurement
ThrombopoietinC74873ThrombopoietinA measurement of the thrombopoietin hormone in a biological specimen.Thrombopoietin Measurement
Thyrotropin Releasing HormoneC74874Thyrotropin Releasing Hormone;Thyrotropin Releasing FactorA measurement of the thyrotropin releasing hormone in a biological specimen.Thyrotropin Releasing Hormone Measurement
Vanillyl Mandelic AcidC74875Vanillyl Mandelic Acid;Vanilmandelic AcidA measurement of the vanillyl mandelic acid metabolite in a biological specimen.Vanillyl Mandelic Acid Measurement
Vitamin AC74895Vitamin A;RetinolA measurement of the Vitamin A in a biological specimen.Vitamin A Measurement
ThiamineC74896Thiamine;Vitamin B1A measurement of the thiamine in a biological specimen.Vitamin B1 Measurement
Vitamin B17C74897Vitamin B17;AmygdalinA measurement of the Vitamin B17 in a biological specimen.Vitamin B17 Measurement
RiboflavinC74898Riboflavin;Vitamin B2A measurement of the riboflavin in a biological specimen.Vitamin B2 Measurement
NiacinC74899Niacin;Vitamin B3A measurement of the niacin in a biological specimen.Vitamin B3 Measurement
Vitamin B5C74900Vitamin B5;Pantothenic AcidA measurement of the Vitamin B5 in a biological specimen.Vitamin B5 Measurement
Vitamin B6C74901Vitamin B6;PyridoxineA measurement of the Vitamin B6 in a biological specimen.Vitamin B6 Measurement
Vitamin B7C74902Vitamin B7;BiotinA measurement of the Vitamin B7 in a biological specimen.Vitamin B7 Measurement
Vitamin CC74903Vitamin C;Ascorbic AcidA measurement of the Vitamin C in a biological specimen.Vitamin C Measurement
Vitamin D2C74904Vitamin D2;ErgocalciferolA measurement of the Vitamin D2 in a biological specimen.Vitamin D2 Measurement
Vitamin D3C74905Vitamin D3;CholecalciferolA measurement of the Vitamin D3 in a biological specimen.Vitamin D3 Measurement
Vitamin EC74906Vitamin E;TocopherolA measurement of the Vitamin E in a biological specimen.Vitamin E Measurement
Vitamin KC74907Vitamin K;NaphthoquinoneA measurement of the Vitamin K in a biological specimen.Vitamin K Measurement
VolumeC74720VolumeA measurement of the volume of a biological specimen.Volume Measurement
Alpha-1 AntitrypsinC80167Alpha-1 Antitrypsin;Serum Trypsin InhibitorA measurement of the alpha-1 antitrypsin in a biological specimen.Alpha-1 Antitrypsin Measurement
Alpha-2 MacroglobulinC80168Alpha-2 MacroglobulinA measurement of the alpha-2 macroglobulin in a biological specimen.Alpha-2 Macroglobulin Measurement
Angiotensin Converting EnzymeC80169Angiotensin Converting EnzymeA measurement of the angiotensin converting enzyme in a biological specimen.Angiotensin Converting Enzyme Measurement
Acid PhosphataseC80163Acid PhosphataseA measurement of the acid phosphatase in a biological specimen.Acid Phosphatase Measurement
Antimitochondrial AntibodiesC81975Antimitochondrial Antibodies;Mitochondrial AntibodyA measurement of the antimitochondrial antibodies in a biological specimen.Antimitochondrial Antibody Measurement
Amyloid Beta 42C84809Amyloid Beta 42;Amyloid Beta 42 ProteinA measurement of the 42 amino acid amyloid beta protein isoform in a biological specimen.Beta Amyloid 42 Measurement
Amyloid, BetaC81999Amyloid, Beta;Beta AmyloidA measurement of the total amyloid beta in a biological specimen.Beta Amyloid Measurement
Amyloid PC81998Amyloid PA measurement of the total amyloid P in a biological specimen.Amyloid P Measurement
Antiglobulin Test, DirectC81974Antiglobulin Test, Direct;Direct Coombs TestA measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.Direct Antiglobulin Test
AntithrombinC81958Antithrombin;Antithrombin III;Antithrombin Activity;Antithrombin III ActivityA measurement of the antithrombin activity in a biological specimen.Antithrombin Measurement
Antithrombin AntigenC81977Antithrombin Antigen;Antithrombin III AntigenA measurement of the antithrombin antigen in a biological specimen.Antithrombin Antigen Measurement
Apolipoprotein AIIC82000Apolipoprotein AIIA measurement of the apolipoprotein AII in a biological specimen.Apolipoprotein AII Measurement
Apolipoprotein CIIIC82001Apolipoprotein CIIIA measurement of the apolipoprotein CIII in a biological specimen.Apolipoprotein CIII Measurement
Apolipoprotein EC82002Apolipoprotein EA measurement of the apolipoprotein E in a biological specimen.Apolipoprotein E Measurement
Apolipoprotein HC82003Apolipoprotein HA measurement of the apolipoprotein H in a biological specimen.Apolipoprotein H Measurement
Specimen AppearanceC25377Specimen AppearanceThe outward or visible aspect of a specimen.Appearance
Anti-Saccharomyces cerevisiae AntibodyC81976Anti-Saccharomyces cerevisiae AntibodyA measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.Anti-Saccharomyces cerevisiae Antibody Measurement
Aspartate Aminotransferase AntigenC81978Aspartate Aminotransferase Antigen;SGOT AntigenA measurement of the aspartate aminotransferase antigen in a biological specimen.Aspartate Aminotransferase Antigen Measurement
Beta-2 Glycoprotein AntibodyC81979Beta-2 Glycoprotein AntibodyA measurement of the beta-2 glycoprotein antibody in a biological specimen.Beta-2 Glycoprotein Antibody Measurement
Beta-2 MicroglobulinC81980Beta-2 MicroglobulinA measurement of the beta-2 microglobulin in a biological specimen.Beta-2 Microglobulin Measurement
Brain-Derived Neurotrophic FactorC82004Brain-Derived Neurotrophic FactorA measurement of the brain-derived neurotrophic factor in a biological specimen.Brain-Derived Neurotrophic Factor Measurement
ProB-type Natriuretic PeptideC82032ProB-type Natriuretic Peptide;proBNP;Pro-Brain Natriuretic PeptideA measurement of the proB-type natriuretic peptide in a biological specimen.ProB-Type Natriuretic Peptide Measurement
Complement C1q AntibodyC80173Complement C1q AntibodyA measurement of the complement C1q antibody in a biological specimen.Complement C1q Antibody Measurement
Complement C3C80174Complement C3A measurement of the complement C3 in a biological specimen.Complement C3 Measurement
Complement C3aC80175Complement C3a;ASP, Complement C3 DesArg, Acetylation-stimulating ProteinA measurement of the complement C3a in a biological specimen.Complement C3a Measurement
Complement C3bC80176Complement C3bA measurement of the complement C3b in a biological specimen.Complement C3b Measurement
Complement C4C80177Complement C4A measurement of the complement C4 in a biological specimen.Complement C4 Measurement
Complement C4aC80178Complement C4aA measurement of the complement C4a in a biological specimen.Complement C4a Measurement
Complement C5aC80179Complement C5aA measurement of the complement C5a in a biological specimen.Complement C5a Measurement
Cancer Antigen 125C81981Cancer Antigen 125A measurement of the cancer antigen 125 in a biological specimen.Cancer Antigen 125 Measurement
Cancer Antigen 19-9C81982Cancer Antigen 19-9A measurement of the cancer antigen 19-9 in a biological specimen.Cancer Antigen 19-9 Measurement
Calcium, IonizedC81948Calcium, IonizedA measurement of the ionized calcium in a biological specimen.Ionized Calcium Measurement
CalprotectinC82005CalprotectinA measurement of the calprotectin in a biological specimen.Calprotectin Measurement
Complement BbC80172Complement BbA measurement of the complement Bb in a biological specimen.Complement Bb Measurement
CD40C82006CD40A measurement of the CD40 in a biological specimen.CD40 Measurement
CD40 LigandC82007CD40 LigandA measurement of the CD40 ligand in a biological specimen.CD40 Ligand Measurement
Carcinoembryonic AntigenC81983Carcinoembryonic AntigenA measurement of the carcinoembryonic antigen in a biological specimen.Carcinoembryonic Antigen Measurement
Cholesterol/HDL-CholesterolC80171Cholesterol/HDL-CholesterolA relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.Cholesterol to HDL-Cholesterol Ratio Measurement
Complement TotalC80160Complement TotalA measurement of the total complement in a biological specimen.Complement Measurement
Type I Collagen C-TelopeptidesC82038Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptideA measurement of the type I collagen C-telopeptides in a biological specimen.Type I Collagen C-Telopeptide Measurement
Type II Collagen C-TelopeptidesC82040Type II Collagen C-TelopeptidesA measurement of the type II collagen C-telopeptides in a biological specimen.Type II Collagen C-Telopeptide Measurement
Starch CrystalsC81951Starch CrystalsA measurement of the starch crystals in a biological specimen.Starch Crystal Measurement
D-DimerC82621D-DimerA measurement of the d-dimers in a biological specimen.D-Dimer Measurement
Anti-DNA AntibodiesC81973Anti-DNA Antibodies;Anti-ds-DNA AntibodiesA measurement of the anti-DNA antibodies in a biological specimen.Anti-DNA Antibody Measurement
Epidermal Growth FactorC82009Epidermal Growth FactorA measurement of the epidermal growth factor in a biological specimen.Epidermal Growth Factor Measurement
Pancreatic Elastase 1C82028Pancreatic Elastase 1A measurement of the pancreatic elastase 1 in a biological specimen.Pancreatic Elastase Measurement
Pancreatic Elastase 1, PolymorphonuclearC82029Pancreatic Elastase 1, PolymorphonuclearA measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.Polymorphonuclear Pancreatic Elastase Measurement
Neutrophil ElastaseC82026Neutrophil ElastaseA measurement of the neutrophil elastase in a biological specimen.Neutrophil Elastase Measurement
Neutrophil Elastase, PolymorphonuclearC82027Neutrophil Elastase, PolymorphonuclearA measurement of the polymorphonuclear neutrophil elastase in a biological specimen.Polymorphonuclear Neutrophil Elastase Measurement
Epith Neutrophil-Activating Peptide 78C82010Epith Neutrophil-Activating Peptide 78A measurement of the epithelial neutrophil-activating peptide in a biological specimen.Epithelial Neutrophil-Activating Peptide 78 Measurement
Endothelin-1C82008Endothelin-1A measurement of the endothelin-1 in a biological specimen.Endothelin-1 Measurement
Extracell Newly Ident RAGE Bind ProteinC82011Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.Extracell Newly Ident RAGE Bind Protein Measurement
Eosinophilic MetamyelocytesC84819Eosinophilic MetamyelocytesA measurement of the eosinphilic metamyelocytes in a biological specimen.Eosinophilic Metamyelocyte Count
Eosinophilic MyelocytesC84821Eosinophilic MyelocytesA measurement of the eosinophilic myelocytes in a biological specimen.Eosinophilic Myelocyte Count
Eotaxin-1C81952Eotaxin-1;Chemokine Ligand 11A measurement of the eotaxin-1 in a biological specimen.Eotaxin-1 Measurement
Eotaxin-2C81953Eotaxin-2;Chemokine Ligand 24A measurement of the eotaxin-2 in a biological specimen.Eotaxin-2 Measurement
Eotaxin-3C81954Eotaxin-3;Chemokine Ligand 26A measurement of the eotaxin-3 in a biological specimen.Eotaxin-3 Measurement
Estriol, FreeC81963Estriol, FreeA measurement of the free estriol in a biological specimen.Free Estriol Measurement
Fatty Acid Binding Protein 1C82012Fatty Acid Binding Protein 1A measurement of the fatty acid binding protein 1 in a biological specimen.Fatty Acid Binding Protein 1 Measurement
Factor IIIC81959Factor III;Tissue Factor, CD142A measurement of the factor III in a biological specimen.Factor III Measurement
Factor VIIC81960Factor VIIA measurement of the factor VII in a biological specimen.Factor VII Measurement
Factor VIIIC81961Factor VIIIA measurement of the factor VIII in a biological specimen.Factor VIII Measurement
Free Fatty AcidC80200Free Fatty Acid;Non-Esterified Fatty Acid, FreeA measurement of the total non-esterified fatty acids in a biological specimen.Non-esterified Fatty Acids Measurement
Free Fatty Acid, SaturatedC80206Free Fatty Acid, Saturated;Non-esterified Fatty Acid, SaturatedA measurement of the saturated non-esterified fatty acids in a biological specimen.Saturated Non-esterified Fatty Acids Measurement
Free Fatty Acid, UnsaturatedC80209Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, UnsaturatedA measurement of the unsaturated non-esterified fatty acids in a biological specimen.Unsaturated Non-esterified Fatty Acids Measurement
Fat Bodies, OvalC81947Fat Bodies, OvalA measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.Oval Fat Body Measurement
Fibrin Degradation ProductsC82013Fibrin Degradation ProductsA measurement of the fibrin degradation products in a biological specimen.Fibrin Degradation Products Measurement
Fibroblast Growth Factor Basic FormC82014Fibroblast Growth Factor Basic Form;FGF2A measurement of the basic form of fibroblast growth factor in a biological specimen.Fibroblast Growth Factor Basic Form Measurement
Glucose-6-Phosphate DehydrogenaseC80184Glucose-6-Phosphate DehydrogenaseA measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.Glucose-6-Phosphate Dehydrogenase Measurement
Glutamic Acid Decarboxylase 1C82015Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67A measurement of the glutamic acid decarboxylase 1 in a biological specimen.Glutamic Acid Decarboxylase 1 Measurement
Glutamic Acid Decarboxylase 2C82016Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65A measurement of the glutamic acid decarboxylase 2 in a biological specimen.Glutamic Acid Decarboxylase 2 Measurement
Glutamic Acid Decarboxylase 2 AntibodyC82017Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 AntibodyA measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.Glutamic Acid Decarboxylase 2 Antibody Measurement
GalaninC80182GalaninA measurement of the galanin in a biological specimen.Galanin Measurement
Granulocyte Colony Stimulating FactorC82018Granulocyte Colony Stimulating FactorA measurement of the granulocyte colony stimulating factor in a biological specimen.Granulocyte Colony Stimulating Factor Measurement
Glucagon-Like Peptide-1C80183Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1A measurement of the total glucagon-like peptide-1 in a biological specimen.Glucagon-like Peptide-1 Measurement
Glucagon-Like Peptide-1, Active FormC80164Glucagon-Like Peptide-1, Active FormA measurement of the active form of glucagon-like peptide-1 in a biological specimen.Active Glucagon-like Peptide-1 Measurement
Granulocyte Macrophage Colony Stm FactorC82019Granulocyte Macrophage Colony Stm FactorA measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.Granulocyte Macrophage Colony Stm Factor Measurement
GoldC80186GoldA measurement of the gold in a biological specimen.Gold Measurement
Glutathione S-Transferase, TotalC80185Glutathione S-Transferase, TotalA measurement of the total glutathione-s-transferase in a biological specimen.Glutathione-S-Transferase Measurement
Glutathione S-Transferase, Alpha/CreatC80166Glutathione S-Transferase, Alpha/CreatA relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement
Glutathione S-Transferase, PiC80203Glutathione S-Transferase, PiA measurement of the Pi glutathione-s-transferase in a biological specimen.Pi Glutathione S-Transferase Measurement
Glutathione S-Transferase, ThetaC80207Glutathione S-Transferase, ThetaA measurement of the theta glutathione-s-transferase in a biological specimen.Theta Glutathione S-Transferase Measurement
Glucuronidase, AlphaC80165Glucuronidase, AlphaA measurement of the alpha glucuronidase in a biological specimen.Alpha Glucuronidase Measurement
Glucuronidase, BetaC80170Glucuronidase, BetaA measurement of the beta glucuronidase in a biological specimen.Beta Glucuronidase Measurement
HDL-Cholesterol Subclass 2C80187HDL-Cholesterol Subclass 2A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.HDL-Cholesterol Subclass 2 Measurement
HDL-Cholesterol Subclass 3C80188HDL-Cholesterol Subclass 3A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.HDL-Cholesterol Subclass 3 Measurement
HistamineC80189HistamineA measurement of the histamine in a biological specimen.Histamine Measurement
Heterophile AntibodiesC81984Heterophile AntibodiesA measurement of the heterophile antibodies in a biological specimen.Heterophile Antibody Measurement
HydroxyprolineC80190HydroxyprolineA measurement of the total hydroxyproline in a biological specimen.Hydroxyproline Measurement
Islet Cell 512 AntibodyC81985Islet Cell 512 AntibodyA measurement of the islet cell 512 antibody in a biological specimen.Islet Cell 512 Antibody Measurement
Islet Cell 512 AntigenC81986Islet Cell 512 AntigenA measurement of the islet cell 512 antigen in a biological specimen.Islet Cell 512 Antigen Measurement
Interferon AlphaC81994Interferon AlphaA measurement of the interferon alpha in a biological specimen.Interferon Alpha Measurement
Interferon BetaC81995Interferon BetaA measurement of the interferon beta in a biological specimen.Interferon Beta Measurement
Interferon GammaC81996Interferon GammaA measurement of the interferon gamma in a biological specimen.Interferon Gamma Measurement
Immunoglobulin AC81969Immunoglobulin AA measurement of the Immunoglobulin A in a biological specimen.Immunoglobulin A Measurement
Immunoglobulin EC81970Immunoglobulin EA measurement of the Immunoglobulin E in a biological specimen.Immunoglobulin E Measurement
Immunoglobulin GC81971Immunoglobulin GA measurement of the Immunoglobulin G in a biological specimen.Immunoglobulin G Measurement
Immunoglobulin MC81972Immunoglobulin MA measurement of the Immunoglobulin M in a biological specimen.Immunoglobulin M Measurement
IndicanC82044IndicanA measurement of the indican present in a biological specimen.Indican Measurement
Islet Neogenesis Assoc Protein AntibodyC81987Islet Neogenesis Assoc Protein AntibodyA measurement of the islet neogenesis associated protein antibody in a biological specimen.Islet Neogenesis Associated Protein Antibody Measurement
Inhibin AC82020Inhibin AA measurement of the inhibin A in a biological specimen.Inhibin A Measurement
F2-IsoprostaneC80180F2-IsoprostaneA measurement of the F2-isoprostane in a biological specimen.F2 Isoprostane Measurement
Lipoprotein-aC82022Lipoprotein-aA measurement of the lipoprotein-a in a biological specimen.Lipoprotein a Measurement
LactoferrinC82021Lactoferrin;LactotransferrinA measurement of the lactoferrin in a biological specimen.Lactoferrin Measurement
LymphotactinC81955Lymphotactin;Chemokine Ligand 1A measurement of the lymphotactin in a biological specimen.Lymphotactin Measurement
Monocyte Chemotactic Protein 1C82025Monocyte Chemotactic Protein 1A measurement of the monocyte chemotactic protein 1 in a biological specimen.Monocyte Chemotactic Protein 1 Measurement
Macrophage Colony Stimulating FactorC80191Macrophage Colony Stimulating FactorA measurement of the macrophage colony stimulating factor in a biological specimen.Macrophage Colony Stimulating Factor Measurement
Macrophage-Derived ChemokineC81956Macrophage-Derived Chemokine;Chemokine Ligand 22A measurement of the macrophage-derived chemokine in a biological specimen.Macrophage-Derived Chemokine Measurement
Macrophage Inflammatory Protein 1 AlphaC82023Macrophage Inflammatory Protein 1 Alpha;Chemokine Ligand 3A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.Macrophage Inflammatory Protein 1 Alpha Measurement
Macrophage Inflammatory Protein 1 BetaC82024Macrophage Inflammatory Protein 1 Beta;Chemokine Ligand 4A measurement of the macrophage inflammatory protein 1 beta in a biological specimen.Macrophage Inflammatory Protein 1 Beta Measurement
Matrix Metalloproteinase 1C80192Matrix Metalloproteinase 1;Interstitial CollagenaseA measurement of the matrix metalloproteinase 1 in a biological specimen.Matrix Metalloproteinase 1 Measurement
Matrix Metalloproteinase 2C80193Matrix Metalloproteinase 2;Gelatinase AA measurement of the matrix metalloproteinase 2 in a biological specimen.Matrix Metalloproteinase 2 Measurement
Matrix Metalloproteinase 3C80194Matrix Metalloproteinase 3;Stromelysin 1A measurement of the matrix metalloproteinase 3 in a biological specimen.Matrix Metalloproteinase 3 Measurement
Matrix Metalloproteinase 7C80195Matrix Metalloproteinase 7;MatrilysinA measurement of the matrix metalloproteinase 7 in a biological specimen.Matrix Metalloproteinase 7 Measurement
Matrix Metalloproteinase 8C80196Matrix Metalloproteinase 8;Neutrophil CollagenaseA measurement of the matrix metalloproteinase 8 in a biological specimen.Matrix Metalloproteinase 8 Measurement
Matrix Metalloproteinase 9C80197Matrix Metalloproteinase 9;Gelatinase BA measurement of the matrix metalloproteinase 9 in a biological specimen.Matrix Metalloproteinase 9 Measurement
MyeloperoxidaseC80198MyeloperoxidaseA measurement of the myeloperoxidase in a biological specimen.Myeloperoxidase Measurement
NeopterinC80199NeopterinA measurement of the neopterin in a biological specimen.Neopterin Measurement
Neutrophilic MetamyelocytesC84822Neutrophilic MetamyelocytesA measurement of the neutrophilic metamyelocytes in a biological specimen.Neutrophilic Metamyelocyte Count
Neutrophilic MyelocytesC84823Neutrophilic MyelocytesA measurement of the neutrophilic myelocytes in a biological specimen.Neutrophilic Myelocyte Count
Neutrophils, SegmentedC81997Neutrophils, SegmentedA measurement of the segmented neutrophils in a biological specimen.Segmented Neutrophil Count
Neutrophils, Segmented/LeukocytesC82045Neutrophils, Segmented/LeukocytesA relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.Segmented Neutrophil to Leukocyte Ratio Measurement
Type I Collagen N-TelopeptidesC82039Type I Collagen N-TelopeptidesA measurement of the type I collagen N-telopeptides in a biological specimen.Type I Collagen N-Telopeptide Measurement
Type II Collagen N-TelopeptidesC82041Type II Collagen N-TelopeptidesA measurement of the type II collagen N-telopeptides in a biological specimen.Type II Collagen N-Telopeptide Measurement
Plasminogen Activator Inhibitor-1C82030Plasminogen Activator Inhibitor-1A measurement of the plasminogen activator inhibitor-1 in a biological specimen.Plasminogen Activator Inhibitor-1 Measurement
Plasminogen Activator Inhibitor-1 AGC81989Plasminogen Activator Inhibitor-1 AGA measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.Plasminogen Activator Inhibitor-1 Antigen Measurement
Prostatic Acid PhosphataseC80204Prostatic Acid PhosphataseA measurement of the prostatic acid phosphatase in a biological specimen.Prostatic Acid Phosphatase Measurement
Pregnancy-Associated Plasma Protein-AC82031Pregnancy-Associated Plasma Protein-AA measurement of the pregnancy-associated plasma protein-A in a biological specimen.Pregnancy-Associated Plasma Protein-A Measurement
Partial Pressure Carbon DioxideC82625Partial Pressure Carbon DioxideA measurement of the pressure of carbon dioxide in a biological specimen.Partial Pressure of Carbon Dioxide Measurement
Platelet Distribution WidthC81962Platelet Distribution WidthA measurement of the range of platelet sizes in a biological specimen.Platelet Distribution Width
Pemphigoid AntibodiesC81988Pemphigoid AntibodiesA measurement of the pemphigoid antibodies in a biological specimen.Pemphigoid Antibody Measurement
Procollagen Type I Carboxy Term PeptideC82033Procollagen Type I Carboxy Term PeptideA measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.Procollagen Type I Carboxy Terminal Peptide Measurement
Pancreatic PolypeptideC80201Pancreatic PolypeptideA measurement of the pancreatic polypeptide in a biological specimen.Pancreatic Polypeptide Measurement
Partial Pressure OxygenC71251Partial Pressure OxygenA measurement of the pressure of oxygen in a biological specimen.Partial Pressure of Oxygen Measurement
ProinsulinC81967ProinsulinA measurement of the proinsulin in a biological specimen.Proinsulin Measurement
Prothrombin Fragments 1 + 2C82034Prothrombin Fragments 1 + 2A measurement of the prothrombin fragments 1 and 2 in a biological specimen.Prothrombin Fragments 1 and 2 Measurement
Parathyroid Hormone, C-TerminalC81964Parathyroid Hormone, C-TerminalA measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.C-Terminal Parathyroid Hormone Measurement
Parathyroid Hormone, Mid-MoleculeC81965Parathyroid Hormone, Mid-MoleculeA measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.Mid-Molecule Parathyroid Hormone Measurement
Parathyroid Hormone, N-TerminalC81966Parathyroid Hormone, N-TerminalA measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.N-Terminal Parathyroid Hormone Measurement
PyridinolineC80211PyridinolineA measurement of the pyridinoline in a biological specimen.Pyridinoline Measurement
Peptide YYC80202Peptide YY;Peptide Tyrosine TyrosineA measurement of the peptide YY in a biological specimen.Peptide YY Measurement
Reg upon Act Normal T-cell Exprd SecrtdC81957Reg upon Act Normal T-cell Exprd Secrtd;Chemokine Ligand 5A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.Reg upon Act Normal T-cell Exprd Secrtd Measurement
Nucleated Erythrocytes/LeukocytesC82046Nucleated Erythrocytes/LeukocytesA relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.Nucleated Erythrocyte to Leukocyte Ratio Measurement
ResistinC80205ResistinA measurement of the resistin in a biological specimen.Resistin Measurement
Triiodothyronine, ReverseC81968Triiodothyronine, ReverseA measurement of the reverse triiodothyronine in a biological specimen.Reverse Triiodothyronine Measurement
Stem Cell FactorC82035Stem Cell Factor;KIT LigandA measurement of the stem cell factor in a biological specimen.Stem Cell Factor Measurement
TransferrinC82037TransferrinA measurement of the transferrin in a biological specimen.Transferrin Measurement
Thyroid AntibodiesC81990Thyroid AntibodiesA measurement of the thyroid antibodies in a biological specimen.Thyroid Antibody Measurement
Thyroid Antimicrosomal AntibodiesC81991Thyroid Antimicrosomal AntibodiesA measurement of the thyroid antimicrosomal antibodies in a biological specimen.Thyroid Antimicrosomal Antibody Measurement
Thyroid Antithyroglobulin AntibodiesC81992Thyroid Antithyroglobulin AntibodiesA measurement of the thyroid antithyroglobulin antibodies in a biological specimen.Thyroid Antithyroglobulin Antibody Measurement
Tissue Inhibitor of Metalloproteinase 1C82036Tissue Inhibitor of Metalloproteinase 1A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.Tissue Inhibitor of Metalloproteinase 1 Measurement
Tissue Plasminogen Activator AntigenC81993Tissue Plasminogen Activator AntigenA measurement of the tissue plasminogen activator antigen in a biological specimen.Tissue Plasminogen Activator Antigen Measurement
Non-Phosphorylated Tau ProteinC84811Non-Phosphorylated Tau ProteinA measurement of the non-phosphorylated Tau protein in a biological specimen.Nonphosphorylated Tau Protein Measurement
Tau ProteinC84810Tau Protein;Total Tau ProteinA measurement of the total Tau protein in a biological specimen.Tau Protein Measurement
Phosphorylated Tau ProteinC84812Phosphorylated Tau ProteinA measurement of the phosphorylated Tau protein in a biological specimen.Phosphorylated Tau Protein Measurement
Total Radical-Trap Antioxidant PotentialC80208Total Radical-Trap Antioxidant PotentialA measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.Total Radical-Trap Antioxidant Potential Measurement
Thrombin TimeC80365Thrombin TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)Thrombin Time
Vascular Cell Adhesion Molecule 1C82042Vascular Cell Adhesion Molecule 1A measurement of the vascular cell adhesion molecule 1 in a biological specimen.Vascular Cell Adhesion Molecule 1 Measurement
Vascular Endothelial Growth FactorC92514Vascular Endothelial Growth FactorA measurement of the vascular endothelial growth factor in a biological specimen.Vascular Endohelial Growth Factor Measurement
ViscosityC75912ViscosityThe resistance of a liquid to sheer forces and flow. (NCI)Viscosity
Vitamin DC84818Vitamin D;Total Vitamin DA measurement of the total Vitamin D in a biological specimen.Vitamin D Measurement
ZincC80210ZincA measurement of the zinc in a biological specimen.Zinc Measurement
Cortisol, FreeC88113Cortisol, FreeA measurement of the free, unbound cortisol in a biological specimen.Free Cortisol Measurement
1, 25-Dihydroxyvitamin DC922671, 25-Dihydroxyvitamin D;Active Vitamin DA measurement of the total active Vitamin D in a biological specimen.1, 25-Dihydroxyvitamin D Measurement
25-Hydroxyvitamin DC9226825-Hydroxyvitamin D;Inactive Vitamin DA measurement of the total inactive Vitamin D in a biological specimen.25-Hydroxyvitamin D Measurement
Acetoacetic AcidC92247Acetoacetic Acid;AcetoacetateA measurement of the acetoacetic acid in a biological specimen.Acetoacetic Acid Measurement
Acyl Coenzyme A OxidaseC92286Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase;Acyl CoA OxidaseA measurement of the acyl coenzyme A oxidase in a biological specimen.Acyl Coenzyme A Oxidase Measurement
Alpha-1 GlobulinC92252Alpha-1 Globulin;A1-GlobulinA measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.Alpha-1 Globulin Measurement
Alpha-1 Globulin/Total ProteinC92253Alpha-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.Alpha-1 Globulin to Total Protein Ratio Measurement
Alpha-2 GlobulinC92254Alpha-2 Globulin;A2-GlobulinA measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.Alpha-2 Globulin Measurement
Alpha-2 Globulin/Total ProteinC92255Alpha-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.Alpha-2 Globulin to Total Protein Ratio Measurement
Amorphous Phosphate CrystalsC92243Amorphous Phosphate CrystalsA measurement of the amorphous phosphate crystals in a biological specimen.Amorphous Phosphate Crystals Measurement
Amorphous Urate CrystalsC92244Amorphous Urate CrystalsA measurement of the amorphous urate crystals in a biological specimen.Amorphous Urate Crystals Measurement
Anti-Single Stranded DNA IgGC92269Anti-Single Stranded DNA IgGA measurement of the anti-single stranded DNA IgG antibody in a biological specimen.Anti-Single Stranded DNA IgG Measurement
Apolipoprotein E4C92293Apolipoprotein E4A measurement of the apolipoprotein E4 in a biological specimen.Apolipoprotein E4 Measurement
Beta GlobulinC92256Beta GlobulinA measurement of the proteins contributing to the beta fraction in a biological specimen.Beta Globulin Measurement
Beta Globulin/Total ProteinC92294Beta Globulin/Total ProteinA relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.Beta Globulin to Total Protein Ratio Measurement
Bone Specific Alkaline PhosphataseC92287Bone Specific Alkaline PhosphataseA measurement of the bone specific alkaline phosphatase isoform in a biological specimen.Bone Specific Alkaline Phosphatase Measurement
Carnitine Acetyl TransferaseC92288Carnitine Acetyl TransferaseA measurement of the carnitine acetyl transferase in a biological specimen.Carnitine Acetyl Transferase Measurement
Chlamydia pneumoniae IgA AntibodyC92432Chlamydia pneumoniae IgA AntibodyA measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.Chlamydia pneumoniae IgA Antibody Measurement
Chlamydia pneumoniae IgM AntibodyC92433Chlamydia pneumoniae IgM AntibodyA measurement of the Chlamydia pneumoniae IgM in a biological specimen.Chlamydia pneumoniae IgM Antibody Measurement
CholinesteraseC92289CholinesteraseA measurement of the cholinesterase in a biological specimen.Cholinesterase Measurement
CitrateC92248CitrateA measurement of the citrate in a biological specimen.Citrate Measurement
CotinineC92249CotinineA measurement of the cotinine in a biological specimen.Cotinine Measurement
Cystatin CC92290Cystatin CA measurement of the cystatin C in a biological specimen.Cystatin C Measurement
Erythrocyte Cell ClumpsC92245Erythrocyte Cell Clumps;Red Blood Cell Clumps;RBC ClumpsA measurement of red blood cell clumps in a biological specimen.Erythrocyte Cell Clumps Measurement
Erythrocyte Cell MorphologyC92296Erythrocyte Cell Morphology;Red Blood Cell Morphology;RBC MorphologyAn examination or assessment of the form and structure of red blood cells.Erythrocyte Cell Morphology
Extractable Nuclear Antigen AntibodyC92270Anti-ENA;Extractable Nuclear Antigen AntibodyA measurement of the extractable nuclear antigen antibody in a biological specimen.Extractable Nuclear Antigen Antibody Measurement
Gamma GlobulinC92257Gamma GlobulinA measurement of the proteins contributing to the gamma fraction in a biological specimen.Gamma Globulin Measurement
Gamma Globulin/Total ProteinC92295Gamma Globulin/Total ProteinA relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.Gamma Globulin to Total Protein Ratio Measurement
Glomerular Filtration RateC90505Glomerular Filtration RateA kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.Glomerular Filtration Rate
Hemoglobin AC92258Hemoglobin AA measurement of the hemoglobin A in a biological specimen.Hemoglobin A Measurement
Hemoglobin A2C92259Hemoglobin A2A measurement of the hemoglobin A2 in a biological specimen.Hemoglobin A2 Measurement
Hemoglobin BC92260Hemoglobin BA measurement of the hemoglobin B in a biological specimen.Hemoglobin B Measurement
Hemoglobin CC92261Hemoglobin CA measurement of the hemoglobin C in a biological specimen.Hemoglobin C Measurement
Hemoglobin FC92262Hemoglobin F;Fetal HemoglobinA measurement of the hemoglobin F in a biological specimen.Hemoglobin F Measurement
Hepatitis A Virus Antibody IgMC92271Hepatitis A Virus Antibody IgMA measurement of hepatitis A virus antibody IgM in a biological specimen.Hepatitis A Virus Antibody IgM Measurement
Hepatitis G RNAC92272Hepatitis G RNAA measurement of the Hepatitis G RNA in a biological specimen.Hepatitis G RNA Measurement
HIV-1 Group M and O Nucleic AcidC92263HIV-1 Group M and O Nucleic AcidA measurement of the HIV-1 group M and O nucleic acids in a biological specimen.HIV-1 Group M and O Nucleic Acid Measurement
HIV-1 Group O AntibodyC92264HIV-1 Group O AntibodyA measurement of the HIV-1 group O antibody in a biological specimen.HIV-1 Group O Antibody Measurement
HIV-1 p24 AntigenC92265HIV-1 p24 AntigenA measurement of the HIV-1 p24 antigen in a biological specimen.HIV-1 p24 Antigen Measurement
HIV-2 Nucleic AcidC92266HIV-2 Nucleic AcidA measurement of the HIV-2 nucleic acids in a biological specimen.HIV-2 Nucleic Acid Measurement
Influenza A H1N1 Viral LoadC92273Influenza A H1N1 Viral LoadA measurement of the Influenza A H1N1 viral load in a biological specimen.Influenza A H1N1 Viral Load Measurement
Influenza A Viral LoadC92274Influenza A Viral LoadA measurement of the Influenza A viral load in a biological specimen.Influenza A Viral Load Measurement
Legionella pneumophila AntigenC92275Legionella pneumophila AntigenA measurement of the Legionella pneumophila antigen in a biological specimen.Legionella pneumophila Antigen Measurement
Legionella pneumophila IgG AntibodyC92276Legionella pneumophila IgG AntibodyA measurement of the Legionella pneumophila IgG antibody in a biological specimen.Legionella pneumophila IgG Antibody Measurement
Legionella pneumophila IgG IgM AntibodyC92277Legionella pneumophila IgG IgM AntibodyA measurement of the Legionella pneumophila IgG and IgM in a biological specimen.Legionella pneumophila IgG IgM Antibody Measurement
Legionella pneumophila IgM AntibodyC92278Legionella pneumophila IgM AntibodyA measurement of the Legionella pneumophila IgM antibody in a biological specimen.Legionella pneumophila IgM Antibody Measurement
Leukocyte Cell MorphologyC92297Leukocyte Cell Morphology;White Blood Cell Morphology;WBC MorphologyAn examination or assessment of the form and structure of white blood cells.Leukocyte Cell Morphology
Leukocyte Cell ClumpsC92246Leukocyte Cell Clumps;White Blood Cell Clumps;WBC ClumpsA measurement of white blood cell clumps in a biological specimen.Leukocyte Cell Clumps Measurement
Monoclonal ProteinC92291Monoclonal Immunoglobulin Protein;ParaproteinA measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.Monoclonal Protein Measurement
M. tuberculosis IFN Gamma ResponseC92241Mycobacterium tuberculosis IFN Gamma ResponseA measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.Mycobacterium tuberculosis Interferon Gamma Response
Mycobacterium tuberculosis Nucleic AcidC92279Mycobacterium tuberculosis Nucleic AcidA measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.Mycobacterium tuberculosis Nucleic Acid Measurement
Myeloid/Erythroid RatioC92242Myeloid/Erythroid RatioA relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.Myeloid to Erythroid Ratio Measurement
Myeloperoxidase AntibodyC92280Myeloperoxidase AntibodyA measurement of the myeloperoxidase antibody in a biological specimen.Myeloperoxidase Antibody Measurement
Neisseria gonorrhoeae ScreeningC92298Neisseria gonorrhoeae ScreeningExamination of a biological specimen to detect the presence of Neisseria gonorrhoeae.Neisseria gonorrhoeae Screening
OsmolarityC74802OsmolarityA measurement of the osmoles of solute per liter of solution.Osmolarity Measurement
OxalateC92250Oxalate;EthanedioateA measurement of the oxalate in a biological specimen.Oxalate Measurement
Protein/OsmolalityC92240Protein/Osmolality;Protein/Osmolality RatioA relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.Protein to Osmolality Ratio Measurement
Sjogrens SS-A AntibodyC92236Ro Antibody;Sjogrens SS-A AntibodyA measurement of the Sjogrens SS-A antibody in a biological specimen.Sjogren's SS-A Antibody Measurement
Sjogrens SS-B AntibodyC92237La Antibody;Sjogrens SS-B AntibodyA measurement of the Sjogrens SS-B antibody in a biological specimen.Sjogren's SS-B Antibody Measurement
Smith AntibodyC92281Smith AntibodyA measurement of the Smith antibody in a biological specimen.Smith Antibody Measurement
Streptolysin O AntibodyC92282Streptolysin O Antibody;Antistreptolysin OA measurement of Streptolysin O Antibody in a biological specimen.Streptolysin O Antibody Measurement
Transitional Epithelial CellsC92251Transitional Epithelial CellsA measurement of the transitional epithelial cells present in a biological specimen.Transitional Epithelial Cells Measurement
TrichomonasC92238TrichomonasExamination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.Trichomonas Screening
TryptaseC92292TryptaseA measurement of the tryptase in a biological specimen.Tryptase Measurement
Type I MyeloblastsC92283Type I MyeloblastsA measurement of type I myeloblast cells per unit of a biological specimen.Type I Myeloblasts Measurement
Type II MyeloblastsC92284Type II MyeloblastsA measurement of type II myeloblast cells per unit of a biological specimen.Type II Myeloblasts Measurement
Type III MyeloblastsC92285Type III MyeloblastsA measurement of type III myeloblast cells per unit of a biological specimen.Type III Myeloblasts Measurement
Yeast HyphaeC92239Yeast HyphaeExamination of a biological specimen to detect the presence of any yeast cells that are in the long, filamentous and branching phase of growth.Yeast Hyphae Screening
Soluble Vasc Cell Adhesion Molecule 1C92533Soluble Vascular Cell Adhesion Molecule 1A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.Soluble Vascular Cell Adhesion Molecule 1
A Fetoprotein L3/A FetoproteinC96565A Fetoprotein L3/A FetoproteinA relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement
Acetylcholine Receptor AntibodyC96559Acetylcholine Receptor AntibodyA measurement of the acetylcholine receptor antibody in a biological specimen.Acetylcholine Receptor Antibody Measurement
AcetylcholinesteraseC96560AcetylcholinesteraseA measurement of the acetylcholinesterase in a biological specimen.Acetylcholinesterase Measurement
Alpha Fetoprotein L1C96562Alpha Fetoprotein L1A measurement of the alpha fetoprotein L1 in a biological specimen.Alpha Fetoprotein L1 Measurement
Alpha Fetoprotein L2C96563Alpha Fetoprotein L2A measurement of the alpha fetoprotein L2 in a biological specimen.Alpha Fetoprotein L2 Measurement
Alpha Fetoprotein L3C96564Alpha Fetoprotein L3A measurement of the alpha fetoprotein L3 in a biological specimen.Alpha Fetoprotein L3 Measurement
Basophilic StipplingC96567Basophilic StipplingA measurement of the basophilic stippling in a biological specimen.Basophilic Stippling Measurement
BenzoylecgonineC75350Benzoylecgonine;Cocaine MetaboliteA measurement of the benzoylecgonine in a biological specimen.Benzoylecgonine Measurement
Beta-HydroxybutyrateC96568Beta-Hydroxybutyrate;B-Hydroxybutyrate;3-HydroxybutyrateA measurement of the total Beta-hydroxybutyrate in a biological specimen.Beta-Hydroxybutyrate Measurement
Broad CastsC96588Broad CastsA measurement of the broad casts in a biological specimen.Broad Casts Measurement
Calcium ClearanceC96589Calcium ClearanceA measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).Calcium Clearance Measurement
Calcium SulphateC96590Calcium SulphateA measurement of the calcium sulphate in a biological specimen.Calcium Sulphate Measurement
CarboxyhemoglobinC96591CarboxyhemoglobinA measurement of the carboxyhemoglobin in a biological specimen.Carboxyhemoglobin Measurement
Circulating Endothelial CellsC96592Circulating Endothelial CellsA measurement of the circulating endothelial cells in a biological specimen.Circulating Endothelial Cell Count
Circulating Tumor CellsC96593Circulating Tumor CellsA measurement of the circulating tumor cells in a biological specimen.Circulating Tumor Cell Count
ClarityC96594ClarityA measurement of the transparency of a biological specimen.Clarity Measurement
Cyclic Citrullinated Peptide AntibodyC96595Cyclic Citrullinated Peptide AntibodyA measurement of the cyclic citrullinated peptide antibody in a biological specimen.Cyclic Citrullinated Peptide Antibody Measurement
Cytomegalovirus IgG AntibodyC96596Cytomegalovirus IgG AntibodyA measurement of the cytomegalovirus IgG antibody in a biological specimen.Cytomegalovirus IgG Antibody Measurement
Cytomegalovirus IgM AntibodyC96597Cytomegalovirus IgM AntibodyA measurement of the cytomegalovirus IgM antibody in a biological specimen.Cytomegalovirus IgM Antibody Measurement
Dehydroepiandrosterone SulfateC96629Dehydroepiandrosterone Sulfate;DHEA-S;sDHEA;DHEA SulfateA measurement of the sulfated Dehydroepiandrosterone in a biological specimen.Sulfated DHEA Measurement
Dilute Russell's Viper Venom TimeC96696Dilute Russell's Viper Venom TimeA measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom.Dilute Russell's Viper Venom Time Measurement
EccentrocytesC96598EccentrocytesA measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.Eccentrocyte Count
Epstein-Barr Capsid IgG AntibodyC96600Epstein-Barr Capsid IgG AntibodyA measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.Epstein-Barr Capsid IgG Antibody Measurement
Epstein-Barr Capsid IgM AntibodyC96601Epstein-Barr Capsid IgM AntibodyA measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.Epstein-Barr Capsid IgM Antibody Measurement
Epstein-Barr Early AntigenC96602Epstein-Barr Early AntigenA measurement of the Epstein-Barr early antigen in a biological specimen.Epstein-Barr Early Antigen Measurement
Epstein-Barr Nuclear AntibodyC96603Epstein-Barr Nuclear AntibodyA measurement of the Epstein-Barr nuclear antibody in a biological specimen.Epstein-Barr Nuclear Antibody Measurement
Epstein-Barr Nuclear AntigenC96604Epstein-Barr Nuclear AntigenA measurement of the Epstein-Barr nuclear antigen in a biological specimen.Epstein-Barr Nuclear Antigen Measurement
Erythrocyte GhostsC96605Erythrocyte Ghosts;RBC GhostsA measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.Erythrocyte Ghost Count
Factor IIC96626Factor II;ProthrombinA measurement of the Factor II in a biological specimen.Prothrombin Measurement
FatC96648FatA measurement of the fat in a biological specimen.Fat Measurement
Fibroblast Growth Factor 23C96650Fibroblast Growth Factor 23;PhosphatoninA measurement of the fibroblast growth factor 23 in a biological specimen.Fibroblast Growth Factor 23 Measurement
Giant NeutrophilsC96651Giant NeutrophilsA measurement of the giant neutrophils in a biological specimen.Giant Neutrophil Count
Glucose ClearanceC96652Glucose ClearanceA measurement of the glucose clearance in a biological specimen.Glucose Clearance Measurement
Glutamic Acid Decarboxylase AntibodyC96653Glutamic Acid Decarboxylase Antibody;GAD AntibodyA measurement of the glutamic acid decarboxylase antibody in a biological specimen.Glutamic Acid Decarboxylase Antibody Measurement
GranulocytesC96654GranulocytesA measurement of the granulocytes in a biological specimen.Granulocyte Count
Hepatitis B Virus Core AntibodyC96660Hepatitis B Virus Core AntibodyA measurement of the hepatitis B virus core antibody in a biological specimen.Hepatitis B Virus Core Antibody Measurement
Hepatitis B Virus Core IgM AntibodyC96661Hepatitis B Virus Core IgM AntibodyA measurement of the hepatitis B virus core IgM antibody in a biological specimen.Hepatitis B Virus Core IgM Antibody Measurement
Hepatitis B Virus e AntibodyC96662Hepatitis B Virus e AntibodyA measurement of the hepatitis B e antibody in a biological specimen.Hepatitis B Virus e Antibody Measurement
Hepatitis B Virus e AntigenC96663Hepatitis B Virus e AntigenA measurement of the hepatitis B e antigen in a biological specimen.Hepatitis B Virus e Antigen Measurement
Hepatitis D Virus AntibodyC96664Hepatitis D Virus Antibody;Hepatitis Delta AntibodyA measurement of the hepatitis D virus antibody in a biological specimen.Hepatitis D Virus Antibody Measurement
Hepatitis E Virus IgM AntibodyC96665Hepatitis E Virus IgM AntibodyA measurement of the hepatitis E virus IgM antibody in a biological specimen.Hepatitis E Virus IgM Antibody Measurement
Herpes Simplex Virus 1 IgG AntibodyC96697Herpes Simplex Virus 1 IgG Antibody;HSV-1 IgG AntibodyA measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.Herpes Simplex Virus 1 IgG Antibody Measurement
Herpes Simplex Virus 1/2 IgG AntibodyC96698Herpes Simplex Virus 1/2 IgG Antibody;HSV-1/2 IgG AbA measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.Herpes Simplex Virus 1/2 IgG Antibody Measurement
Herpes Simplex Virus 1/2 IgM AntibodyC96666Herpes Simplex Virus 1/2 IgM Antibody;HSV-1/2 IgM AbA measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.Herpes Simplex Virus 1/2 IgM Antibody Measurement
Herpes Simplex Virus 2 IgG AntibodyC96667Herpes Simplex Virus 2 IgG Antibody;HSV-2 IgG AntibodyA measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.Herpes Simplex Virus 2 IgG Antibody Measurement
HexokinaseC96668HexokinaseA measurement of the hexokinase in a biological specimen.Hexokinase Measurement
HyperchromiaC96669HyperchromiaA measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.Hyperchromia Measurement
Immature BasophilsC96670Immature BasophilsA measurement of the immature basophils in a biological specimen.Immature Basophil Count
Immature Basophils/LeukocytesC96671Immature Basophils/LeukocytesA relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.Immature Basophil to Leukocyte Ratio Measurement
Immature CellsC96672Immature CellsA measurement of the total immature cells in a blood specimen.Immature Cell Count
Immature EosinophilsC96673Immature EosinophilsA measurement of the immature eosinophils in a biological specimen.Immature Eosinophil Count
Immature Eosinophils/LeukocytesC96674Immature Eosinophils/LeukocytesA relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.Immature Eosinophil to Leukocyte Ratio Measurement
Immature GranulocytesC96675Immature GranulocytesA measurement of the total immature granulocytes in a biological specimen.Immature Granulocyte Count
Immature MonocytesC96676Immature MonocytesA measurement of the immature monocytes in a biological specimen.Immature Monocyte Count
Immature Monocytes/LeukocytesC96677Immature Monocytes/LeukocytesA relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.Immature Monocyte to Leukocyte Ratio Measurement
Immature NeutrophilsC96678Immature NeutrophilsA measurement of the total immature neutrophils in a biological specimen.Immature Neutrophil Count
Immature Plasma CellsC96679Immature Plasma CellsA measurement of the immature plasma cells in a biological specimen.Immature Plasma Cell Count
Immature Plasma Cells/LymphocytesC96680Immature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.Immature Plasma Cell to Lymphocyte Ratio Measurement
Inhibin BC96681Inhibin BA measurement of the inhibin B in a biological specimen.Inhibin B Measurement
Kurloff CellsC96682Kurloff CellsA measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.Kurloff Cells Measurement
Liver Kidney Microsomal Type 1 AntibodyC96683Liver Kidney Microsomal Type 1 Antibody;LKM-1A measurement of the liver kidney microsomal type 1 antibody in a biological specimen.Liver Kidney Microsomal Type 1 Antibody Measurement
Mean Platelet ComponentC96686Mean Platelet ComponentA measurement of the mean platelet component (platelet activity) in a blood specimen.Mean Platelet Component Measurement
MegakaryocytesC96688MegakaryocytesA measurement of the megakaryocytes per unit of a biological specimen.Megakaryocyte Count
MethemoglobinC96689MethemoglobinA measurement of the methemoglobin in a biological specimen.Methemoglobin Measurement
Methylmalonic AcidC96690Methylmalonic AcidA measurement of the methylmalonic acid in a biological specimen.Methylmalonic Acid Measurement
N-Terminal ProB-type Natriuretic PeptideC96610N-Terminal ProB-type Natriuretic Peptide;NT proBNP II;N-terminal pro-Brain Natriuretic PeptideA measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.N-Terminal ProB-type Natriuretic Peptide Measurement
Oxygen CapacityC96614Oxygen CapacityA measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.Oxygen Capacity Measurement
Oxygen SaturationC68032Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
OxyhemoglobinC96616OxyhemoglobinA measurement of the oxyhemoglobin in a biological specimen.Oxyhemoglobin Measurement
Parvovirus B19 IgG AntibodyC96617Parvovirus B19 IgG AntibodyA measurement of the Parvovirus B19 IgG antibody in a biological specimen.Parvovirus B19 IgG Antibody Measurement
Parvovirus B19 IgM AntibodyC96618Parvovirus B19 IgM AntibodyA measurement of the Parvovirus B19 IgM antibody in a biological specimen.Parvovirus B19 IgM Antibody Measurement
PhospholipidC96623PhospholipidA measurement of the phospholipids in a biological specimen.Phospholipid Measurement
Platelet ClumpsC96624Platelet Clumps;PLT ClumpsA measurement of the platelet clumps in a biological specimen.Platelet Clumps Count
Procollagen 1 N-Terminal PropeptideC96625Procollagen 1 N-Terminal Propeptide;Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1A measurement of the procollagen 1 N-terminal propeptide in a biological specimen.Procollagen 1 N-Terminal Propeptide Measurement
Reptilase TimeC96628Reptilase TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.Reptilase Time Measurement
Target CellsC96636Leptocytes;Target CellsA measurement of the target cells in a biological specimen.Target Cell Count
ThyroperoxidaseC96639Thyroperoxidase;Thyroid PeroxidaseA measurement of the thyroperoxidase in a biological specimen.Thyroperoxidase Measurement
Thyroperoxidase AntibodyC96638Thyroperoxidase AntibodyA measurement of the thyroperoxidase antibody in a biological specimen.Thyroperoxidase Antibody Measurement
Toxic GranulationC96641Toxic GranulationA measurement of the toxic granulation in neutrophilic blood cells.Toxic Granulation Measurement
Urea/CreatinineC96645Urea/CreatinineA relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.Urea to Creatinine Ratio Measurement
ADV Viral LoadC98705ADV Viral LoadA measurement of the adenovirus viral load in a biological specimen.Adenovirus Viral Load Measurement
Anti-Factor Xa ActivityC98706Anti-Factor Xa ActivityA measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.Anti-Factor Xa Activity Measurement
Amylase, PancreaticC98767Amylase, PancreaticA measurement of the pancreatic enzyme amylase in a biological specimen.Pancreatic Amylase Measurement
Amylase, SalivaryC98780Amylase, SalivaryA measurement of the salivary enzyme amylase in a biological specimen.Salivary Amylase Measurement
Activated PTT/StandardC98862Activated PTT/StandardA relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT/Standard Ratio Measurement
Basophils/Total CellsC98865Basophils/Total CellsA relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).Basophil to Total CellRatio Measurement
BKV Viral LoadC98710BKV Viral LoadA measurement of the BK virus viral load in a biological specimen.BK Virus Viral Load Measurement
Myeloblasts/Total CellsC98761Myeloblasts/Total CellsA relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).Myeloblast to Total Cell Ratio Measurement
MegakaryoblastsC98752MegakaryoblastsA measurement of the megakaryoblasts in a biological specimen.Megakaryoblast Cell Count
Megakaryoblasts/Total CellsC98753Megakaryoblasts/Total CellsA relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).Megakaryoblast to Total Cell Ratio Measurement
Normoblasts/Total CellsC98764Normoblasts/Total CellsA relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).Normoblast to Total Cell Ratio Measurement
Pronormoblasts/Total CellsC98870Pronormoblasts/Total CellsA relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).Pronormoblast to Total CellRatio Measurement
CMV Viral LoadC98716CMV Viral LoadA measurement of the cytomegalovirus viral load in a biological specimen.Cytomegalovirus Viral Load Measurement
EBV Viral LoadC98721EBV Viral LoadA measurement of the Epstein-Barr virus viral load in a biological specimen.Epstein-Barr Virus Viral Load Measurement
Eosinophils/Total CellsC98720Eosinophils/Total CellsA relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).Eosinophils to Total Cell Ratio Measurement
Factor IXC98725Factor IXA measurement of the factor IX in a biological specimen.Factor IX Measurement
Factor VC98726Factor VA measurement of the factor V in a biological specimen.Factor V Measurement
von Willebrand FactorC98799von Willebrand FactorA measurement of the von Willebrand factor in a biological specimen.von Willebrand Factor Measurement
Factor XC98727Factor XA measurement of the factor X in a biological specimen.Factor X Measurement
Fat DropletC98728Fat DropletA measurement of the triglyceride aggregates within a biological specimen.Fat Droplet Measurement
Glomerular Filtration Rate Adj for BSAC98734Glomerular Filtration Rate Adj for BSAA measurement of the glomerular filtration rate adjusted for body size.Glomerular Filtration Rate Adjusted for BSA
GFR from Creatinine Adjusted for BSAC98735GFR from Creatinine Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on creatinine.Glomerular Filtration Rate from Creatinine Adjusted for BSA
GFR from Cystatin C Adjusted for BSAC98736GFR from Cystatin C Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on cystatin C.Glomerular Filtration Rate from Cystatin C Adjusted for BSA
Granulocytes/Total CellsC98866Granulocytes/Total CellsA relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).Granulocyte to Total CellRatio Measurement
Human Anti-Sheep IgE AntibodyC98740Human Anti-Sheep IgE AntibodyA measurement of the human anti-sheep IgE antibodies in a biological specimen.Human Anti-Sheep IgE Antibody Measurement
Human Anti-Sheep IgG AntibodyC98741Human Anti-Sheep IgG AntibodyA measurement of the human anti-sheep IgG antibodies in a biological specimen.Human Anti-Sheep IgG Antibody Measurement
Human Anti-Sheep IgM AntibodyC98742Human Anti-Sheep IgM AntibodyA measurement of the human anti-sheep IgM antibodies in a biological specimen.Human Anti-Sheep IgM Antibody Measurement
HemosiderinC96659HemosiderinA measurement of the hemosiderin complex in a biological specimen.- - -
Herpes Simplex Virus 1 IgM AntibodyC98738Herpes Simplex Virus 1 IgM AntibodyA measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.Herpes Simplex Virus 1 IgM Antibody Measurement
Herpes Simplex Virus 2 IgM AntibodyC98739Herpes Simplex Virus 2 IgM AntibodyA measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.Herpes Simplex Virus 2 IgM Antibody Measurement
Immunoglobulin DC98745Immunoglobulin DA measurement of the Immunoglobulin D in a biological specimen.Immunoglobulin D Measurement
Inulin ClearanceC98748Inulin ClearanceA measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).Inulin Clearance
Iothalamate ClearanceC98749Iothalamate ClearanceA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).Iothalamate Clearance
Iothalamate Clearance Adjusted for BSAC98750Iothalamate Clearance Adjusted for BSAA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.Iothalamate Clearance Adjusted for BSA
Kappa Light Chain, FreeC98730Kappa Light Chain, FreeA measurement of the free kappa light chain in a biological specimen.Free Kappa Light Chain Measurement
Kappa Lt Chain,Free/Lambda Lt Chain,FreeC98731Kappa Lt Chain,Free/Lambda Lt Chain,FreeA relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement
Megakaryocytes/Total CellsC98867Megakaryocytes/Total CellsA relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).Megakaryocyte to Total CellRatio Measurement
Lambda Light Chain, FreeC98732Lambda Light Chain, FreeA measurement of the free lambda light chain in a biological specimen.Free Lambda Light Chain Measurement
Lymphocytes/Total CellsC98751Lymphocytes/Total CellsA relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).Lymphocyte to Total Cell Ratio Measurement
Metamyelocytes/Total CellsC98754Metamyelocytes/Total CellsA relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).Metamyelocyte to Total Cell Ratio Measurement
Monocytes/Total CellsC98872Monocytes/Total CellsA relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).Monocytes to Total CellRatioMeasurement
Myelocytes/Total CellsC98868Myelocytes/Total CellsA relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).Myelocyte to Total CellRatio Measurement
Neutrophils/Total CellsC98763Neutrophils/Total CellsA relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).Neutrophil to Total Cell Ratio Measurement
Natural Killer CellsC98762Natural Killer CellsA measurement of the total natural killer cells in a biological specimen.Natural Killer Cell Count
Plasma Cells/Total CellsC98869Plasma Cells/Total CellsA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).Plasma Cell to Total CellRatio Measurement
Promyelocytes/Total CellsC98773Promyelocytes/Total CellsA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).Promyelocyte to Total Cell Ratio Measurement
Prothrombin ActivityC98774Prothrombin ActivityA measurement of the biological activity of prothrombin in a biological specimen.Prothrombin Activity Measurement
Reticulocyte HemoglobinC98776Reticulocyte HemoglobinA measurement of the amount of hemoglobin in reticulocytes.Reticulocyte Hemoglobin Measurement
Transferrin SaturationC98792Transferrin SaturationA measurement of the iron bound to transferrin in a biological specimen.Transferrin Saturation Measurement
Varicella Zoster Virus IgA AntibodyC98795Varicella Zoster Virus IgA AntibodyA measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.Varicella Zoster Virus IgA Antibody Measurement
Varicella Zoster Virus IgG AntibodyC98796Varicella Zoster Virus IgG AntibodyA measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.Varicella Zoster Virus IgG Antibody Measurement
Varicella Zoster Virus IgM AntibodyC98797Varicella Zoster Virus IgM AntibodyA measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.Varicella Zoster Virus IgM Antibody Measurement
3,4-DihydroxyphenylglycolC1010173,4-Dihydroxyphenylglycol;3.4 DihydroxyphenylglycolA measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.3,4-Dihydroxyphenylglycol Measurement
Activated Protein C ResistanceC100471Activated Protein C Resistance;Factor V Leiden ScreenA measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.Activated Protein C Resistance Measurement
Activated PTT/Standard PTTC100421Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin TimeA relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT to Standard PTT Ratio Measurement
Alanine AminopeptidaseC100430Alanine AminopeptidaseA measurement of the alanine aminopeptidase in a biological specimen.Alanine Aminopeptidase Measurement
Alpha-1 Acid GlycoproteinC100429Alpha-1 Acid GlycoproteinA measurement of the alpha-1 acid glycoprotein in a biological specimen.Alpha-1 Acid Glycoprotein Measurement
Alpha-1 MicroglobulinC100461Alpha-1 Microglobulin;Protein HCA measurement of the alpha-1 microglobulin in a biological specimen.Alpha-1 Microglobulin Measurement
Alpha-1 Microglobulin/CreatinineC100462Alpha-1 Microglobulin/CreatinineA relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.Alpha-1 Microglobulin to Creatinine Ratio Measurement
Apolipoprotein C2C100427Apolipoprotein C2;Apolipoprotein CIIA measurement of the apolipoprotein C2 in a biological specimen.Apolipoprotein C2 Measurement
Apolipoprotein JC100428Apolipoprotein J;ClusterinA measurement of the apolipoprotein J in a biological specimen.Apolipoprotein J Measurement
Beta CaroteneC100472Beta Carotene;b-Carotene;Beta CarotinA measurement of the beta carotene in a biological specimen.Beta Carotene Measurement
Beta-Trace ProteinC100426Beta-Trace ProteinA measurement of the beta-trace protein in a biological specimen.Beta-Trace Protein Measurement
Carbohydrate-Deficient TransferrinC101016Carbohydrate-Deficient TransferrinA measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.Carbohydrate-Deficient Transferrin Measurement
CeruloplasminC100432Ceruloplasmin;CaeruloplasminA measurement of ceruloplasmin in a biological specimen.Ceruloplasmin Measurement
Complement CH50C100423Complement CH50;Total Hemolytic Complement;CH50A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.CH50 Measurement
Chemokine (C-X-C Motif) Receptor 3C100431Chemokine (C-X-C Motif) Receptor 3;GPR9, CD183, CXCR3A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.Chemokine Receptor CXCR3 Measurement
Chlamydia trachomatis IgA AntibodyC100464Chlamydia trachomatis IgA AntibodyA measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.Chlamydia trachomatis IgA Antibody Measurement
Chlamydia trachomatis IgG AntibodyC100466Chlamydia trachomatis IgG AntibodyA measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.Chlamydia trachomatis IgG Antibody Measurement
Chlamydia trachomatis IgM AntibodyC100465Chlamydia trachomatis IgM AntibodyA measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.Chlamydia trachomatis IgM Antibody Measurement
DTPA ClearanceC100441DTPA ClearanceA measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.Diethylene Triamine Pentaacetic Acid Clearance
DNase-B AntibodyC100463DNase-B Antibody;Anti-Dnase BA measurement of Dnase-B antibody in a biological specimen.DNase-B Antibody Measurement
Ecarin Clotting TimeC100422Ecarin Clotting TimeA measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.Ecarin Clotting Time Measurement
EDTA ClearanceC100440EDTA ClearanceA measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.EDTA Clearance
Free GlycerolC100448Free Glycerol;Free GlycerinA measurement of the amount of unbound glycerol in a biological specimen.Free Glycerol Measurement
GFR from B-2 Microglobulin Adj for BSAC100450GFR from B-2 Microglobulin Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement
GFR from Beta-Trace Protein Adj for BSAC100449GFR from Beta-Trace Protein Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement
HDL Cholesterol/LDL Cholesterol RatioC100425HDL Cholesterol/LDL Cholesterol RatioA relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.HDL Cholesterol to LDL Cholesterol Ratio Measurement
HLA-B27 AntigenC100460HLA-B27 Antigen;Human Leukocyte Antigen B27A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.HLA-B27 Antigen Measurement
Homostat Model Assess of Insulin RstnC100447Homostat Model Assess of Insulin Rstn;Homeostatic Model Assessment of Insulin ResistanceAn assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.Homeostatic Model Assessment of Insulin Resistance
Immature Granulocytes/LeukocytesC100445Immature Granulocytes/LeukocytesA relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).Immature Granulocytes to Leukocytes Ratio Measurement
Immature LymphocytesC100444Immature LymphocytesA measurement of the immature lymphocytes in a biological specimen.Immature Lymphocytes Measurement
Immature Lymphocytes/LeukocytesC100443Immature Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.Immature Lymphocytes to Leukocytes Ratio Measurement
Immature Neutrophils/LeukocytesC100442Immature Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.Immature Neutrophils to Leukocytes Ratio Measurement
Iohexol ClearanceC100439Iohexol ClearanceA measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.Iohexol Clearance
Jo-1 AntibodyC100459Jo-1 AntibodyA measurement of the Jo-1 antibody in a biological specimen.Jo-1 Antibody Measurement
Kidney Injury Molecule-1C100433Kidney Injury Molecule-1;KIM-1;Hepatitis A Virus Cellular Receptor 1A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.Kidney Injury Molecule-1 Measurement
Liver Kidney Microsomal Type 1 IgA AbC100456Liver Kidney Microsomal Type 1 IgA AbA measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgA Antibody Measurement
Liver Kidney Microsomal Type 1 IgG AbC100454Liver Kidney Microsomal Type 1 IgG AbA measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgG Antibody Measurement
Liver Kidney Microsomal Type 1 IgM AbC100455Liver Kidney Microsomal Type 1 IgM AbA measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgM Antibody Measurement
Non-Prostatic Acid PhosphataseC100434Non-Prostatic Acid PhosphataseA measurement of the non-prostatic acid phosphatase in a biological specimen.Non-Prostatic Acid Phosphatase Measurement
Ova and ParasiteC100452Ova and ParasiteA measurement of the parasites and ova in a biological specimen.Ova and Parasite Measurement
Pepsinogen AC100469Pepsinogen A;PGAA measurement of the pepsinogen A in a biological specimen.Pepsinogen A Measurement
Pepsinogen CC100470Pepsinogen C;PGCA measurement of the pepsinogen C in a biological specimen.Pepsinogen C Measurement
Pepsinogen IC100467Pepsinogen I;PGIA measurement of the pepsinogen I in a biological specimen.Pepsinogen I Measurement
Pepsinogen IIC100468Pepsinogen II;PGIIA measurement of the pepsinogen II in a biological specimen.Pepsinogen II Measurement
PepsinogenC100122PepsinogenA measurement of the pepsinogen in a biological specimen.Pepsinogen Measurement
PlasmodiumC100453PlasmodiumExamination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.Plasmodium Measurement
Platelet HematocritC100424Platelet Hematocrit;ThrombocytocritA relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.Platelet Hematocrit Measurement
PrealbuminC100435PrealbuminA measurement of the prealbumin in a biological specimen.Prealbumin Measurement
ProerythroblastC100446ProerythroblastA measurement of the proerythroblasts in a biological specimen.Proerythroblast Measurement
Protein SC100436Protein SA measurement of the protein S in a biological specimen.Protein S Measurement
Retinol Binding ProteinC100437Retinol Binding ProteinA measurement of the total retinol binding protein in a biological specimen.Retinol Binding Protein Measurement
Ribonucleoprotein AntibodyC100457Ribonucleoprotein Antibody;RNP AntibodyA measurement of the ribonucleoprotein antibody in a biological specimen.Ribonucleoprotein Antibody Measurement
Ringed SideroblastsC100419Ringed SideroblastsA measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.Ringed Sideroblast Measurement
Scl-70 AntibodyC100458Scl-70 Antibody;Scleroderma-70 AntibodyA measurement of the Scl-70 antibody in a biological specimen.Scl-70 Antibody Measurement
SideroblastC100418SideroblastA measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.Sideroblast Measurement
Soluble Transferrin ReceptorC100438Soluble Transferrin ReceptorA measurement of the soluble transferrin receptor in a biological specimen.Soluble Transferrin Receptor Measurement
Tricyclic AntidepressantsC100420Tricyclic AntidepressantsA measurement of tricyclic antidepressants in a biological specimen.Tricyclic Antidepressant Measurement
Back to top
CL.C71113.FREQFrequency
(FREQ)
text
Extensible: Yes
C71113FrequencyThe terminology that includes terms pertaining to frequency within CDISC.CDISC SDTM Frequency Terminology
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
CONTINUOUSC53279ContinuousRemain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)Continue
BIDC64496BD;Twice per dayTwo times per day, at unspecified times. (NCI)Twice Daily
BISC64497Twice per weekTwo times per week. (NCI)Twice Weekly
QMC64498Every MonthEvery month. (NCI)Monthly
PRNC64499As neededAs needed. (NCI)As Necessary
Q10HC64500Every 10 hoursEvery ten hours. (NCI)Every Ten Hours
Q11HC64501Every 11 hoursEvery eleven hours. (NCI)Every Eleven Hours
Q12HC64502Every 12 hoursEvery twelve hours. (NCI)Every Twelve Hours
Q13HC64503Every 13 hoursEvery thirteen hours. (NCI)Every Thirteen Hours
Q14HC64504Every 14 hoursEvery fourteen hours. (NCI)Every Fourteen Hours
Q15HC64505Every 15 hoursEvery fifteen hours. (NCI)Every Fifteen Hours
Q16HC64506Every 16 hoursEvery sixteen hours. (NCI)Every Sixteen Hours
Q17HC64507Every 17 hoursEvery seventeen hours. (NCI)Every Seventeen Hours
Q18HC64508Every 18 hoursEvery eighteen hours. (NCI)Every Eighteen Hours
Q19HC64509Every 19 hoursEvery nineteen hours. (NCI)Every Nineteen Hours
QHC64510Every hourEvery hour. (NCI)Every Hour
Q20HC64511Every 20 hoursEvery twenty hours. (NCI)Every Twenty Hours
Q21HC64512Every 21 hoursEvery twenty-one hours. (NCI)Every Twenty-One Hours
Q22HC64513Every 22 hoursEvery twenty-two hours. (NCI)Every Twenty-Two Hours
Q23HC64514Every 23 hoursEvery twenty-three hours. (NCI)Every Twenty-Three Hours
Q24HC64515Every 24 hoursEvery twenty-four hours. (NCI)Every Twenty-Four Hours
Q2HC64516Every 2 hoursEvery two hours. (NCI)Every Two Hours
Q3HC64517Every 3 hoursEvery three hours. (NCI)Every Three Hours
Q4HC64518Every 4 hoursEvery four hours. (NCI)Every Four Hours
Q5HC64519Every 5 hoursEvery five hours. (NCI)Every Five Hours
Q6HC64520Every 6 hoursEvery six hours. (NCI)Every Six Hours
Q7HC64521Every 7 hoursEvery seven hours. (NCI)Every Seven Hours
Q8HC64523Every 8 hoursEvery eight hours. (NCI)Every Eight Hours
Q9HC64524Every 9 hoursEvery nine hours. (NCI)Every Nine Hours
QODC64525Every other dayEvery other day. (NCI)Every Other Day
TIDC645273 times per dayThree times per day. (NCI)Three Times Daily
TISC64528Three times a weekThree times per week. (NCI)Three Times Weekly
Q4SC64529Every 4 weeksEvery four weeks. (NCI)Every Four Weeks
QIDC645304 times per dayFour times per day. (NCI)Four Times Daily
QISC645314 times per weekFour times per week. (NCI)Four Times Weekly
Q3DC64533Every 3 daysEvery three days. (NCI)Every Three Days
Q4DC64534Every 4 daysEvery four days. (NCI)Every Four Days
Q3SC64535Every 3 weeksEvery three weeks. (NCI)Every Three Weeks
Q2MC64536Every two monthsEvery two months. (NCI)Every Two Months
Q3MC64537Every 3 monthsEvery three months. (NCI)Every Three Months
Q4MC64538Every 4 monthsEvery four months. (NCI)Every Four Months
ONCEC64576OnceA one time intervention. (NCI)Once
QSC67069Every week;Per WeekEvery week. (NCI)Weekly
Q5DC71124Every 5 daysEvery five days. (NCI)Every Five Days
Q2SC71127Every 2 weeksEvery two weeks. (NCI)Every Two Weeks
BIMC71129Twice per monthTwice per month. (NCI)Twice Per Month
INTERMITTENTC71325IntermittentPeriodically stopping and starting. (NCI)Intermittent
QDC25473DailyOccurring or done each day.Daily
OCCASIONALC64954OccasionalNot occurring regularly or at short intervals.Infrequent
AD LIBITUMC64636Ad LibitumAs much as desired.As Much as Desired
1 TIME PER WEEKC64526One Time Per WeekOne time per week. (NCI)Once Weekly
2 TIMES PER YEARC988612 Times Per YearTwo times per year. (NCI)Two Times Yearly
3 TIMES PER MONTHC988593 Times Per MonthThree times per month. (NCI)Three Times Monthly
3 TIMES PER YEARC988603 Times Per YearThree times per year. (NCI)Three Times Yearly
4 TIMES PER MONTHC988524 Times Per MonthFour times per month. (NCI)Four Times Monthly
4 TIMES PER YEARC988534 Times Per YearFour times per year. (NCI)Four Times Yearly
5 TIMES PER DAYC988495 Times DailyFive times per day. (NCI)Five Times Daily
5 TIMES PER MONTHC988505 Times Per MonthFive times per month. (NCI)Five Times Monthly
5 TIMES PER WEEKC855525 Times Per WeekFive times per week. (NCI)Five Times Weekly
5 TIMES PER YEARC988515 Times Per YearFive times per year. (NCI)Five Times Yearly
6 TIMES PER DAYC988556 Times DailySix times per day. (NCI)Six Times Daily
6 TIMES PER MONTHC988566 Times Per MonthSix times per month. (NCI)Six Times Monthly
6 TIMES PER WEEKC988576 Times Per WeekSix times per week. (NCI)Six Times Weekly
6 TIMES PER YEARC988586 Times Per YearSix times per year. (NCI)Six Times Yearly
7 TIMES PER WEEKC988547 Times Per WeekSeven times per week. (NCI)Seven Times Weekly
PAC74924Per Annum;Per YearA frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.Per Year
Q6SC89788Every 6 WeeksEvery six weeks. (NCI)Every Six Weeks
Back to top
CL.C71148.POSITIONPosition
(POSITION)
text
Extensible: Yes
C71148PositionTerminology codelist used with Body Position within CDISC.CDISC SDTM Body Position Terminology
SITTINGC62122SittingThe state or act of one who sits; the posture of one who occupies a seat. (NCI)Sitting
PRONEC62165ProneAn anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI)Prone Position
STANDINGC62166StandingThe act of assuming or maintaining an erect upright position. (NCI)Standing
SUPINEC62167SupineA posterior recumbent body position whereby the person lies on its back and faces upward. (NCI)Supine Position
TRENDELENBURGC62168TrendelenburgA supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI)Trendelenburg
REVERSE TRENDELENBURGC62169Reverse TrendelenburgA supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI)Reverse Trendelenburg
RIGHT LATERAL DECUBITUSC62171Right lateral decubitusA recumbent right lateral side position. (NCI)Right Lateral Decubitus Position
LEFT LATERAL DECUBITUSC62172Left lateral decubitusA recumbent left lateral side position. (NCI)Left Lateral Decubitus Position
FOWLERSC62173FowlersA semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI)Fowler's Position
SEMI-FOWLERSC62174Semi-FowlersA semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI)Semi-Fowler's Position
UNCONSTRAINEDC90480UnconstrainedThe ability to move body parts and limbs without physical restriction. (NCI)Unconstrained Body Movement
SLINGC92604SlingA position in which the subject's body is supported by a sling.Patient in Body Sling
LATERAL DECUBITUSC100758Lateral DecubitusLying down on one side.Lateral Decubitus Position
Back to top
CL.C71150.EGSTRESCECG Result
(EGSTRESC)
text
Extensible: Yes
C71150ECG ResultTerminology codelist used with ECG Findings and Abnormalities within CDISC.CDISC SDTM ECG Finding Terminology
SINUS TACHYCARDIAC26889Sinus tachycardiaA heart rate of more than 100 beats per minute, with its origin in the sinus node. (NCI)Sinus Tachycardia
SINUS BRADYCARDIAC26923Sinus bradycardiaA heart rate of less than 60 beats per minute, with its origin in the sinus node. (NCI)Sinus Bradycardia
VENTRICULAR ARRHYTHMIA ASSOCIATED WITH LONG QT SYNDROMEC34786Ventricular arrhythmia associated with long QT syndromeA ventricular arrhythmia characterized by syncopal episodes and a long QT interval, sometimes leading to sudden death due to paroxysmal ventricular arrhythmia. This arrhythmia is associated with a prolongation of repolarization following depolarization of the cardiac ventricles. The prolongation of the Q-T interval combined with torsades de pointes manifests as several different forms; some may be acquired or congenital; some may lead to serious arrhythmia and sudden cardiac death. (NCI)Long QT Syndrome
PRE-EXCITATIONC34940Pre-excitationA condition characterized by the activation of the whole or some part of the ventricle by the transmission of an atrial impulse along an accessory pathway rather than by way of the normal specific conduction system which includes a delay at the atrioventricular node. (NCI)Pre-Excitation Syndrome
AV NODE RE-ENTRYC35058AV node re-entryA supraventricular tachycardia due to reentry along a circuit contained within the AV node. AVNRT is the most common form of supraventricular tachycardia and usually presents as a narrow QRS complex tachycardia at a rate between 150 and 250 beats per minute. (NCI)Atrioventricular Nodal Reentry Tachycardia
JUNCTIONAL TACHYCARDIAC35059Junctional tachycardiaAn automatic tachycardia originating in the atrioventricular junction, typically arising in the conduction tissues surrounding the atrioventricular node. A junctional tachycardia tends to be a regular, narrow complex tachycardia and usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication. The rate may range from 140 to 250 beats per minute. (NCI)Junctional Tachycardia
SUPRAVENTRICULAR TACHYCARDIAC35061Supraventricular tachycardiaA generic expression for any tachycardia that originates in the atria or the atrioventricular node. (NCI)Supraventricular Tachycardia
WOLFF-PARKINSON-WHITE SYNDROMEC35132Wolff-Parkinson-White syndromeA type of ventricular pre-excitation resulting from the activation of an accessory pathway known as the Bundle of Kent. This pathway presents an abnormal electrical communication from the atria to the ventricles. Wolff-Parkinson-White syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. (NCI)Wolff-Parkinson-White Syndrome
ATRIAL TACHYCARDIAC35481Atrial tachycardiaAny rapid heart rhythm originating in the atria. Atrial fibrillation and atrial flutter are varieties of atrial tachycardia. Atrial tachycardia is an electrical circuit originating in the upper or atrial chambers. This electrical circuit or focus takes over and generates rapid impulses across the atrial chambers. These impulses are transmitted to the ventricular chambers resulting in a rapid rate. These arrhythmias may originate from a variety of places across the atria. They may exist as an isolated problem or be related to an ongoing structural problem within the heart. (NCI)Atrial Tachycardia
ATRIAL FIBRILLATIONC50466Atrial fibrillationA supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact. (NCI)Atrial Fibrillation
3RD DEGREE AV BLOCKC505013rd degree AV blockComplete failure of atrial electrical impulse conduction through the AV node to the ventricles. (NCI)AV Block Third Degree
TORSADES DE POINTESC50779Torsades de pointesAn atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline. In addition the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. (NCI)Torsades De Pointes
VENTRICULAR FIBRILLATIONC50799Ventricular fibrillationAn arrhythmia characterized by an irregular pattern of high or low-amplitude waves that cannot be differentiated into QRS complexes or T waves. These electrocardiographic waves occur as a result of fibrillary contractions of the ventricular muscle due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricle. (NCI)Ventricular Fibrillation
VENTRICULAR FLUTTERC50800Ventricular flutterA ventricular tachyarrhythmia characterized by a high ventricular rate (180 and 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI)Ventricular Flutter
VENTRICULAR TACHYCARDIAC50802Ventricular tachycardiaA tachycardia arising distal to bundle of His, with a rate greater than 100 beats per minute. (NCI)Ventricular Tachycardia
ATRIAL FLUTTERC51224Atrial flutterAn electrocardiographic finding of an organized rhythmic contraction of the atria which is generally at a rate of 200-300 beats per minute. (NCI)Atrial Flutter
R ON T PHENOMENONC61395R on T phenomenonAn electrocardiographic finding phenomena in which the R wave occurs on top of the T wave; this can trigger ventricular fibrillation or ventricular tachycardia. (NCI)R On T Phenomenon
1ST DEGREE AV BLOCKC620151st degree AV blockA delay in the time required for the conduction of an electrical impulse through the atrioventricular (AV) node beyond 0.2 seconds; prolongation of the PR interval beyond 200 milliseconds. (NCI)AV Block First Degree
2ND DEGREE AV BLOCKC620162nd degree AV blockIntermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles. (NCI)AV Block Second Degree
VENTRICULAR TACHYCARDIA, MONOMORPHICC62234Ventricular tachycardia, monomorphicA ventricular tachycardia in which the ventricular activation sequence is constant. The morphology of the electrocardiographic waveform is unchanging and is referred to as monomorphic. (NCI)Monomorphic Ventricular Tachycardia
VENTRICULAR TACHYCARDIA, POLYMORPHICC62236Ventricular tachycardia, polymorphicA ventricular tachycardia in which the ventricular activation sequence is variable. The morphology of the electrocardiographic waveform is variable and is referred to as polymorphic. (NCI)Polymorphic Ventricular Tachycardia
SINUS ARRHYTHMIAC62239Sinus arrhythmiaIrregularity of the heartbeat due to a variation in the sinus rhythm resulting in cyclic changes in the heart rate during breathing. This rhythm is most commonly seen with breathing due to fluctuations in parasympathetic vagal tone. During inspiration stretch receptors in the lungs stimulate the cardioinhibitory centers in the medulla via fibers in the vagus nerve. Irregularity of the heartbeat due to a variation in the sinus rhythm resulting in cyclic changes in the heart rate during breathing. This rhythm is most commonly seen with breathing due to fluctuations in parasympathetic vagal tone. During inspiration stretch receptors in the lungs stimulate the cardioinhibitory centers in the medulla via fibers in the vagus nerve. (NCI)Sinus Arrhythmia
WANDERING ATRIAL PACEMAKERC62240Wandering atrial pacemakerA condition characterized by the site of origin of impulses, controlling the heart rate, changing within the atria, including the sinus node. Variations within P waves and PR intervals occur and an irregular rate of impulse formation is observed. (NCI)Wandering Atrial Pacemaker
SINUS ARREST/PAUSEC62242Sinus arrest/pauseA failure of impulse formation in the sinus node. Sinus arrest is indistinguishable from third degree sinoatrial exit block on the standard ECG. (NCI)Sinus Arrest
SINUS NODE DYSFUNCTION (BRADYCARDIA)C62243Sinus node dysfunction (bradycardia)A derangement in the normal functioning of the sinoatrial node. Typically, SA node dysfunction is manifest as sinoatrial exit block or sinus arrest, but may present as an absolute or relative bradycardia in the presence of a stressor. It may be associated with bradycardia-tachycardia syndrome. (NCI)Sinus Node Dysfunction
SICK SINUS SYNDROMEC62244Sick sinus syndromeA constellation of signs and symptoms which may include syncope, fatigue, dizziness, and alternating periods of bradycardia and atrial tachycardia, which is caused by sinoatrial node dysfunction. (NCI)Sick Sinus Syndrome
ECTOPIC ATRIAL RHYTHMC62245Ectopic atrial rhythmA cardiac rhythm resulting from either an abnormal electrical focus in the atria or intra-atrial reentry. Atrial ectopic beats (AEB) refer to a contraction of the upper heart chamber which occurs before it would be expected. Atrial ectopic beats are also known as premature atrial beats, premature atrial complex (PAC), or atrial extrasystole. (NCI)Ectopic Atrial Rhythm
SHORT PR INTERVALC62246Short PR intervalA PR interval of less than 0.12 seconds. (NCI)Short PR Interval
PR PROLONGATIONC62247PR prolongationA PR interval of more than 0.20 seconds in adults. (NCI)Prolonged PR Interval
ISORHYTHMIC DISSOCIATIONC62248Isorhythmic dissociationA type of atrioventricular dissociation characterized by atria and ventricles beating at similar rates, although independently. (NCI)Isorhythmic Atrioventricular Dissociation
PAROXYSMAL AV BLOCKC62250Paroxysmal AV blockSudden onset AV block, often associated with preexisting conduction disorders. (NCI)Paroxysmal Atrioventricular Block
INAPPROPRIATE SINUS TACHYCARDIAC62253Inappropriate sinus tachycardiaInappropriate sinus tachycardia (IST) is a rare form of supraventricular tachycardia involving the sinus node, in which a patient has an abnormally high heart rate, occurring both at rest and in response to stressors (such as physical activity). (NCI)Inappropriate Sinus Tachycardia
PREMATURE VENTRICULAR COMPLEXC62256PVCEctopic impulses originating in the ventricles. (NCI)Ventricular Premature Complex
PREMATURE ATRIAL COMPLEXESC62257Premature atrial complexesEctopic impulses originating in the atria. (NCI)Atrial Premature Complex
DELTA WAVEC62258Delta waveAn initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic EKG pattern is typically seen in Wolff-Parkinson-White syndrome. (NCI)EKG Delta Wave
VENTRICULAR COUPLETC62259Ventricular coupletTwo sequential ventricular premature complexes. An otherwise normal finding, but possibly indicative of electrical heart disease particularly in comparison with a single ventricular premature complexes. (NCI)Ventricular Couplet
AV RE-ENTRANT TACHYCARDIAC62261AV re-entrant tachycardiaA supraventricular tachycardia due to reentry along a circuit including a concealed AV nodal bypass tract. This tachycardia circuit proceeds in an antegrade fashion through the AV node and then is conducted retrograde through the bypass tract into the atria. (NCI)Atrioventricular Reentrant Tachycardia
ACCELERATED IDIOVENTRICULAR RHYTHMC62266Accelerated idioventricular rhythmThe term accelerated idioventricular rhythm describes an ectopic ventricular rhythm with 3 or more consecutive ventricular premature beats with a rate faster than the normal ventricular intrinsic escape rate of 30 to 40 beats per minute, but slower than ventricular tachycardia. Accelerated idioventricular rhythm differs from ventricular tachycardia by additional features such as the onset with a long coupling interval and the end by a gradual decrease of the ventricular rate or increase of the sinus rate. (NCI)Accelerated Idioventricular Rhythm
LEFT ANTERIOR FASCICULAR BLOCKC62267Left anterior fascicular blockAn impairment of transmission of the cardiac electrical impulse along the fibers of the left anterior fascicle. In left anterior fascicular block (LAFB) the posteroinferior regions of the left ventricular endocardium are activated abnormally before the anterosuperior left ventricular area. After emerging from the posteroinferior division of the left bundle branch, the impulse first propagates in an inferior, rightward, and usually anterior direction for a short period of time. This orientation is responsible for the small Q waves in leads 1 and aVL and for the R waves in leads II, III, and aVF. (NCI)Left Anterior Fascicular Block
LEFT POSTERIOR FASCICULAR BLOCKC62268Left posterior fascicular blockAn impairment of transmission of the cardiac electrical impulse along the fibers of the left posterior fascicle. In pure left posterior fascicular block (LPFB), the impulse emerges from the unblocked anterosuperior division, thus producing small q waves in leads II, III, and aVF. Thereafter, the impulse moves through the electrically predominant left ventricle in an inferior and rightward direction, thus explaining the S waves in leads I and aVL as well as the R waves in leads II, III, and aVF. (NCI)Left Posterior Fascicular Block
LEFT BUNDLE BRANCH BLOCKC62269Left bundle branch blockAn impairment of transmission of the cardiac electrical impulse along the fibers of the left main bundle branch, or both the left anterior fascicle and left posterior fascicle. This conduction disturbance is characterized by wide (greater than 0.11s) QRS complexes. The diagnostic criteria consist of prolongation of the QRS complexes (over 0.11s) with neither a Q wave nor an S wave in lead V1 and in the properly placed V6. A wide R wave with a notch on its top (plateau) is seen in these leads. In hearts with an electrical (and anatomic) vertical position a small Q wave may be seen in AVL in the absence of MI. Right chest lead V1 may or may not show an initial R wave, but the latter should be present in lead V2. (NCI)Left Bundle Branch Block
RIGHT BUNDLE BRANCH BLOCKC62270Right Bundle Branch BlockAn impairment of transmission of the cardiac electrical impulse along the fibers of the right bundle branch. A "complete RBBB pattern" (with QRS duration > 0.11s) does not necessarily reflect the existence of a total conduction block in the right branch. This pattern only indicates that the entire or major parts of both ventricles are activated by the impulse emerging from the left branch. Thus, a significant degree of conduction delay ("high-grade" or "incomplete RBBB") can produce a similar pattern. (NCI)Right Bundle Branch Block
INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFICC62271Intraventricular conduction delay, nonspecificA delay in transmission of cardiac electrical impulses in the His-Purkinje system, diagnosed when the QRS is modestly prolonged (< 120 msec) and the QRS pattern and axis are not typical of a hemiblock. The conduction delay is considered to occur beyond the Purkinje's myocardial gates and arises from slow cell-to-cell conduction. The phenomenon is common in patients with acute MI. (NCI)Nonspecific Intraventricular Conduction Delay
ST SEGMENT ABNORMALITYC71026ST segment abnormalityAn electrocardiographic finding of the ST segment elevation or depression which is not indicative of ischemia or infarction. (NCI)ST Segment Abnormality
ST DEPRESSIONC71027ST depressionAn electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI)ST Depression
ST ELEVATIONC71028ST elevationAn electrocardiographic finding of ST segment elevation above the baseline. (NCI)ST Elevation
ST ELEVATION PERICARDITISC71029ST elevation pericarditisAn electrocardiographic finding of ST changes consistent with pericarditis. (NCI)ST Elevation Pericarditis
J POINT ELEVATIONC71030J point elevationElevation of the J point above the baseline; the J point represents the end of ventricular depolarization and located at the terminus of the QRS complex. (NCI)J Point Elevation
NON-SPECIFIC ST-T CHANGESC71031Non-specific ST-T changesAn electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI)Non-Specific ST-T Changes
NOTCHED T-WAVESC71032Notched T-wavesAny depression occurring in a positive t wave. (NCI)Notched T-Waves
POOR R WAVE PROGRESSIONC71033Poor R Wave ProgressionLack of progression of R wave height across precordial leads. (NCI)Poor R Wave Progression
PROLONGED QTC71034Prolonged QTA QT interval that is prolonged. The length of the QT interval varies with the heart rate. (NCI)Prolonged QT Interval
ELECTRICAL ALTERNANSC71035Electrical alternansAn electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI)Electrical Alternans
SINOATRIAL EXIT BLOCKC50553Sinoatrial exit blockA blockage of electrical conduction within the sinoatrial node resulting in the failure of impulse transmission from the sinoatrial node. (NCI)Sinoatrial Node Exit Block
ATRIAL ENLARGEMENTC71039Atrial EnlargementAn electrocardiographic finding which comprises left, right or bilateral atrial enlargement. (NCI)EKG Finding Atrial Enlargement
LEFT ATRIAL ENLARGEMENTC71040P-mitraleAn electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI)P-mitrale
RIGHT ATRIAL ABNORMALITYC71041P-pulmonaleAn electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI)P-pulmonale
ECTOPIC VENTRICULAR RHYTHMC71042Ectopic ventricular rhythmA cardiac rhythm resulting from either an abnormal electrical focus in the ventricle. Ventricular ectopic beats (VEB) refer to a contraction of the lower heart chamber which occurs before it would be expected. Ventricular ectopic beats are also known as premature ventricular beats, premature ventricular complex (PVC), or ventricular extrasystole. (NCI)Ectopic Ventricular Rhythm
ECTOPIC SUPRAVENTRICULAR RHYTHMC71043Ectopic supraventricular rhythmAn electrocardiographic finding of a rhythm originating at a site other than the sinoatrial node, which is also above the atrioventricular node. (NCI)Ectopic Supraventricular Rhythm
2:1 AV BLOCKC710442:1 AV blockA electrocardiographic finding of an electrical phenomenon in which the ratio of electrical impulse generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. (NCI)2:1 Atrioventricular Block
ATRIOVENTRICULAR DISSOCIATIONC71045Atrioventricular dissociationAn electrocardiographic finding in which the electrical activity of the atria and ventricles are causally independent of one another. (NCI)Atrioventricular Dissociation
BIFASCICULAR BLOCKC71046Bifascicular blockAn electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI)Bifascicular Block
INCOMPLETE LEFT BUNDLE BRANCH BLOCKC71047Incomplete left bundle branch blockAn partial impairment of transmission of the cardiac electrical impulse along the fibers of the left bundle branch. (NCI)Incomplete Left Bundle Branch Block
INCOMPLETE RIGHT BUNDLE BRANCH BLOCKC71048Incomplete right bundle branch blockVarious mechanisms may result in a pattern showing an incomplete right bundle branch block (RBBB). These include different degrees of conduction delay through the main trunk of the right bundle branch; increased conduction time through an elongated right bundle branch; diffuse Purkinje-myocardial delay due to right ventricular stretch or dilatation; surgical trauma or disease-related interruption of the major ramifications of the right branch (distal RBBB or right fascicular blocks); congenital variations of the distribution of the major ramifications resulting in a slight delay in the activation of the crista supraventricularis. (NCI)Incomplete Right Bundle Branch Block
INCOMPLETE BUNDLE BRANCH BLOCKC71049Incomplete bundle branch blockAn electrocardiographic finding of bundle branch block which does not meet the criteria for a more specific bundle branch block. (NCI)Incomplete Bundle Branch Block
MULTIFOCAL ATRIAL TACHYCARDIAC71050Multifocal atrial tachycardiaAn electrocardiographic finding in which the electrical axis of the p wave is variable and the rate is greater than 100 beats per minute. To meet criteria for multifocal atrial tachycardia, the p wave must exhibit three distinct morphologies on the rhythm strip. (NCI)Multifocal Atrial Tachycardia
JUNCTIONAL RHYTHMC71051Junctional rhythmAn electrocardiographic finding in which the pacer of the heart is located in the AV junction, normally presenting with a narrow QRS complex and a rate of 60-100 beats per minute. (NCI)Junctional Rhythm
SUSTAINED VENTRICULAR TACHYCARDIAC71052Sustained ventricular tachycardiaAn electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI)Sustained Ventricular Tachycardia
NON-SUSTAINED VENTRICULAR TACHYCARDIAC71053Non-sustained ventricular tachycardiaAn electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI)Non-Sustained Ventricular Tachycardia
BIGEMINYC71054BigeminyAn electrocardiographic finding of a normal QRS followed by a premature ventricular contraction; a rhythmic pairing of normal and abnormal beats originating in the ventricles in a 1-1 ratio. (NCI)Bigeminy
TRIGEMINYC71055TrigeminyAn electrocardiographic finding of normal QRS followed by a premature ventricular contraction; a rhythmic pairing of normal and abnormal beats originating from the ventricles in a 1-2 ratio. (NCI)Trigeminy
VENTRICULAR TACHYCARDIA STORMC71056Ventricular tachycardia stormMultiple, temporally related, episodes of ventricular tachycardia or fibrillation, occurring three or more times in a 24 hour period. (NCI)Ventricular Tachycardia Storm
ADENOSINE-SENSITIVE VENTRICULAR TACHYCARDIAC71057Adenosine-sensitive ventricular tachycardiaA condition that occurs as a result of cAMP-mediated triggered activity and typically originates from the right ventricular outflow tract (RVOT). This type of tachycardia occurs in patients with apparently normal hearts. (NCI)Adenosine-Sensitive Ventricular Tachycardia
VERAPAMIL-SENSITIVE VENTRICULAR TACHYCARDIAC71058Verapamil-sensitive ventricular tachycardiaA well-recognized condition that is believed to result from triggered activity. Despite its uniform response to verapamil, however, this uncommon form of ventricular tachycardia may not be as homogeneous a condition as first believed. (NCI)Verapamil-Sensitive Ventricular Tachycardia
VENTRICULAR ARRHYTHMIA ASSOCIATED WITH BRUGADA SYNDROMEC71059Ventricular arrhythmia associated with Brugada syndromeA condition characterized by a pattern of right bundle branch block (RBBB) and ST-segment elevation within electrocardiogram (ECG) leads V1-V3 . This pattern emerges as a result of a defect in ion channel genes, resulting in abnormal electrophysiological activity in the right ventricle and a propensity to malignant tachyarrhythmias. (NCI)Brugada Syndrome
VENTRICULAR ARRHYTHMIA ASSOCIATED WITH SHORT QT SYNDROMEC71060Ventricular arrhythmia associated with short QT syndromeVentricular tachyarrhythmias occurring in association with short QT syndrome. (NCI)Short QT Syndrome
FASCICULAR TACHYCARDIAC71061Fascicular tachycardiaA distinct subgroup of idiopathic ventricular tachycardia (VT) that may be confused with either typical VT or supraventricular tachycardia (SVT). It is characterized by the absence of structural heart disease and classic electrocardiographic and electrophysiological features. It originates from the region of the posterior fascicle (or occasionally the anterior fascicle) of the left bundle branch and is partly propagated by the His-Purkinje network. It therefore produces QRS complexes of relatively short duration (0.11-0.14)s. (NCI)Fascicular Tachycardia
BUNDLE BRANCH REENTRANT TACHYCARDIAC71062Bundle branch reentrant tachycardiaAn uncommon form of ventricular tachycardia (VT) incorporating both bundle branches into the reentry circuit. Surface electrocardiogram (ECG) of sinus rhythm (SR) characteristically shows intraventricular conduction defects. Patients typically present with presyncope, syncope or sudden death because of VT with fast rates frequently above 200 beats per minute. The QRS morphology during VT is a typical bundle branch block pattern, usually left bundle branch block, and may be identical to that in SR. (NCI)Bundle Branch Re-Entrant Ventricular Tachycardia
IDIOPATHIC RIGHT BUNDLE BRANCH BLOCK VENTRICULAR TACHYCARDIAC71063Idiopathic right bundle branch block ventricular tachycardiaIdiopathic ventricular tachycardia (VT) is a type of ventricular tachycardia occurring unrelated to any organic cardiac disease. The abnormality is probably congenital, be it a focus of abnormal automaticity or myocardial tissue that can sustain re-entry. The clinical presentation for idiopathic VT can be very much like a paroxysmal supraventricular tachycardia. That is, most patients are generally younger without overt cardiac disease and present with paroxysmal palpitations. Idiopathic ventricular tachycardia is not generally life-threatening. (NCI)Idiopathic Right Bundle Branch Block
OUTFLOW TRACT VENTRICULAR TACHYCARDIAC71064Outflow tract ventricular tachycardiaRight ventricular outflow tract tachycardia (RVOT) is the most common with a female predominance. It is often exercise induced or enhanced. The site of origin is the right ventricular outflow tract and hence the electrocardiographic appearance is that of left bundle branch block and inferior axis. The mechanism is thought to be abnormal automaticity that is sensitive to adenosine. (NCI)Right Ventricular Outflow Tract Tachycardia
ACUTE ANTERIOR WALL MIC71065Acute Anterior Wall Myocardial InfarctionElectrocardiographic finding showing a current of injury in leads corresponding to the anatomic region of the anterior wall of the heart. (NCI)Acute Anterior Wall Myocardial Infarction
ACUTE INFERIOR WALL MIC71066Acute Inferior Wall Myocardial InfarctionElectrocardiographic finding showing a current of injury in leads corresponding to the anatomic region of the inferior wall of the heart. (NCI)Acute Inferior Wall Myocardial Infarction
ACUTE LATERAL WALL MIC71067Acute Lateral Wall Myocardial InfarctionElectrocardiographic finding showing a current of injury in leads corresponding to the anatomic region of the lateral wall of the heart. (NCI)Acute Lateral Wall Myocardial Infarction
ACUTE POSTERIOR WALL MIC71068Acute Posterior Wall Myocardial InfarctionElectrocardiographic finding showing a current of injury in leads corresponding to the anatomic region of the posterior wall of the heart. (NCI)Acute Posterior Wall Myocardial Infarction
ANTERIOR WALL MYOCARDIAL INFARCTIONC71069Anterior Wall Myocardial InfarctionElectrocardiographic finding showing an injury in leads corresponding to the anatomic region of the anterior wall of the heart. (NCI)Anterior Wall Myocardial Infarction
INFERIOR WALL MYOCARDIAL INFARCTIONC71070Inferior Wall Myocardial InfarctionElectrocardiographic finding showing an injury in leads corresponding to the anatomic region of the inferior wall of the heart. (NCI)Inferior Wall Myocardial Infarction
INTRAATRIAL CONDUCTION DELAYC71073Intraatrial Conduction DelayA delay in impulse propagation through the atria. (NCI)Intra-Atrial Conduction Delay
JUNCTIONAL BRADYCARDIAC71074Junctional bradycardiaAn electrocardiographic finding in which the pacer of the heart is located in the AV junction, normally presenting with a narrow QRS complex at a rate less than 60 beats per minute. (NCI)Junctional Bradycardia
LATERAL WALL MYOCARDIAL INFARCTIONC71075Lateral Wall Myocardial InfarctionElectrocardiographic finding showing an injury in leads corresponding to the anatomic region of the lateral wall of the heart. (NCI)Lateral Wall Myocardial Infarction
LEFT VENTRICULAR HYPERTROPHYC71076Left Ventricular HypertrophyElectrocardiographic findings suggestive of a hypertrophic left ventricle. (NCI)EKG Finding Left Ventricular Hypertrophy
RIGHT VENTRICULAR HYPERTROPHYC71077Right ventricular HypertrophyElectrocardiographic findings suggestive of an enlarged right ventricle. (NCI)EKG Finding Right Ventricular Hypertrophy
LOW QRS VOLTAGEC71078Low QRS voltageAn electrocardiographic finding of a QRS amplitude less than or equal to 5mm in the limb leads or QRS amplitude less than or equal to 10mm in the precordial leads. (NCI)Low QRS Voltage
NON Q WAVE MYOCARDIAL INFARCTIONC71080Non Q Wave Myocardial InfarctionA myocardial infarction in the absence of observable Q wave abnormalities in the ECG. (NCI)Non Q Wave Myocardial Infarction
POSTERIOR WALL MYOCARDIAL INFARCTIONC71081Posterior Wall Myocardial InfarctionElectrocardiographic finding showing an injury in leads corresponding to the anatomic region of the posterior wall of the heart. (NCI)Posterior Wall Myocardial Infarction
SEPTAL MYOCARDIAL INFARCTIONC71082Septal myocardial infarctionElectrocardiographic findings suggesting an infarction in the anatomic location of the cardiac septum. (NCI)Septal Myocardial Infarction
T WAVE ABNORMALITYC71083T wave abnormalityAn electrocardiographic finding of a T wave which appears peaked, inverted, flattened or biphasic. (NCI)T Wave Abnormality
VENTRICULAR HYPERTROPHYC71084Ventricular HypertrophyElectrocardiographic findings suggestive of enlarged cardiac ventricles. (NCI)Ventricular Hypertrophy
T WAVE INVERSIONC71085T Wave InversionAn electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI)T Wave Inversion
T WAVE PEAKEDC71086T wave peakedAn electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI)T Wave Peaked
T WAVES BIPHASICC71087T waves biphasicAn electrocardiographic finding in which the T wave is asymmetric. (NCI)T Waves Biphasic
T WAVES FLATC71088T waves flatAn electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI)T Waves Flat
U WAVESC71089U wavesAn electrocardiographic finding of a small hump following the T wave occurring during the final phase of Purkinje repolarization. (NCI)U Waves
WIDE QRS TACHYCARDIAC71090Wide QRS tachycardiaAn electrocardiographic finding of a QRS complex. (NCI)Wide QRS Tachycardia
Q AXIS, LEFT AXIS DEVIATIONC71094Q Axis, Left axis deviationQ axis from -30 to -90 degrees. (NCI)Q Axis Left Axis Deviation
Q AXIS, RIGHT AXIS DEVIATIONC71095Q Axis, Right axis deviationQ axis from +90 to +180 degrees. (NCI)Q Axis Right Axis Deviation
QTCB PROLONGATION >500 MSECC71096QTcB prolongation >500 msecCorrected QT interval longer than 500 msec, in accordance with Bazett's correction formula. (NCI)QTcB Prolongation Greater Than 500 msec
QTCF PROLONGATION >500 MSECC71097QTcF prolongation >500 msecCorrected QT interval greater than 500 msec, in accordance with Fridericia's correction formula. (NCI)QTcF Prolongation Greater Than 500 msec
AV MOBITZ IC83811AV Mobitz IIntermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse.AV Mobitz I
AV MOBITZ IIC83812AV Mobitz IIIntermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse.AV Mobitz II
PACED RHYTHMC88140Paced Rhythm;Atrial and/or Ventricular Paced RhythmAn electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker.Paced Rhythm
BORDERLINE QTcBC92228Borderline QTcBAn electrocardiographic finding in which the QTcB is approximately 430-470 msec. There is variation among subpopulations.Borderline QTcB
BORDERLINE QTcFC92229Borderline QTcFAn electrocardiographic finding in which the QTcF is approximately 430-470 msec. There is variation among subpopulations.Borderline QTcF
EARLY R WAVE PROGRESSIONC92230Early R Wave ProgressionAn electrocardiographic finding in which the amplitude of the R wave is abnormally increased in the anterior precordial leads.Early R Wave Progression
LEFT VENTRICULAR CONDUCTION DELAYC92231Left Ventricular Conduction DelayAn electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired.Left Ventricular Conduction Delay
PACED ATRIAL AND VENTRICULAR RHYTHMC92232Paced Atrial And Ventricular RhythmAn electrocardiographic finding in which both the atrial and ventricular rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker.Paced Atrial And Ventricular Rhythm
PACED ATRIAL RHYTHMC92233Paced Atrial RhythmAn electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker.Paced Atrial Rhythm
PACED VENTRICULAR RHYTHMC92234Paced Ventricular RhythmAn electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker.Paced Ventricular Rhythm
RIGHT VENTRICULAR CONDUCTION DELAYC92235Right Ventricular Conduction Delay;Right Ventricular DelayAn electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired.Right Ventricular Conduction Delay
RSR PRIMEC92227RSR'An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave.RSR'
BRADYCARDIAC37920BradycardiaNon-sinus origin slow heart rate.Bradycardia
P WAVE ABNORMALITYC90430P Wave AbnormalityAn electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI)P Wave Abnormality
P WAVE NOTCHEDC90431P Wave NotchedP waves with two peaks longer in duration than normal and amplitude greater than normal. (NCI)P Wave Notched
PAROXYSMAL VENTRICULAR TACHYCARDIAC34902Paroxysmal Ventricular TachycardiaAn episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI)Paroxysmal Ventricular Tachycardia
QRS COMPLEX ABNORMALITYC90440QRS Complex AbnormalityAn electrocardiographic finding for the QRS complex that is atypical either for the shape, duration, amplitude, axis or polarity. (NCI)QRS Complex Abnormality
QRS COMPLEX ABSENTC90441QRS Complex AbsentA disturbance in the depolarization of the ventricular myocardium which leads to an absence of the QRS complex in the electrocardiogram tracing. (NCI)QRS Complex Absent
R WAVE ABNORMALITYC90443R Wave AbnormalityAn abnormal R wave that is part of the QRS complex in an electrocardiographic recording, which occurs due to a disturbance in the depolarization mechanism of the ventricular myocardium. (NCI)R Wave Abnormality
R WAVE NOTCHEDC90444R Wave NotchedAn R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI)R Wave Notched
RESPIRATORY SINUS ARRHYTHMIAC90450Respiratory Sinus ArrhythmiaThe inherent change of a subject's heart rate associated with each excursion of breath, which can be traced in an electrocardiographic recording. (NCI)Respiratory Sinus Arrhythmia
S WAVE ABNORMALITYC90451S Wave AbnormalityAn abnormal S wave that is part of the QRS complex in an electrocardiographic recording, which occurs due to a disturbance in the depolarization of the ventricular myocardium. (NCI)S Wave Abnormality
TACHYCARDIAC38029TachycardiaAn abnormally rapid heartbeat, usually applied to a heart rate above 100 per minute.Tachycardia
VENTRICULAR ESCAPE BEATC90483Ventricular Escape BeatA compensatory ectopic beat that occurs in the ventricle after a pause in the ventricular rhythm, which is due to an absence in electrical activity to the ventricles. (NCI)Ventricular Escape Beat
Back to top
CL.C71153.EGTESTCDECG Test Code
(EGTESTCD)
text
Extensible: Yes
C71153ECG Test CodeTerminology codelist used with ECG Tests within CDISC.CDISC SDTM ECG Test Terminology by Code
HRMAXC39779Summary (Max) Heart RateThe minimum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Maximum Heart Rate
PRMEANC62086Summary (Mean) PR DurationThe average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Mean PR Duration
QRSDURC62087Summary (Mean) QRS DurationThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI)EKG Mean QRS Duration
QTMEANC62089Summary (Mean) QT DurationThe average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)EKG Mean QT Duration
RRMEANC62090Summary (Mean) RR DurationThe average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)EKG Mean RR Duration
RRMINC62093Summary (Min) RR DurationThe minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)EKG Minimum RR Duration
RRMAXC62094Summary (Max) RR DurationThe maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)EKG Maximum RR Duration
HRMEANC62095Summary (Mean) Heart RateThe average (mean) number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Mean Heart Rate
HRMINC62096Summary (Min) Heart RateThe maximum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Minimum Heart Rate
QTCBC62112QTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcB-Bazett's Correction Formula
QTCFC62113QTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcF-Fridericia's Correction Formula
QTCLCC62114QTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcLC-Linear Correction Formula
JTMEANC62115Summary (Mean) JT IntervalThe average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Mean JT Duration
JTMINC62116Summary (Min) JT IntervalThe minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Minimum JT Duration
JTMAXC62117Summary (Max) JT IntervalThe maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Maximum JT Duration
JTCBC62118JTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcB-Bazett's Correction Formula
JTCFC62119JTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcF-Fridericia's Correction Formula
JTCLCC62120JTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI)JTcLC-Linear Correction Formula
PAXISC62121Summary (Mean) P AxisThe mean (average) direction (range -180 degrees to 180 degrees) of the electrical potential generated by atrial depolarization in a particular plane (usually the frontal plane). (NCI)EKG Mean P Axis
PWAVEDURC62123Summary (Mean) P Wave DurationThe average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)EKG Mean P Wave Duration
PWAVEHTC62124Summary (Mean) P Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI)EKG Mean P Wave Height
PRMINC62125Summary (Min) PR DurationThe minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Minimum PR Duration
PRMAXC62131Summary (Max) PR DurationThe maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Maximum PR Duration
QRSAXISC62132Summary (Mean) QRS AxisThe mean (average) direction of the electrical potential generated by ventricular depolarization. (NCI)Mean QRS Axis
QTMINC62133Summary (Min) QT DurationThe minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Minimum QT Duration
QTMAXC62135Summary (Max) QT DurationThe maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)EKG Maximum QT Duration
RWAVEAMPC62136Summary (Mean) R Wave AmplitudeThe average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)EKG Mean R Wave Amplitude
SWAVEAMPC62137Summary (Mean) S Wave AmplitudeThe average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)EKG Mean S Wave Amplitude
RSAMPC62144Summary (Mean) R+S AmplitudeThe average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)EKG Mean R+S Amplitude
STSEGDURC62145Summary (Mean) ST Segment DurationThe duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave. (NCI)EKG Mean ST Segment Duration
TAXISC62146Summary (Mean) T Wave AxisThe mean (average) direction of the electrical potential generated by ventricular repolarization. (NCI)EKG Mean T Wave Axis
TWAVEDURC62147Summary (Mean) T Wave DurationThe average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI)EKG Mean T Wave Duration
TWAVAREAC62148Summary (Mean) T Wave AreaThe average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)EKG Mean T Wave Area
TWAVEHTC62149Summary (Mean) T Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)EKG Mean T Wave Height
VRMEANC62152Summary (Mean) Ventricular RateThe average (mean) number of cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Mean Ventricular Heart Rate
VRMINC62153Summary (Min) Ventricular RateThe minimum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Minimum Ventricular Heart Rate
VRMAXC62154Summary (Max) Ventricular RateThe maximum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Maximum Ventricular Heart Rate
STDVMEANC62155Summary (Mean) ST DeviationThe average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Mean ST Deviation
STDVMINC62156Summary (Min) ST DeviationThe minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Minimum ST Deviation
STDVMAXC62157Summary (Max) ST DeviationThe maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Maximum ST Deviation
STELMEANC62158Summary (Mean) ST ElevationThe average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Mean ST Segment Elevation
STELMINC62159Summary (Min) ST ElevationThe minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Minimum ST Segment Elevation
STELMAXC62160Summary (Max) ST ElevationThe maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Maximum ST Segment Elevation
STDPMEANC62161Summary (Mean) ST DepressionThe average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Mean ST Segment Depression
STDPMINC62162Summary (Min) ST DepressionThe minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Minimum ST Segment Depression
STDPMAXC62163Summary (Max) ST DepressionThe maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Maximum ST Segment Depression
QTCVC90442QTcV - Van de Water's Correction FormulaA mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI)QTcV Van de Water's Correction Formula
INTPC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
QRSDURVPC100390QRS Duration Ventricular PacedThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.EKG Mean QRS Duration Ventricular Paced
QTCC100391QT Interval, CorrectedThe time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.Corrected QT Interval
Back to top
CL.C71152.EGTESTECG Test Name
(EGTEST)
text
Extensible: Yes
C71152ECG Test NameTerminology codelist used with ECG Test Names within CDISC.CDISC SDTM ECG Test Name Terminology
Summary (Max) Heart RateC39779Summary (Max) Heart RateThe minimum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Maximum Heart Rate
Summary (Mean) PR DurationC62086Summary (Mean) PR DurationThe average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Mean PR Duration
Summary (Mean) QRS DurationC62087Summary (Mean) QRS DurationThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI)EKG Mean QRS Duration
Summary (Mean) QT DurationC62089Summary (Mean) QT DurationThe average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)EKG Mean QT Duration
Summary (Mean) RR DurationC62090Summary (Mean) RR DurationThe average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)EKG Mean RR Duration
Summary (Min) RR DurationC62093Summary (Min) RR DurationThe minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)EKG Minimum RR Duration
Summary (Max) RR DurationC62094Summary (Max) RR DurationThe maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)EKG Maximum RR Duration
Summary (Mean) Heart RateC62095Summary (Mean) Heart RateThe average (mean) number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Mean Heart Rate
Summary (Min) Heart RateC62096Summary (Min) Heart RateThe maximum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)Minimum Heart Rate
QTcB - Bazett's Correction FormulaC62112QTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcB-Bazett's Correction Formula
QTcF - Fridericia's Correction FormulaC62113QTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcF-Fridericia's Correction Formula
QTcLC - Linear Correction FormulaC62114QTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcLC-Linear Correction Formula
Summary (Mean) JT IntervalC62115Summary (Mean) JT IntervalThe average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Mean JT Duration
Summary (Min) JT IntervalC62116Summary (Min) JT IntervalThe minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Minimum JT Duration
Summary (Max) JT IntervalC62117Summary (Max) JT IntervalThe maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)EKG Maximum JT Duration
JTcB - Bazett's Correction FormulaC62118JTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcB-Bazett's Correction Formula
JTcF - Fridericia's Correction FormulaC62119JTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcF-Fridericia's Correction Formula
JTcLC - Linear Correction FormulaC62120JTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI)JTcLC-Linear Correction Formula
Summary (Mean) P AxisC62121Summary (Mean) P AxisThe mean (average) direction (range -180 degrees to 180 degrees) of the electrical potential generated by atrial depolarization in a particular plane (usually the frontal plane). (NCI)EKG Mean P Axis
Summary (Mean) P Wave DurationC62123Summary (Mean) P Wave DurationThe average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)EKG Mean P Wave Duration
Summary (Mean) P Wave HeightC62124Summary (Mean) P Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI)EKG Mean P Wave Height
Summary (Min) PR DurationC62125Summary (Min) PR DurationThe minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Minimum PR Duration
Summary (Max) PR DurationC62131Summary (Max) PR DurationThe maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)EKG Maximum PR Duration
Summary (Mean) QRS AxisC62132Summary (Mean) QRS AxisThe mean (average) direction of the electrical potential generated by ventricular depolarization. (NCI)Mean QRS Axis
Summary (Min) QT DurationC62133Summary (Min) QT DurationThe minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Minimum QT Duration
Summary (Max) QT DurationC62135Summary (Max) QT DurationThe maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)EKG Maximum QT Duration
Summary (Mean) R Wave AmplitudeC62136Summary (Mean) R Wave AmplitudeThe average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)EKG Mean R Wave Amplitude
Summary (Mean) S Wave AmplitudeC62137Summary (Mean) S Wave AmplitudeThe average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)EKG Mean S Wave Amplitude
Summary (Mean) R+S AmplitudeC62144Summary (Mean) R+S AmplitudeThe average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)EKG Mean R+S Amplitude
Summary (Mean) ST Segment DurationC62145Summary (Mean) ST Segment DurationThe average (mean) duration (time) from the end of ventricular depolarization (end of QRS complex) to the end of ventricular repolarization (end of the T wave). (NCI)EKG Mean ST Segment Duration
Summary (Mean) T Wave AxisC62146Summary (Mean) T Wave AxisThe mean (average) direction of the electrical potential generated by ventricular repolarization. (NCI)EKG Mean T Wave Axis
Summary (Mean) T Wave DurationC62147Summary (Mean) T Wave DurationThe average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI)EKG Mean T Wave Duration
Summary (Mean) T Wave AreaC62148Summary (Mean) T Wave AreaThe average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)EKG Mean T Wave Area
Summary (Mean) T Wave HeightC62149Summary (Mean) T Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)EKG Mean T Wave Height
Summary (Mean) Ventricular RateC62152Summary (Mean) Ventricular RateThe average (mean) number of cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Mean Ventricular Heart Rate
Summary (Min) Ventricular RateC62153Summary (Min) Ventricular RateThe minimum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Minimum Ventricular Heart Rate
Summary (Max) Ventricular RateC62154Summary (Max) Ventricular RateThe maximum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)Maximum Ventricular Heart Rate
Summary (Mean) ST DeviationC62155Summary (Mean) ST DeviationThe average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Mean ST Deviation
Summary (Min) ST DeviationC62156Summary (Min) ST DeviationThe minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Minimum ST Deviation
Summary (Max) ST DeviationC62157Summary (Max) ST DeviationThe maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)EKG Maximum ST Deviation
Summary (Mean) ST ElevationC62158Summary (Mean) ST ElevationThe average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Mean ST Segment Elevation
Summary (Min) ST ElevationC62159Summary (Min) ST ElevationThe minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Minimum ST Segment Elevation
Summary (Max) ST ElevationC62160Summary (Max) ST ElevationThe maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)EKG Maximum ST Segment Elevation
Summary (Mean) ST DepressionC62161Summary (Mean) ST DepressionThe average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Mean ST Segment Depression
Summary (Min) ST DepressionC62162Summary (Min) ST DepressionThe minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Minimum ST Segment Depression
Summary (Max) ST DepressionC62163Summary (Max) ST DepressionThe maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)EKG Maximum ST Segment Depression
QTcV - Van de Water's Correction FormulaC90442QTcV - Van de Water's Correction FormulaA mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI)QTcV Van de Water's Correction Formula
InterpretationC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
QRS Duration Ventricular PacedC100390QRS Duration Ventricular PacedThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.EKG Mean QRS Duration Ventricular Paced
QT Interval, CorrectedC100391QT Interval, CorrectedThe time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.Corrected QT Interval
Back to top
CL.C71151.EGMETHODECG Test Method
(EGMETHOD)
text
Extensible: Yes
C71151ECG Test MethodTerminology codelist used with ECG Test Methods within CDISC.CDISC SDTM ECG Test Method Terminology
12 LEAD UNSPECIFIEDC7110112 Lead UnspecifiedAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI)12 Lead Placement Unspecified
12 LEAD STANDARDC7110212 Lead StandardAn electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven's triangle, and are represented by leads I, II, and III. Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the V leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line. (NCI)12 Lead Placement Standard
12 LEAD MASON LIKARC7110312 Lead Mason LikarAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites. (NCI)12 Lead Placement Mason Likar
12 LEAD MODIFIED MASON LIKARC7111012 Lead Modified Mason LikarAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI)12 Lead Placement Mason Likar Modified
12 LEAD SINGLE PADC7111212 Lead Single PadAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI)12 Lead Placement Chest
12 LEAD NON-STANDARDC7111412 Lead Non-StandardAn electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI)12 Lead Placement Non-Standard
STANDARD LEADS FOR BICYCLE EXERCISEC71115Standard leads for bicycle exercise. Limb leads on the back (shoulder and on the hips)Limb leads on the back (shoulder and on the hips). (NCI)Lead Placement Bicycle
12 LEAD CABRERAC7111612 Lead CabreraAn electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs. (NCI)12 Lead Placement Cabrera
STANDARD LEADS ONE INTERCOSTAL SPACE HIGHERC71117Standard leads one intercostal space higherAn electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI)Lead Placement Standard Intercostal Space Higher
FRANK LEAD SYSTEMC71118Frank lead systemAn electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, usually 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation. (NCI)Lead Placement Frank
MCFEE-PARUNGAO LEAD SYSTEMC71119McFee-Parungao lead systemAn electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field. (NCI)Lead Placement McFee-Parungao
CUBE LEAD SYSTEMC71120Cube lead systemAn electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI)Lead Placement Cube
BIPOLAR UNCORRECTED XYZ LEAD SYSTEMC71121Bipolar uncorrected XYZ lead systemAn electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin. (NCI)Lead Placement Bipolar Uncorrected XYZ
PSEUDO-ORTHOGONAL XYZ LEAD SYSTEMC71122Pseudo-orthogonal XYZ lead systemAn electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation. (NCI)Lead Placement Pseudo Orthogonal XYZ
12 LEAD EASI DOWER TRANSFORMATIONC7112312 Lead EASI Dower TransformationAn electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontal and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead. (NCI)Lead Placement EASI Dower Transformation
12 LEAD 1 LEAD MISSINGC7112512 Lead 1 Lead MissingAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI)12 Lead Placement 1 Lead Missing
STANDARD 12-LEAD AND CM5-CC5-CH5C71126Standard 12-lead and CM5-CC5-CH5An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5. (NCI)12 Lead Placement Standard And CC5-CM5-CH5
STANDARD 12-LEAD AND CC5-CM5-MLC71128Standard 12-lead and CC5-CM5-MLAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI)12 Lead Placement Standard And CC5-CM5-ML
STANDARD 12-LEAD EXTENDED RIGHTC71130Standard 12-lead extended to the right by V5R, V4R, V3RAn electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R. (NCI)12 Lead Placement Standard Extended Right
STANDARD 12-LEAD EXTENDED LEFTC71131Standard 12-lead extended to the left by V7, V8, V9An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. (NCI)12 Lead Placement Standard Extended Left
VECTORCARDIOGRAPH CORRECTEDC71092Vectorcardiograph CorrectedA recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI)Vectorcardiograph Corrected
VECTORCARDIOGRAPH UNCORRECTEDC71093Vectorcardiograph UncorrectedA recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI)Vectorcardiograph Uncorrected
6 LEAD STANDARDC903506 Lead StandardAn electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart.6 Lead Standard
10 LEAD STANDARDC9034910 Lead StandardAn electrocardiogram lead placement on the subject using a ten electrod